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Abstract 
The cerebellum is a unique and often overlooked component of the central nervous system, with a 
lobular and multi-layered structure. It consists of a dense interwoven network of interacting neurons 
and glia with only one major output; through Purkinje neuron afferent projections.  Upwards of 80% 
of the cells in the cerebellum are cerebellar granule neurons (CGNs). CGNs arise from highly 
proliferative, MATH1+ progenitors (CGNPs) in the embryonic brain, found in a germinal region 
called the rhombic lip (RL). RL progenitors respond to mitogenic signals and cues initiated by 
transcription factors and migrate along the cerebellar anlage, forming the external granule layer 
(EGL). Mitogens such as Sonic Hedgehog (SHH), encourage these progenitors to proliferate in the 
EGL, before they differentiate and migrate inwards forming the internal granule layer (IGL). This 
migration results in eventual disintegration of the EGL early in postnatal development. One family 
of transcription factors identified to play a role in self-renewal and differentiation of stem and 
progenitor populations is the Nuclear Factor One (NFI) family. 
 
NFIA, NFIB and NFIX are expressed throughout the central nervous system (CNS) and are essential 
for normal development.  NFI-mutant mice are embryonic or postnatal lethal, with a number of 
developmental defects. In the cerebellum, loss of NFIX has been shown to cause delays in the 
development of both neurons and glia. As the cerebellum consists of almost a dozen different cell 
types, the first step of this thesis was to examine the cell-type specific expression of NFIX. 
Immunohistochemistry and co-immunofluorescence analysis revealed that NFIX is strongly 
expressed in proliferative progenitors in the RL, embryonic and postnatal EGL, as well as in post-
mitotic CGNs in the IGL. NFIX was also expressed in Bergmann glia, and GFAP expressing 
astrocytes in the IGL and white matter. NFIX was expressed in stellate and basket interneurons, as 
well as in subpopulations of unipolar brush cells, microglia and oligodendrocytes. Interestingly, 
NFIX was not expressed in Purkinje neurons, despite strong NFIX expression in the ventricular and 
nuclear transitory zone of the embryonic cerebellum. Lastly, analysis revealed the presence of four 
NFIX transcript variants in isolated CGNPs. Together these findings suggest NFIX may play an 
extensive role in cerebellar development, especially in the maturation of CGNs.  
 
Nfix-/- mice display delays in cerebellar granule neuron progenitor (CGNP) differentiation, yet the 
mechanisms behind this delay are yet to be determined. Using co-immunofluorescence staining with 
granule neuron and proliferative markers, we determined that a delay EGL differentiation is present 
at P15, with a higher number of proliferative and mitotically active CGNPs. Furthermore, in vitro 
analysis revealed increased proliferation of Nfix-/- neurospheres, compared to wild-type controls. As 
CGNPs are the cell of origin of some medulloblastomas (MB), and loss of NFIA expression has led 
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to poorer outcomes in mouse models of MB, we decided to look at NFIX expression in human MB 
cell lines. NFIX expression was markedly reduced, suggesting that NFIX is crucial for CGNP 
differentiation. Lastly, to identify mechanistic determinants of this developmental delay, we 
performed both ChIP-seq for NFIX and RNA-seq on Nfix-/- and control CGNPs at P7. Combining 
these data with a DNase I hypersensitive site dataset (accessible chromatin) and an RNA-seq dataset 
from Math1-/- CGNPs, we revealed 578 directly regulated gene targets of NFIX in CGNPs, of which 
90 were co-ordinately regulated by Math1.  One of these downstream targets was the Reelin-pathway 
scaffold protein Itsn1. We showed that like Nfix, loss of Itsn1 results in a delay in CGNP 
differentiation, potentially exacerbated Nfix-mediated manipulation of Itsn1 binding partner Dab1.  
Lastly, we also found that ITSN1 expression was downregulated in human MB cell lines. 
Collectively, this showed that NFI-mediation of downstream targets genes is a crucial in the 
regulation of CGNP differentiation,  
 
Previous analysis has shown that NFI expression overlaps in progenitor populations in the developing 
CNS, suggesting a redundant, compensatory or synergistic mechanism may direct progenitor cell 
differentiation. Indeed, using co-immunofluorescence staining we found that NFIA and X expression 
overlaps in both CGNPs, postnatal CGNs and Bergmann glia throughout postnatal development. As 
co-expression suggests the potential for an overlapping role in development, we performed RNA-seq 
in Nfiafl/fl; Math1-cre+ CGNPs, and compared this with our Nfix-/- RNA-seq dataset from the previous 
chapter, to reveal co-ordinately mis-regulated gene targets of NFIA and NFIX. Then, combining these 
data with a DNase I hypersensitive site dataset, and NFIX, NFIA and NFIB ChIP-seq datasets in P7 
CGNPs, we reveal 304 directly regulated gene targets of NFIA and NFIX, of which 283 show co-
ordinate regulation, Additionally, 282 of these contain an NFIB-associated ChIP-peak. Further 
examination of these targets using Gene Ontology reveal co-ordinate regulation of genes involved in 
nervous system development and cell differentiation, as well as a suite of other transcription factors.  
 
Collectively, this thesis presents an in-depth characterisation of both the expression and multifaceted 
roles of NFI transcription factors in the postnatal cerebellum.  
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 - Nuclear Factor One transcription factors 
and the developing cerebellum. 
  
 2 
1.1 Scope of thesis and structure 
This work conducted and constituting this thesis examines the role of the Nuclear Factor One (NFI) 
transcription factor family in the development of the mouse cerebellum. Primarily, this research 
focuses on the role of Nuclear Factor One X (Nfix) in the development of the most populous neuron 
of the cerebellum, the cerebellar granule neuron. Initially (Chapter 1), this thesis broadly reviews 
murine cerebellar development at a cellular level, and examines the role of transcription factors 
(including the Nfi family) in regulating stem and progenitor cell populations during neural 
development. Chapter 2 focuses on identifying the expression of NFIX in the embryonic and 
postnatal cerebellum of wild-type mice, in a number of neuronal and glial cell lineages. Next 
(Chapter 3), the role of Nfix in regulating the differentiation of cerebellar granule neuron precursors 
in the postnatal mouse cerebellum is explicitly examined, identifying the scaffolding protein 
Intersectin 1 (ITSN1) as a directly and co-ordinately regulated target of Nfix and the transcription 
factor Mouse Atonal Homologue 1 (Math1). The third data chapter of this thesis (Chapter 4) 
investigates co-ordinate regulation of genes in these cells by Nfia, Nfib and Nfix. Lastly in Chapter 
5, this thesis finishes by discussing how this new work expands on previous knowledge and 
repositions NFI transcription factors as central regulators of CGNP and cerebellar development. 
 3 
1.2 Aims of Chapter 1 
 
The aim of this chapter is to introduce the reader to the broad mechanisms governing both 
embryonic and postnatal development of the mouse cerebellum, at a gross morphological and 
cellular level. I aim to describe cerebellar development from two key germinal zones, the cerebellar 
ventricular zone (VZ) and the rhombic lip (RL), and introduce the different cell types that arise 
from these zones respectively; I pay particular attention to cerebellar granule neurons and their 
precursors. Next, I transition into identifying the role of transcription factors in regulating cerebellar 
development, paying particular focus to the Nuclear factor one (NFI) family. Previously, NFIs have 
been suggested to play a key role in promoting the differentiation of both stem and progenitor 
populations in the central nervous system (CNS), but this research has predominately focussed on 
other regions of the CNS such as the hippocampus, forebrain, corpus callosum and spinal cord. 
Additionally, this research is usually conducted in neural stem cells (NSCs) and glia. Thus, there is 
little known about the role of NFIs in the cerebellar progenitors or precursors, such as cerebellar 
granule neuron progenitors (CGNPs).  
 
Early research has shown that the absence of Nfix in mice leads to what appears to be a delay in the 
differentiation or development of CGNPs, from broad histological studies suggesting that like other 
regions of the brain, Nfix regulates the differentiation of these progenitors as well. But transcription 
factors are far from black and white in their function- indeed the role of NFIs themselves have been 
shown to be very cell-type specific and may change based on the cellular context or indeed the 
stage of development. To address this, I aim to direct the reader to what we already know about the 
role of NFIs in CGNPs, specifically elaborating on proposed roles of Nfix in these cells and where 
the gaps in our knowledge lie. 
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1.3 Introduction 
The cerebellum is a lobular, bi-hemispheric structure, situated inferior to the occipital and temporal 
lobes of the brain, within the posterior fossa. Historically, the cerebellum is associated with motor 
control, controlling functions such as the timing, co-ordination and precision of movement. However, 
in recent decades, the idea of the functions of the cerebellum have expanded, with prominent roles in 
cognition identified in humans (for an extensive review, see [1]). This multifaceted component of the 
brain is often overlooked in its functionality and essential role in numerous daily processes. The 
cerebellum is a largely unique structure in the brain, that it primarily operates with a ‘feed-forward’ 
processing system, with an immense multitude of inputs converging onto one primary output, moving 
in a unilateral direction [2]. Simplistically, input to the cerebellum primarily comes from mossy fibres 
that form excitatory synapses with cerebellar granule neurons (CGNs). These granule neurons then 
interact with Purkinje neurons via parallel fibres, which then in turn interact with a scarce number of 
deep cerebellar nuclei (DCN) embedded in the white matter. The cerebellum is also unique in that a 
significant proportion of its structural and morphological development occurs postnatally. Embryonic 
cerebellar development follows a program that has many elements, both in common and distinct to 
the program governing postnatal cerebellar development. Thus, to get a rounded view of cerebellar 
development, there is merit in investigating both embryonic and postnatal development 
independently. As the cerebellum is the centre of many crucial human functions, disorders and 
diseases during cellular development can have severely debilitating results, with disorders ranging 
from motor defects to devastating tumour formation [3]. Medulloblastoma, the most common primary 
paediatric brain tumour arises predominately in the cerebellum, with a substantial proportion having 
a proposed granule neuron progenitor cell of origin [4, 5]. Understanding the cell intrinsic and cell 
extrinsic mechanisms governing cerebellar development is essential if we are to better understand its 
role both in disease and as a crucial component of the brain.  
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1.3.1  Early embryonic development of the murine cerebellum 
A significant proportion of cerebellar development occurs embryonically. In the developing embryo, 
the CNS is first evident as a cluster of epithelial cells, known as the neural plate. As development 
progresses, this plate thickens and folds dorsally to form the neural tube. The neural tube can be 
separated into three sections: the prosencephalon, mesencephalon and rhombencephalon, the latter of 
which forms the hindbrain [6]. The rhombencephalon is further divided into sections, known as 
rhombomeres, numbered from R0 to R7.  Development of the pre-cerebellum is first evident in the 
mouse embryo when isthmic constriction occurs, separating the mesencephalon and the upper 
rhombomeres. Eventually, R0 and R1 will go on to develop into the cerebellum. Development of the 
early embryonic mouse cerebellum relies on the interaction of a number of different families of 
proteins, such as transcription factors, signalling proteins and growth factors [7]. For example, at 
E7.5, separation of the midbrain and hindbrain can be characterised molecularly, with expression of 
the transcription factors OTX2 and GBX2 confined to the upper and lower sides of the isthmus 
respectively [8-10]. At around E9, with the establishment of the mid-hindbrain boundary, two 
separate germinal zones form; the Rhombic Lip (RL) and the Ventricular Zone (VZ) and cerebellar 
histogenesis begins [11, 12]. The RL and VZ give rise to multiple lineages of glutamatergic and 
GABAergic neurons respectively. Both the RL and VZ cease to exist as germinal zones towards the 
end of embryogenesis (~E17.5 onwards). At around this time, the cerebellar primordium loses its 
smooth surface and begins to fold, a product of the formation of ‘anchoring centres’, Sonic Hedgehog 
(SHH) signalling and resultant CGNP proliferation [13, 14].  
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1.3.2 Structure of the postnatal and adult cerebellum 
The adult mouse cerebellum consists of three major lobes (anterior, posterior and flocculonodular), 
divided into approximately 10 lobules. It has been noted that the total number of lobules and overall 
size of the cerebellum can vary based on the genetic background of the mouse analysed [15, 16]. The 
posterior lobe can further be divided into superior and inferior subdivisions. The anterior lobe consists 
of lobules I-V, superior posterior of lobules VI, VIIa and VIIb, inferior posterior of lobes VIIIa, VIIIb 
and IX, and flocculonodular lobe X [16]. From a posterior viewpoint, the vermis runs medially 
through the cerebellum, splitting it into two separate hemispheres. Viewing a cross section sagitally 
Figure 1-1), the cerebellar cortex can be broadly broken up into roughly three-four layers; the 
molecular layer (ML), Purkinje cell layer (PCL), internal granule layer (IGL) and the external granule 
layer (EGL). The latter consists of proliferative progenitor cells and is present up until the third week 
postnatally in mice. These progenitors eventually differentiate and migrate into the IGL. Each layer 
is home to a discrete population of cells that interact with one another in discrete signalling networks. 
In the adult cerebellum the ML is home to basket and stellate interneurons, as well as the projections 
of Bergmann glia and Purkinje neurons in the layers below [17-20]. Additionally, parallel fibres from 
granule neurons in the IGL travel up through the PCL and ML towards the pial surface where they 
extend tangentially. The PCL predominately contains the soma of the PNs and Bergmann glia as well 
as Candelabrum cells, although these have only been vaguely described in the cerebellum [20-23]. 
The IGL sits below the PCL and contains a multitude of cell types including: post-mitotic cerebellar 
granule neurons, Golgi cells, Lugaro cells, unipolar brush cells, protoplasmic astrocytes and 
oligodendrocytes [21, 24-26].  Importantly, it houses ascending tracts of climbing and mossy fibres 
as well as the descending axons of Purkinjie neurons. Below the IGL is the white matter (WM) of the 
cerebellum, which contains astrocytes and Deep Cerebellar Nuclei (DCN). The latter act as the 






Figure 1-1 Sagittal cross section of the mouse cerebellum showing a simplified version of 
the cerebellar cytoarchitecture  
The cerebellar cortex can broadly be divided into three or four layers, depending on the stage of 
development. The external granule layer (EGL) contains proliferative CGNPs (light green) 
which mature and migrate through to the internal granule layer (IGL). This layer is only present 
in adolescence and is depleted by ~P16 in normal mice. During migration, mature CGNs (dark 
green) extend long parallel fibers that traverse the pial surface. The molecular layer (ML) houses 
stellate (red) and basket (orange) inhibitory interneurons which interact with Purkinje neurons 
(pink) and CGN parallel fibers (dark green). The Purkinje cell layer (PCL) houses the cell bodies 
of Purkinje neurons and Bergmann glia (dark blue), that latter which acts as a scaffold for 
migratory CGNs. Golgi cells (yellow) are inhibitory interneurons generally found in the upper 
aspects of the IGL and interact with CGN – mossy fiber (brown) synapses. Climbing fibers 
(black) extend from the inferior olivary nucleus and form excitatory synapses with PNs in the 
ML. The sole output of the cerebellum is through long descending PN axons (pink, arrow).  
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1.4 Cerebellar cellular development from the ventricular zone 
The cerebellar ventricular zone (VZ) is the primary germinal zone of GABAergic interneurons and 
DCN, Purkinje neurons and astrocytes [21, 28-31]. Cells from the ventricular zone generally follow 
an ‘inside out’ path of maturation, developing first in the ventricular zone and then in the prospective 
white matter (PWM) before migrating towards their terminal positions in the adult cerebellum. 
Progenitor cells in the VZ express the proneural bHLH transcription factors PTF1A and MASH1 
during embryogenesis [28, 29, 32]. Additionally, a subset of these progenitors expressed the paired 
homeobox transcription factor PAX2 [29, 33, 34].  
1.4.1 Golgi Cells 
Golgi cells are GABAergic inhibitory interneurons and play a chief role in the organisation of 
spatiotemporal responses in the cerebellum. Alike with other GABAergic interneurons, Golgi cells 
are born out of progenitors from the VZ and undergo final maturation in the WM, as they migrate to 
the ML [28, 35]. They provide an inhibitory input on CGNs whilst themselves receiving inhibition 
from mossy fibres, which also synapse with CGNs [36, 37]. Thus, Golgi cells form both feed forward 
and feedback inhibitory circuits that are crucial in maintaining signalling between layers of the 
cerebellum [38]. 
1.4.2 Lugaro cells  
Lugaro cells are interneurons with cell bodies located predominantly near the upper border of the 
IGL, just below the Purkinjie cell layer [39].  They are large GABAergic interneurons with two 
dendrites emerging from opposite poles of their cell body [40, 41]. Lugaro cells receive inputs from 
CGNs, Purkinje neurons, Basket Cells and Stellate cells. Their main axon extends from the proximal 
dendrite body and travels up into the ML to terminate on the dendrites of Basket and Stellate cells 
[41, 42]. Furthermore, they form synapses with the apical dendrites of Golgi cells. Two types of 
Lugaro cells have been identified in the cerebellum with slightly differing morphological 
characteristics, however functionality seems conserved as the two subtypes have similar synaptic 
connections [42]. 
1.4.3 Basket and stellate interneurons 
Basket and stellate cells are the principal GABAergic interneurons of the molecular layer of the 
cerebellum [43].  Whilst both form inhibitory synapses with the secondary and tertiary dendrites of 
PCs, basket cells also form synapses that envelope the soma of the PC [18, 43, 44]. Additionally, 
Stellate cells form synapses with parallel fibres, potentially mediating synaptic efficacy in the 
cerebellum during motor learning [45].  
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1.4.4 Glia 
The cerebellum is home to several main types of glia: protoplasmic velate astrocytes, 
oligodendrocytes and Bergmann Glia (BG). Whilst it is generally accepted that protoplasmic 
astrocytes, oligodendrocytes and BG develop from precursors in the VZ [46-49], the possibility of a 
small population of glia generated from the upper rhombic lip has been suggested, although this has 
yet to be proved with fate-mapping experiments [50, 51]. Interestingly, a small population of 
Bergmann glia has been found to arise from the postnatal EGL [52]. Furthermore, the origin of 
oligodendrocytes is a point of contention, with recent studies suggesting an extracerebellar point of 
origin [31]. BG cell bodies sit in the PCL, with long radial processes extending up through the ML 
to the basement membrane. These processes play a crucial role in the migration of post-mitotic 
granule cells from the EGL to the IGL and wrap around the dendrites of PCs in the ML [19, 20]. BG 
have also been suggested to act as regulators of PC and interneuron excitability in the ML [53]. Less 
is known about the function of velate protoplasmic astrocytes, which are found in the IGL and WM 
of the cerebellum [35]. It has been suggested that they play a localised role in signalling and 
information transfer through to the ML, through calcium-based signalling mechanisms, similar to 
those found in BG [54].  
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1.4.5 Purkinje neurons 
Purkinje neurons are the largest cells in the cerebellum and are easily characterised by their shape; a 
large, ovular cell body located in the PCL from which extends an expansive network of dendrites up 
to the surface of the cerebellum. From the bottom of the soma extends a long axon that travels through 
the IGL to the WM, to project onto DCN [55]. In common with other GABAergic interneurons, PN 
are born from the ventricular zone in the developing cerebellum [34]. PNs develop between E10.5 
and E12.5 in the VZ, before a majority of other GABAergic neurons and glia [48]. Early born PNs 
originate in the aspect of the VZ closest to the RL and migrate outwards towards the pial surface. 
Early during PN migration, cells form a multilayer ‘Purkinje plate’, in response to Reelin, initially 
secreted by DCNs, and then later from CGNPs in the EGL [23, 27, 56, 57]. Activation of Reelin 
signalling triggers PNs to disperse into a single monolayer that runs parallel to the pial surface, seen 
clearly in early postnatal mice [58]. Dendritic development of PCs occurs in the post-natal brain, with 
extensive branching of PN dendrites clearly visible in the second week postnatal. Purkinje neurons 
are crucial components in the complex signalling network of the cerebellum. Climbing fibres from 
the Inferior Olive form powerful excitatory synapses with the proximal dendrites. An interesting 
selection process takes place during development; initially PCs synapse with multiple climbing fibres 
but as development progresses, these synapses get eliminated postnatally so that in the adult brain 
each PC receives a single input from one CF [59, 60]. PCs receive further excitatory inputs from the 
interaction of CGN parallel fibres with PC dendrites near the surface of the cerebellum. Stellate and 
basket cells both form inhibitory synapses with distal PC dendrites, with Basket cells also synapsing 
on the PC soma [44].  
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1.5 Cerebellar development from the RL 
The rhombic lip (RL) is a dorsal region of the neural tube, responsible for the generation of cerebellar 
glutamatergic neurons, such as cerebellar granule neurons, Unipolar Brush Cells and glutamatergic 
deep cerebellar nuclei [27, 30, 32]. Mouse rhombic lip precursors are identified by their expression 
of the bHLH transcription factor Mouse Atonal Homologue 1 (MATH1), that is in turn essential for 
their production [50, 61-63]. The rhombic lip is first evident from around E9 onwards, and from 
~E10.5, cells begin to migrate away from the germinal zone in a stepwise manner. First, cerebellar 
nuclei leave the RL (E10-E12.5) followed by CGNPs (E12.5 onwards) and lastly Unipolar Brush 
Cells (~E14-E18). Despite the common site of origin, the developmental profile of these cells types 
differs greatly 
1.5.1 Unipolar brush cells 
Unipolar Brush Cells (UBC) are small, glutamatergic, excitatory interneurons that, like CGNs, are 
recipients of mossy fibre afferent outputs in the IGL of the cerebellum [64]. Slightly larger than 
granule cells but smaller than Golgi cells, their most striking feature is undoubtedly their solitary 
output- a dendritic ‘brush’, consisting of hundreds of fine, closely clustered dendrite branches [26]. 
A single mossy fibre terminal forms a giant synapse around the UBC brush, making contract with 
all dendrites, the largest synapse found in the CNS. UBCs can be broadly separated into two types. 
Type I UBCs express the calcium binding protein Calretinin whilst Type II UBCs express the 
metabotropic mGluR1a receptor [65].Whilst a vast majority of the immature cells in the rhombic 
lip are immature granule neurons, studies using the transcription factor TBR2 as a marker of UBCs 
have revealed that, despite previous speculation of a ventricular zone origin (VZ), UBCs are indeed 
produced from the MATH1+ precursors in the RL [66]. Unlike CGNPs however, UBCs migrate to 
the IGL through the cerebellar white matter and reach their final position by P10 [66].  In their final 
positions, they then undergo further maturation and dendritogenesis as late as P28 in rat brains [67]. 
It has been noted that unlike other cells in the cerebellum, UBCs have uneven distribution, with 
more located in the ventral than distal lobules [68]. 
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1.5.2 Glutamatergic Deep Cerebellar Nuclei 
Deep cerebellar nuclei (DCN) are the major output sources for the cerebellum and in the adult 
brain, consist of a mixture of glutamatergic projection neurons and GABAergic interneurons. 
Glutamatergic projection neurons are the first cells generated from Math1+ progenitors in the 
rhombic lip, with progenitors identified as early as E10.5 [50]. DCN are the first cells to migrate 
from the rhombic lip, followed by CGNPs and UBCs. In the adult brain, DCN are located in the 
white matter, where they receive excitatory inputs from mossy fibres [69], climbing fibres from the 
inferior olive [70] and inhibitory inputs from the Purkinjie cells in the PCL.  DCN provide 
cerebellar outputs to the premotor areas as well as to the inferior olive (IO), establishing a feedback 
loop. In common with other cells of RL origin, glutamatergic DCN express PAX6, TBR1 and 
TBR2 sequentially during embryonic development [27]. 
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1.5.3 Cerebellar Granule Neurons 
Cerebellar Granule Neurons (CGN) are the most numerous neurons in the cerebellum and indeed the 
brain, and arise from a pool of precursors (CGNPs) that undergo clonal expansion in the RL [71, 72]. 
Between ~E12.5 and E16, CGNPs from the RL begin to migrate, spreading across the cerebellar 
anlage to form the external granule cell layer (EGL). CGNPs in the RL strongly express a number 
key transcription factors including MATH1[50, 61], the zinc finger proteins ZIC1 and ZIC2[73] and 
the master regulator of development PAX6[74].  Expression of MATH1 is associated with CGP 
identity and is induced by BMP/SMAD signalling from cells in the choroid plexus and the roof plate 
of the developing cerebellum (for a review of BMP signalling in the cerebellum, see [75]).  
After rostro-medial migration from the RL, CGNPs in the EGL rapidly proliferate, driven mainly by 
the expression of the protein Sonic Hedgehog (SHH) from nearby Purkinjie Neurons [13].  
 
Signalling through the Notch pathway also plays a role in encouraging expansion of CGNPs in the 
EGL. Activation of NOTCH2 and JAG1 stimulate proliferation, which peaks between days 7 and 10 
postnatal [76, 77]. As proliferation starts to decrease, so does the expression of MATH1 in EGL cells, 
whilst the expression of the adhesion molecule TAG1 increases, indicating parallel fibre extension of 
now post-mitotic CGNs and further tangential migration. Working concurrently with this, WNT3 
expression starts to inhibit CGNP proliferation by down-regulating expression of SHH and MATH1 
target genes. Furthermore, BMP2 and BMP4 mediated SMAD expression supresses and overcomes 
the effects of SHH, allowing the switch from proliferation to differentiation in maturing granule cells 
[78, 79]. Once in their final position in the EGL, Semaphorin 6A (SEMA6A) helps facilitate the 
switch from tangential to radial migration [80], and post-mitotic granule cells extend a solitary 
vertical process and migrate along Bergmann glia, through the molecular layer (ML) and Purkinjie 
cell layer (PCL) and into their final positions in the internal granule layer (IGL) [17, 19]. Upon 
migration to the IGL, mossy fibres extend afferent axons to form excitatory synapses with granule 
cells. Receiving stimulation from mossy fibres, granule cells generate synchronous charges that travel 
up their ascending axons to synapses with Golgi cells [37] or Purkinjie neurons, which also receive 
inputs via synapses with CGN parallel fibres [81]. 
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1.6 Cerebellar stem cells and NFI transcription factors. 
 It has been well established that both cerebellar neurons and glia originate from pools of neural 
stem and progenitor cells. At a cellular level, the cerebellum is a heterogeneous mixture of different 
cell types, that originate from the same stem cell pool. Thus, there is great merit in investigating 
what causes these stem cells to become lineage specific and lose their ‘stem-ness’ as it not only 
provides insights into the mechanisms controlling brain development, but may also as to what 
happens when development goes wrong. Neural stem cells are self-renewing and multipotent. They 
either undergo symmetric division or asymmetric division, the former giving rise to two daughter 
stem cells and the latter giving rise to one stem cell and one intermediate or specialised progenitor 
cell. The change in division, and the eventual differentiation of stem and progenitor cells is driven 
in part by the action of transcription factors (TF), often activating or being activated in turn by 
signalling pathways, such as Shh, Wnt and Notch. Transcription factors play a crucial role in 
regulating gene expression throughout neural development and in the adult brain. Previously, NFI 




1.6.1 The NFI Family 
In mammals, the NFI family of TFs consists of four members, Nfia, Nfib, Nfic and Nfix, originally 
isolated from HeLa cells and identified as being essential for in vitro replication of adenovirus DNA 
[88]. NFI proteins bind as both hetero- and homo-dimers to the nucleotide motif 
TTGCC(N5)GGCAA and have been shown to be expressed in multiple vertebrate species with very 
high levels of sequence conservation [89]. Additionally, one NFI protein homologue is also found in 
C. elegans, Xenopus and Drosophila spp. Interestingly, no orthologues have been found in 
prokaryotes. NFIs are constitutively expressed throughout the developing CNS, including in the 
spinal cord, hippocampus, sub-ventricular zones and the cerebellum [86, 90-92]. During 
development, mRNA species of all four NFIs have been identified in the brain [93]. Despite 
similarities in binding domains and overlapping expression of NFIs in the neo-cortex during 
development, no evidence of compensatory function has been found [82, 93, 94]. This may be due to 
differences is the C-terminal domain of the different NFI family members. Furthermore, alternatively 
spliced variants of all four NFIs have been discovered, with each variant having different promoter 
binding and thus, gene expression profiles [95].Crucially, NFIs have been shown to regulate the 
differentiation and proliferation of neural progenitor cells, with loss of function mutants displaying 
delayed glial differentiation and malformations in the structure of the hippocampus and forebrain [94, 
96-98]. Furthermore, complete Nfi knockout models have shown similar phenotypes in the 
cerebellum.  
NFIs have been shown to act upstream of Tag-1 to regulate parallel fibre axon extension in CGNs 
indicating they might play a crucial role in progenitor maturation [99, 100].This is supported by data 
investigating cerebellar phenotypes in Nfix-/- mice, which display delayed differentiation and 
migration of progenitor cells of both neuronal and glial lineages. [91].Interestingly, Nfi genes have 
been implicated in the regulation of multiple ‘late’ genes governing processes including CGN 
maturation, parallel fibre extension and dendrite formation. These include, but are not limited to: Tag-
1, Wnt7a, Cdh2 and Gabra6 [99-101]. The interaction with Gabra6 is of particular interest as it 
selectively expressed over other GABAA receptor subunits in CGNs, and is crucial in driving granule 
cell dendritogenesis [102, 103]. NFIs have been found to directly bind to a consensus site in the 
proximal promoter of Gabra6, with lentiviral repression of NFIs resulting in up to a fourfold 




Somatic deletion of Nfia results in severe developmental defects in mice. On a Swiss-black 
background, homozygous deletion of Nfia results in lethality within the first day of birth for a majority 
of mice, with ~95% dying within the first two postnatal weeks. A similar phenotype was seen in Nfia-
/- mice backcrossed onto an inbred C57BL/6 background, with loss of over 90% of mice [104]. Of the 
mice that survive to adulthood, all have agenesis of the corpus callosum (CC), severe hydrocephalus 
as well as sterility in males and low fertility in females [104]. NFIA (and NFIB) have recently been 
identified to play a major role in the control of the onset of gliogenesis. In Nfia-/- mice, there is a 
dysgenesis of the corpus callosum, related to a severe delay in the development of midline glia and 
their projections [105]. Previously, NFIA expression has been determined to be non-essential for cell 
viability and DNA replication but essential for proper neural development [104]. Recent studies in 
Nfia knockout mice elucidated possible causes of delayed brain development, including elevated 
doublecortin (DCX, a marker of migratory neurons) mRNA at P16, decreased levels of GABRA6 
(expressed in differentiated neurons), decreased levels of differentiated astrocytes (as determined by 
expression of GFAP, a glial marker), increased expression of precursor oligodendrocyte markers such 
as SOX2, decreased size and aberrant foliation of the cerebellum and a general delay cerebellar 
granule neuron (CGN) migration to the internal granule cell layer (IGL) at P17 [106, 107].  
1.6.3 NFIB 
In the developing brain, Nfib has a very similar role to Nfia and thus, deletion results in a similar, 
albeit more severe, phenotype. For example, whilst both Nfia-/- and Nfib-/- mice display defects of the 
corpus callosum and forebrain, defects from Nfib knockout extend to aberrant formation of the 
hippocampus and basilar pons, as well as enlarged lateral ventricles and failure of glial maturation at 
the cortical midline[108]. Furthermore, these mice also exhibit major lung defects and subsequently 
die at birth[108-110].  Interestingly, Nfib-null mice also exhibit altered foliation of the cerebellum 
late in embryogenesis[108]. Nfib has been shown to play a role in regulating expression of cellular 
adhesion molecules during cerebellar development. Specifically, in Nfib-null mice, expression of 
transient axonal glycoprotein 1 (TAG1), is markedly reduced at E18 [99]. TAG1 is normally 
expressed in the cell body and elongating parallel fibres of late stage cerebellar granule neuron 
progenitors (CGNPs) and is required for path-finding of neuronal axons [111]. Thus, NFIB is 
proposed to affect CGNP maturation at this age [103]. 
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1.6.4 NFIC 
NFIC is expressed in the brain and is also expressed in the liver, spleen and heart [112]. Unlike other 
NFIs, Nfic-/- mutants do not display serious neurological or physical defects. Nfic is, however, 
essential for tooth development, with deletion resulting in major molar and tooth deformities [108, 
113]. Deletion also results in the failure of odontoblasts to differentiate in the developing mouse 
[114]. Nfic has a regulatory role in modulating TGF-b1 signalling in stem cells from the apical papilla. 
TGF-b1 signalling is in turn, required for NFIC expression in the cranial neural crest derived dental 
mesenchyme (SMAD4-SHH-NFIC) [115, 116]. Interestingly, NFIC has recently been found to 
supress migration and invasion of breast cancer cells by modulating expression of the zinc finger 
transcription factor KLF4, upregulating E-cadherin expression by binding to the E-cadherin promoter 
[117].  
1.6.5 NFIX 
Nfix has been suggested to play a critical role in neural development, however less is known of its 
role compared to that of Nfia or Nfib. However, Nfix deficiency is linked to a number of 
developmental disorders. Indeed, Heterozygosity or loss of function of one allele of NFIX in humans 
results in Malan Syndrome (Sotos syndrome 2), characterised by macrocephaly, intellectual 
impairment, developmental delay and other CNS abnormalities[118-125]. NFIX is highly expressed 
in different stem cell niches in the CNS and is a mediator of quiescence in neural stem cells [83-87, 
126]. NFIX has been identified as a key transcription factor involved in promoting expression of 
astrocyte-specific genes during development, as well as regulating the timing of progenitor cell 
differentiation in the hippocampus and cerebellum [91, 98]. Nfix-/- mutants display delayed eye and 
ear opening, slow weight gain and postnatal mortality at around ~P21 [96]. They also develop severe 
hydrocephalus, have partial agenesis of the CC as well as kyphosis of the spine and other bone and 
muscle deformities.  Significantly, Nfix-/- mice have significant abnormalities of the cerebellum at 
both a gross morphological level and at a cellular level [91]. The Nfix-null cerebellum is hypoplastic 
in the first week postnatally and displays overgrowth and misshapen lobules in the third postnatal 
week. In addition to this, development of both Bergmann glia and Purkinje neurons are delayed [91]. 
Whilst NFIX expression has been identified in the EGL and IGL of the postnatal cerebellum, analysis 
has been largely limited to single-antibody immunohistochemistry without any cell-type specific co-
expression analysis [91]. NFI transcription factors are ubiquitously expressed in a number of tissues 
throughout the body and CNS, so expression in cerebellar cells of different developmental origins in 
not unexpected. Indeed, extrapolating on the role of Nfix in neural stem cells and the brain, it is 
plausible that Nfix has a key role in the development of granule neuron progenitors in the developing 
cerebellum.  
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1.7 Identifying the role of Nfix in the cerebellum 
Proper spatial organisation of CGNs and their progenitors, and the establishment of synaptic 
connections is crucial for proper morphology of the overall cerebellum. For example, in the Nfix-/- 
mutant the size of the cerebellum is greatly reduced [91, 96]. Furthermore, CGN, astrocyte and 
Purkinje cell development is also significantly delayed, with the latter showing aberrant dendritic 
branching at P5 [91]. Whether the changes in Purkinje neuron, granule neuron and glial development 
is due to cell autonomous or endogenous effects, or indeed a combination of both is yet to be 
determined.  
 
It is already known that SHH expression from PNs has a major role in the proliferation and eventual 
maturation of CGNPs. A potential role of NFIX in this process, if any, is yet to be determined.  SHH 
is secreted continuously from PCs from approximately E17.5 onwards [127] and binds to the Patched 
1 (PTCH1) cell surface receptor. This relieves PTCH1-mediated inhibition of Smoothened (SMO), 
which in turn activates translocation of GLI transcription factors to the cell nucleus [128]. 
Interestingly, the Notch pathway protein HES1 has been shown to be a SHH-mediated direct 
transcriptional target of GLI2 in proliferative cells of the retina[129]. Although NFIA has recently 
been shown to suppress HES1 in the cerebellum[130], a relationship between HES1 and NFIX is yet 
to be described. Recent evidence suggests that activated Notch interferes with the transcriptional 
activity of NFIX in myogenic stem cells[131], so further investigation may reveal a common 
interaction found between NFI and Notch in multiple stem and progenitor cell types. Notch and SHH 
are by no means the only two pathways implicated in CGN development. Canonical and non-
canonical WNT as well as BMP/SMAD signalling have been flagged to facilitate a number of 
processes in these cells [75, 78]. Additionally, as each pathway has dozens of cross-regulatory and 
independent protein interactions, it is highly possible that Nfix is regulating aspects of these pathways 
during CGNP maturation.  
  
Determining the role of NFIX during cerebellar development needs to be approached in a stepwise 
manner. First, cell-type specific expression of NFIX in all major neuronal and glial lineages of the 
cerebellum need to be undertaken to determine where in the cerebellar architecture NFIX is 
potentially playing a cell autonomous role during development. Expression of NFIX for examples 
has not been investigated in stellate or basket interneurons. Their interaction with CGNs in the ML 
raises the possibility that Nfix deletion may have an effect on their function, maturation or 
morphology, whether through direct or indirect means. Compared to interneurons, we know more 
about the potential role of Nfix in cerebellar astrocytes and glia, as research has determined that 
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NFIX drives the expression of several astrocyte-specific genes during development [132]. 
Additionally Nfix-/- mutants display delayed differentiation of mature glia in the cerebellum [91]. 
Despite this phenotype, NFIX expression has not been characterised in these cells or in their 
progenitors with cell-type specific markers. Thus, the first aim of this project is to thoroughly 
analyse the cell-type specific role of Nfix in the developing mouse cerebellum. Expression of NFIX 
in granule neurons and their precursors needs to be established throughout cerebellar development, 
to determine whether NFIX plays a temporal role or continual role throughout the granule neuron 
life cycle. Ubiquitous expression in cerebellar germinal zones, or temporally and spatially restricted 
expression would provide us with a picture of the role of NFIX in the genesis of both neuronal and 
glial cell lineages in the cerebellum. Further, expression in multiple mature lineages of neurons and 
glia will clarify cell autonomous or non-autonomous roles of Nfix, in addition to providing a clearer 
picture of where NFIs fit into the developmental picture of the cerebellum, especially due to the 
breadth of literature demonstrating interactions between BG, interneurons and granule neurons. 
  
Whilst co-expression analysis provides a general picture of the role of Nfix in germinal zones, 
transcriptomic profiling is needed to provide analysis at a molecular level. Indeed, the next aim of 
this project is to utilise both RNA-seq and ChIP-seq technologies to identify direct targets of NFIX 
in CGNPs. Previous research suggests a delay in CGNP differentiation in Nfix-/- mice, potentially 
related to an arrest of precursor cell differentiation. Therefore, comparison of both wild-type and Nfix-
null CGNPs should provide us with a discrete list of genes involved in the proliferation-differentiation 
switch in these progenitors. As previously discussed, there is already a wealth of literature identifying 
regulators of CGNP proliferation. This experimental design presents an unbiased way to identify 
novel regulators of this process and validate their role in the development of granule neuron 
precursors. 
 
Due to potentially overlapping expression patterns of NFIs in the cerebellum, the question arises as 
to whether these transcription factors have functional redundancies or complementing roles during 
development. We aim to address this by again conducting further transcriptomic analysis, this time 
utilising both an Nfix-/- mouse line and an Nfiafl/fl; Math1-cre conditional deletion mutant, to 
selectively ablate NFIA expression in CGNPs.  This will shed insight into whether or not these 
transcription factors work co-ordinately or in tandem to drive CGN development and differentiation.  
 
Overall, this work will provide a comprehensive picture of NFI-mediated transcriptional regulation 
of the developing mouse cerebellum. NFIs have an irreplaceable role in the development of the CNS, 
with manipulation of their expression resulting in drastic disorder and developmental disease [96, 
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104-106, 108, 118-124, 133-136]. If we can better understand the role of these TFs during 
neurogenesis, we may better be able to conceptualise new treatment strategies and gene targets for a 
number of CNS tumours such as glioma and medulloblastoma, of which NFIs are suggested to play 
a role [133, 137, 138].  
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2.1 Aim and overview of Chapter 2 
Chapter 2, the first data chapter of this thesis, aims to examine the expression of NFIX in the 
developing cerebellum to shed light on potential roles in neural development. Initially, this chapter 
uses IHC to examine the expression of NFIX in the embryonic cerebellum, as well as the postnatal 
cerebellum at from P5-adulthood. Next, it uses co-immunofluorescence staining to examine the 
cell-type specific expression of NFIX in a number of different neuronal and non-neuronal cell 
types, focusing on the postnatal cerebellum. Lastly, it examines the expression of alternate NFIX 
transcripts in postnatal CGNPs.  
 
2.2 Abstract 
Transcription factors from the Nuclear Factor One (NFI) family have been shown to play a central 
role in regulating neural progenitor cell differentiation within the embryonic and postnatal brain. 
NFIA and NFIB, for instance, promote the differentiation and functional maturation of granule 
neurons within the cerebellum. Mice lacking Nfix exhibit delays in the development of neuronal and 
glial lineages within the cerebellum, but the cell type-specific expression of this transcription factor 
remains undefined. Here we examined the expression of NFIX, together with various cell type-
specific markers, within the developing and adult cerebellum using co-immunofluorescence 
labelling and confocal microscopy. In embryos, NFIX was expressed by progenitor cells within the 
rhombic lip and ventricular zone. After birth, progenitor cells within the external granule layer, as 
well as migrating and mature granule neurons, expressed NFIX. Within the adult cerebellum, NFIX 
displayed a broad expression profile, and was evident within granule cells, Bergmann glia and 
interneurons, but not within Purkinje neurons. Furthermore, transcriptomic profiling of cerebellar 
granule neuron progenitor cells showed that multiple splice variants of Nfix are expressed within 
this germinal zone of the postnatal brain. Collectively, these data suggest that NFIX plays a role in 
regulating progenitor cell biology within the embryonic and postnatal cerebellum, as well as an 
ongoing role within multiple neuronal and glial populations within the adult cerebellum
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2.3 Introduction 
The cerebellum is a hindbrain-derived structure that plays a central role in the regulation of motor 
control, co-ordination, and the timing and precision of movement. Consequently, disorders 
involving the abnormal development of the cerebellum can be severely debilitating. Furthermore, 
the cerebellum is prone to the development of a number of different types of paediatric and adult 
cancers [139, 140], highlighting the need to clearly map the expression of key genes involved in the 
regulation of cerebellar development, especially those genes governing cellular differentiation, 
identity and proliferation. 
 
The mature cerebellum consists of multiple developmentally distinct cell types including cerebellar 
granule neurons, Purkinje cells, unipolar brush cells, deep cerebellar neurons and various 
interneurons and glial cells [21, 41, 68, 71, 72]. CGNPs are the most populous cerebellar neuron; 
indeed there are more of these than any other neuronal cell type within the central nervous system 
[141].  Developmentally, these cells arise from a highly proliferative region of the neuroepithelium 
known as the rhombic lip. In mice, MATH1+ CGNPs form at the rhombic lip from approximately 
embryonic day (E) 12 onwards [61]. Here, they rapidly proliferate and then migrate tangentially to 
populate the external surface of the cerebellar anlage, forming a transient germinal zone called the 
external granule layer (EGL) [71]. Postnatally, CGNPs continue to proliferate, before differentiating 
into immature neurons, which migrate radially through the molecular layer to become mature 
granule cells within the internal granule layer [142]. In rodents, the differentiation of CGNPs 
ensures that the EGL is fully depleted approximately two weeks after birth, with the cerebellum 
being functionally mature around the third week after birth, [76, 143]. Granule cells are not the only 
cells produced in the rhombic lip, with glutamatergic deep cerebellar neurons produced between 
E9.5 and E12 and unipolar brush cells after E12 [61, 66]. 
 
GABAergic inhibitory interneurons, Purkinje cells and glia on the other hand, are derived from a 
pool of precursor cells in the ventricular zone adjacent to the rhombic lip between E10.5 and E13.5 
in mice [144]. Progenitor cells from the ventricular zone follow a developmental trajectory distinct 
to those found within the rhombic lip. For example, Purkinje cells are generated between E11-E13 
from progenitor cells within the ventricular zone, and they subsequently migrate through the 
cerebellar anlage to form the Purkinje cell layer underneath the EGL. Purkinje cells play a crucial 
role in the expansion of CGNPs within the EGL, through the secretion of Sonic hedgehog (SHH) 
and Jagged-1, both of which promote CGNP proliferation [13, 77]. Furthermore, recent studies 
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suggest that the SHH pathway is both active and required for development of interneuron 
progenitors in the developing cerebellum [144, 145].  
 
Cerebellar development is largely dependent on the coordinated activity of transcription factors. For 
example, the sequential expression of PAX6, TBR2, and TBR1 is essential for the differentiation of 
radial glia within the rhombic lip into deep cerebellar neurons [27, 146]. Unipolar brush cells 
express PAX6 and TBR2 en route to the internal granule layer and cerebellar granule neurons 
express PAX6 throughout all stages of their development, although these cells express TBR2 only 
transiently during their migration from the EGL to the internal granule layer [147].  The 
transcription factor MATH1 is another key protein that regulates cerebellar development; indeed, 
all progenitor cells within the rhombic lip express MATH1 [61, 148]. Math1 is also intimately 
associated with the regulation of CGNP proliferation within the postnatal cerebellum and is 
essential for morphological formation of this structure [62]. Indeed, Math1-/- mice, which die shortly 
after birth, display cerebellar defects such as the absence of the EGL [63, 149]. The importance of 
MATH1 in regulating CGNP proliferation is also highlighted by the fact that the overexpression of 
this transcription factor has been identified as a hallmark in the SHH-subgroup of medulloblastoma 
[150], a cerebellar cancer that is the most frequent paediatric malignancy of the brain. 
  
Another group of transcription factors that have recently been shown to play a prominent role in 
postnatal cerebellar development are the Nuclear Factor One (NFI) family, which consists of four 
members in vertebrates: NFIA, NFIB, NFIC and NFIX [107]. These transcription factors are 
expressed in neural stem cell populations throughout the developing central nervous system [83, 84, 
104, 151]. Critically, knockout mouse models have highlighted the role of this family in 
contributing to neural progenitor cell differentiation during development. Indeed, mice lacking Nfi 
genes display deficits in neural stem cell differentiation within the neocortex, hippocampus and 
spinal cord [104, 108]. Within the cerebellum, NFIA and NFIB are expressed in CGNPs and mature 
granule neurons, and at a mechanistic level, have been shown to promote migration, maturation and 
synaptogenesis within nascent granule neurons [99, 100]. NFIX is also expressed by CGNPs within 
the postnatal cerebellum, and a preliminary report revealed that mice lacking Nfix exhibit delayed 
cerebellar development [91]. However, a comprehensive analysis of NFIX expression at a cell-type 
specific level within the embryonic, postnatal and adult cerebellum has yet to be performed.  Such 
an analysis is critical if we are to understand the different roles NFIX plays during development and 
in the adult, and to enable the interpretation of cerebellar phenotype of Nfix-/- mice. Here we address 
this issue using co-immunofluorescence labelling and confocal microscopy, coupled with RNA-
sequencing of isolated postnatal day (P) 7 CGNPs.  We reveal a broad and dynamic pattern of NFIX 
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expression within multiple cell types, indicative of a key role for this transcription factor in the 




C57Bl/6J mice were used in this study with approval from the University of Queensland Animal 
Ethics Committee (AEC approval number: QBI/353/13/NHMRC). All experiments were performed 
according to the Australian Code of Practice for the Care and Use of Animals for Scientific 
Purposes.  
2.4.2 Immunohistochemistry 
Mice were anesthetised and perfused transcardially with phosphate-buffered saline (PBS), followed 
by 4% paraformaldehyde (PFA), then post-fixed for 48-72 h before long term storage in PBS at 
4°C. Whole brains (E15.5 and E18) and dissected cerebella (post-natal ages) were embedded in 3% 
Noble agar and sectioned in a sagittal plane at 50 µm intervals using a vibratome. Sections were 
mounted on slides before heat-mediated antigen retrieval was performed in 10 mM sodium-citrate 
solution at 95°C for 15 min. Chromogenic immunohistochemistry (IHC) using 3,3’-
diaminobenzidine (DAB) or fluorescence immunohistochemistry (IF) was then performed as 
previously described [130]. A table of antibodies can be found in Table 1. 
 
Table 1 Antibodies used in this chapter 
Antibody Source species Company 
Catalogue 
number Dilution used Purpose 
NFIX Mouse SIGMA SAB1401263 1/200; 1/1000 IF/IHC 
NFIX Rabbit ABCAM AB101341 1/100 IF 
Ki67 (conjugated) Rat eBioscience 11-5698-82 1/400 IF 
PAX6 Rabbit Millipore AB2237 1/200 IF 
NEUN Rabbit Millipore MAB377 1/200 IF 
Calbindin Rabbit SWANT CB38 1/400 IF 
Parvalbumin Mouse SIGMA P3088 1/200 IF 
GFAP Rabbit DAKO Z0334 1/1000 IF 
OLIG2 Rabbit Millipore AB9610 1/400 IF 
IBA1 Rabbit Wako 019-19741 1/400 IF 




2.4.3  Cerebellar Imaging 
IHC sections were imaged with both a 5x and 20x objective, using bright-field microscopy. For 
IHC, a Zeiss Axio Imager fluorescent microscope was used, with Zeiss Zen 2009 (Zeiss, Germany) 
software. Fluorescent sections were imaged using a 20x objective on a Zeiss LSM 510 META 
Inverted Confocal Microscope, using Zeiss Zen 2009 software (Zeiss, Germany). In all cases high 
magnification images were taken of the same lobule of the cerebellum (VI) due to its distinctive 
shape, and sections close to the midline were selected for analysis. In all cases we analysed 
expression using at least three biological replicates at each of the ages assessed. For quantification 
of NFIX co-expression with cellular markers in the cerebellum, approximately 200 cells (from 3 
biological replicates) were counted from 1 µm-thick optical sections of the cerebellum using the 
cell counter plugin in FIJI (NIH, USA).  
 
2.4.4 Granule cell isolation 
CGNPs from P7 adolescent mice were isolated using the method outlined by [141] and a Papain 
Dissociation Kit (Worthington Biochemical, USA). Briefly, the cerebellum was dissected from 
three wild-type and three Nfix-/- mice and the tissue was dissociated using a 20 units/ml papain 
solution at 37°C for 15 mins.  A single cell suspension was obtained by trituration with a serum-
coated P1000 pipette tip and nuclear membranes were removed using an albumin-ovomucoid 
inhibitor gradient.  CGNPs were separated from large non-neuronal cells using a 35%-60% percoll 
gradient.  Purified CGNP cells were then lysed in Trizol (Ambion, USA) and RNA isolated using 
an RNeasy miniprep kit (Qiagen, USA).  RNA-sequencing was then performed on these samples 
using the Illumina NextSeq High Output system (Illumina; 150 base pair read length, paired-end 
reads).  
 
2.4.5 RNA-seq analysis 
TopHat2 (v2.0.9) and Cufflinks (v2.1.1) were used to identify known Nfix transcripts 
(NM_001081981, NM_001297601, NM_001081982 and NM_010906) present in the RNA-
sequencing results for wild type (WT) samples of P7 CGNPs [152]. TopHat2 was used to align each 
WT sample to the Mus musculus, UCSC, mm10 reference transcriptome and FASTA annotation 
downloaded from the TopHat Index and annotations page 
(https://ccb.jhu.edu/software/tophat/igenomes.shtml). Cufflinks was then used to assemble the 
transcripts based on the alignment files generated by TopHat for each WT sample. Cuffmerge was 
used to create a single assembly containing transcripts across all WT samples. All transcripts 
annotated with “Nfix”, based on the label in the reference transcriptome, were extracted from the 
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merged.gtf result file for further analysis. Three of the four known Nfix transcript variants were 
identified from this analysis. The nucleotide sequence for all four variants was aligned using the 
Clustal Omega website and unique regions for each were used to quantify the level of expression by 
qPCR.   
 
2.4.6 qPCR analysis 
cDNA was prepared from the original RNA samples used for RNA-seq using the Superscript III 
Reverse Transcription kit (Invitrogen) and qPCR performed with the Quantifast SYBR kit (Qiagen, 
USA). Primers used for qPCR are shown in Table 2. The level of expression was calculated as the 
fold change compared to the housekeeping gene, glyceraldehyde-3-phosphatedehydrogenase 
(Gapdh). 
 
Table 2 qPCR primers used in this chapter 
 Forward Primer Reverse Primer Product length 
Nfix variant 1 AGTCAGACCAGGGAGCCC TCGTTGTGAATGCTGTCCG 199 base pairs 




154 base pairs 




149 base pairs 








2.5.1 Expression of NFIX within the embryonic cerebellum. 
NFIX expression has been reported to be present at low levels within the EGL of E17 mice [91], but 
whether it is present within cells of the rhombic lip or ventricular zone that give rise to the mature 
cells of the cerebellum is unclear. To address this, we first investigated the expression of NFIX 
within the E15.5 hindbrain and cerebellum (Figure 2-1). Co-immunofluorescence labelling using 
antibodies specific for NFIX and the proliferative marker Ki67 revealed that NFIX was strongly 
expressed by proliferating cells within the rhombic lip (Figure 2-1D-D’’). Expression of NFIX was 
also evident, albeit at a reduced level, within cells of the adjacent ventricular zone (Figure 2-1B).  
Expression of NFIX by cells within the developing cerebellar anlage was also detected (Figure 
2-1A) these cells likely represent neurons derived from the cerebellar ventricular zone. However, 
despite the presence of proliferating precursor cells with the EGL, ((Figure 2-1C’), we did not 
detect any appreciable expression of NFIX by CGNPs at this age (Figure 2-1C).  By E18, 
chromogenic immunohistochemistry revealed that NFIX was expressed by CGNPs within the EGL 
(Figure 2-2 A-C). NFIX expression was stronger in regions of the EGL closest to the rhombic lip 
(Figure 2-2 C’). Collectively these data reveal that NFIX is expressed in both the rhombic lip and 
the cerebellar ventricular zone, indicative of this transcription factor playing a role during the early 





Figure 2-1: NFIX expression within the embryonic cerebellum. 
 (A) Mid-sagittal section of an E15.5 cerebellum stained with antibodies against 
NFIX red), the proliferative marker Ki67 (green) and the nuclear marker DAPI (blue). 
(B-B’’) Cells within the ventricular zone adjacent to the rhombic lip expressed both 
NFIX and Ki67 (arrows). (C-C’’) Within the nascent EGL, NFIX expression was not 
detected within the nuclei of proliferating cells at this age. Some NFIX-expressing 
cells were, however, observed within the cerebellar anlage (arrows). (D’-D’’) NFIX 
was highly expressed by cells within the rhombic lip (arrows). Scale bar (in A) A 
=100 µm, B-D’’ = 50 µm. 
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Figure 2-2 Expression of NFIX within the late-embryonic cerebellum. 
(A-C) Chromogenic immunohistochemistry revealing the expression of NFIX within a mid-
sagittal section of an E18 cerebellum. NFIX expression was evident within cells of the external 
granule layer (EGL) at this age (B, C), with EGL cells closer to the rhombic lip expressing NFIX 
at a higher level (C) than those more distant from the rhombic lip (B). NFIX expression was 
also evident within cells located in the internal granule layer (IGL) at this age. ML – molecular 




2.5.2 Expression of NFIX within the postnatal and adult cerebellum. 
NFIX is expressed by CGNPs and CGNs postnatally, and by granule neurons in the adult 
cerebellum [91]. Is NFIX expression confined to these cellular populations? To address this 
question, we first performed chromogenic immunohistochemistry within the postnatal (Figure 2-3) 
and adult cerebellum (Figure 2-4). This analysis confirmed the expression of NFIX by CGNPs 
within the EGL postnatally (Figure 2-3) and by mature CGNs at all postnatal ages including in 
adults Figure 2-4). Interestingly, we also observed expression of NFIX by cells within the 
molecular layer at all of the ages examined. Postnatally, these cells likely represent postmitotic 
granule neurons migrating radially into the internal granule layer.  Within the adult, these NFIX-
expressing cells are potentially basket or stellate cells, as these interneurons have their cell bodies 
within the molecular layer of the mature cerebellum [29]. In the adult cerebellum, NFIX expression 
was also prominent within cells located in the white matter, suggesting that NFIX may also be 




Figure 2-3: Dynamic expression of NFIX within the postnatal cerebellum. 
Chromogenic immunohistochemistry revealing the expression of NFIX within 
mid-sagittal sections of P5 (A, B), P10 (C, D), P15 (E, F) and P20 (G, H) 
cerebellum. At P5, NFIX expression was evident within the external granule 
layer (EGL) and the internal granule layer (IGL; A, B), a pattern that was 
replicated at both P10 and P15 (C-F).  EGL cells also express NFIX at P20 (G, 
H).  Scattered cells within the molecular layer (ML) also expressed NFIX at each 
of these postnatal ages.  Scale bar (in H) A, C = 250 µm, E, G = 400 µm; B, D = 
50 µm; F, H = 75 µm. 
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2.5.3 Proliferative cells within the postnatal EGL and post-mitotic cells within the IGL 
express NFIX. 
We next analysed NFIX expression at a cell type-specific level using co-immunofluorescence 
labelling and confocal microscopy. Firstly, to verify the expression of NFIX by cells within the 
EGL of the postnatal brain we performed co-labelling with markers expressed by CGNPs, including 
PAX6 (Figure 2-5) and Ki67 (Figure 2-6). Between P5 and P15, NFIX expression was co-incident 
with both PAX6 and Ki67 within the EGL. Indeed, within the EGL of P5 mice, ~97% of PAX6-
positive cells expressed NFIX, a number that was even higher at P15 (~99%). Moreover, within the 
internal granule layer, PAX6-positive cells were nearly all immunopositive for NFIX (99% at P5; 
98% at P15). Furthermore, NFIX was co-expressed with PAX6 by immature granule neurons 
migrating radially through the ML into the IGL (Figure 2-5). However, not all of the NFIX-positive 
cells within the molecular layer were immunopositive for PAX6 or Ki67. This indicates that a 
different population of cells within the molecular layer of the postnatal cerebellum expresses NFIX. 
These are likely to be basket and stellate cells, as these interneuron populations reside within the 
molecular layer of the cerebellum [153].PAX6 expression is maintained by granule neurons within 
the internal granule layer of the adult cerebellum [154] and NFIX expression was observed in the 
majority of these cells within the adult cerebellum (99% of PAX6-expressing cells were 
immunopositive for NFIX). PAX6 and NFIX were also co-expressed by a small number of cells 
with in the molecular layer of the adult cerebellum (Figure 2-5). These cells are likely to be ectopic 
granule neurons, as previous reports indicate that stellate and basket cells express PAX2 and not 
PAX6 [155]. 
 
 Next, we used the expression of NeuN to label post-mitotic neurons within the postnatal and adult 
cerebellum (Figure 2-7). NFIX was co-expressed by NeuN-positive cells localised to the inner 
EGL, at P5 (99%) and P15 (99%) and by mature granule neurons within the internal granule layer 
of the adult cerebellum (98%). We also observed a small population of cells immunopositive for 
both NeuN and NFIX in the molecular layer of the adult cerebellum, again likely representing 
ectopic granule cells , as basket and stellate cells do not express NeuN [156]. Collectively, these 
findings demonstrate a broad pattern of NFIX expression within both CGNPs and mature CGNs 





Figure 2-4: Robust expression of NFIX by granule neurons of the mature 
cerebellum. 
(A) Mid-sagittal section of an adult cerebellum stained with antibodies against 
NFIX.  NFIX expression was clearly evident within the granule cells in the 
internal granule layer (IGL; A, arrows in B). There were also many scattered 
cells within the molecular layer that express NFIX (arrowheads, B). Within the 
white matter (C, D), there were also cells that were immuno-positive for NFIX 
within the adult cerebellum (arrows).  ML – molecular layer. Scale bar (in A) 




Figure 2-5: Granule neuron progenitors within the postnatal EGL express NFIX. 
Expression of DAPI (A, E, I), NFIX (B, F, J) and PAX6 (C, G, K) in the cerebellum of P10 (A-
D), P15 (E-H) and adult (I-L) mice.  Merged panels are shown in D, H and L. PAX6 was 
expressed by proliferative cells within the external granule layer (EGL; arrows), cells within the 
molecular layer (arrowheads) and granule neurons within the internal granule layer (double 
arrowheads). NFIX expression was also evident within these cellular populations. Within the 
molecular layer however, there were also cells exhibiting NFIX expression that were not 




Figure 2-6 Proliferating cells within the postnatal EGL express NFIX 
Expression of DAPI (A, E), NFIX (B, F) and Ki67 (C, G) in the cerebellum of P5 (A-D) and 
P10 (E-H) mice. Merged panels are shown in D and H. Proliferating Ki67-potitive cells within 
the EGL of postnatal mice co-express NFIX (arrows), as do proliferative cells within the 
molecular layer at these ages (arrowheads). Within the molecular layer and internal granule layer 
of the postnatal cerebellum there are numerous post-mitotic cells that express NFIX (double 




2.5.4 Astrocytes and cerebellar interneurons express NFIX within the adult cerebellum. 
Having established that CGNPs and their progeny express NFIX, we next sought to investigate its 
expression by other cell-types within the cerebellum, including GFAP-expressing astrocytes, 
Purkinje cells and interneurons. The cerebellum is known to contain multiple types of astrocytes. 
For example, Bergmann Glia play a crucial role during development in that they help guide 
astrotactin-expressing immature granule neurons towards the internal granule layer [19]. These cells 
also persist in the adult cerebellum. Immunolabelling with antibodies against NFIX and glial 
fibrillary acidic protein (GFAP) revealed that GFAP-expressing Bergmann glia (which have their 
cell bodies within the Purkinje cell layer), likely co-express NFIX within the postnatal and adult 
cerebellum (Figure 2-8). Similarly, protoplasmic astrocytes within both the internal granule layer 
and white matter of the adult cerebellum were immunopositive for NFIX. One caveat to this 
interpretation is that NFIX is found in the nucleus, whereas GFAP immunoreactivity is confined to 
the cytoplasm. As such, it can be difficult to unequivocally determine co-expression with these two 
markers. However, given that our analysis was performed using confocal microscopy, and that 
GFAP-expressing fibres were in many cases seen to envelop NFIX-expressing nuclei, we are 
confident that cerebellar astrocytes do indeed express NFIX. These data suggest a role for NFIX in 
astrocyte development and biology, a finding supported by studies in vitro [82], as well as the 
delayed cerebellar astrocyte development evident within postnatal Nfix-/- mice [91]. 
 
The presence of cells within the molecular layer that were immunoreactive for NFIX, but not for 
NeuN or PAX6 (Figures 4 and 6) led us to speculate as to whether interneurons also express this 
transcription factor. We first investigated the expression of NFIX by Purkinje cells in the 
developing and postnatal cerebellum. Using the expression of the calcium binding protein calbindin 
[156] to identify Purkinje cells, we discovered that these cells do not express NFIX either during the 
postnatal period, or within the adult cerebellum (Figure 2-9).  Similarly, when we used a second 
Purkinje cell marker, parvalbumin, we did not observe any NFIX expression by Purkinje cells 
(Figure 2-10). However, we did observe many instances of parvalbumin-expressing cells what were 
also immunoreactive for NFIX within the molecular layer of the postnatal and adult cerebellum 
(Figure 2-10and data not shown), confirming that basket and stellate cells express NFIX within the 




Finally, we used the expression of calretinin to identify unipolar brush cell, and IBA1 and OLIG2 to 
label microglia and oligodendroglia, respectively. Analysis of cerebella from developing (P5 and 
P10) and adult mice revealed that NFIX was expressed by a small proportion of unipolar brush cells 
(6/45 cells at P5, 1/41 cells at P15, and 2/53 cells in the adult; Figure 2-11), microglia (10/37 cells 
at P5, 8/40 cells at P15, and 1/38 cells in the adult; Figure 2-12) and oligodendroglia (20/172 cells 




Figure 2-7 NeuN expressing neurons co-express NFIX within the developing and adult 
cerebellum. 
Expression of DAPI (A, E, I), NFIX (B, F, J) and NeuN (C, G, K) in the cerebellum of P5 (A-
D), P15 (E-H) and adult (I-L) mice.  Merged panels are shown in D, H and L. At P5 and P15, 
NeuN-expressing cells are seen within the inner EGL, as well as the molecular layer and internal 
granule cell layer. These cells also express NFIX (arrows). Within the adult cerebellum (I-L) 
NFIX and NeuN are co-expressed by granule neurons within the internal granule layer (arrows), 
as well as by a small population of cells within the molecular layer (arrowheads). Interestingly, 
there were also cells within the molecular layer of the adult cerebellum that were 




Figure 2-8 Expression of NFIX by mature astrocytes within the cerebellum. 
Expression of DAPI (blue), NFIX (red) and GFAP (green) in mid-sagittal sections of P20 (A, 
B) and adult (C-F’’) cerebellar tissue.  At P20, expression of GFAP delineates the processes 
of Bergman glia (A, arrows in B’, B’’). Many of these GFAP-positive processes envelop 
NFIX-expressing nuclei, suggesting that these glia express NFIX.  Similarly, within the adult 
cerebellum (C), the processes of GFAP-positive Bergmann glia encircle NFIX-expressing 
nuclei (arrows in D-D’’), as do those in the internal granule layer (arrows in E-E’’) and white 
matter (arrows in F-F’’), indicating that many cerebellar astrocytes likely express NFIX. Scale 
bar (in F’’) = 50 µm. 
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2.5.5 Multiple Nfix isoforms are expressed by CGNPs within the postnatal cerebellum. 
Nfix, like other Nfi genes, undergoes alternative splicing [95, 157], but almost nothing is known 
about the relative expression of these transcripts within the developing brain. Given the expression 
of NFIX by cells within the postnatal EGL, we used a percoll-based centrifugation technique [141] 
to isolate a highly purified population of these cells from the cerebellum of P7 wild-type mice, in 
order to determine which Nfix isoforms were expressed at this age of development. This was 
achieved by isolating RNA from these cells and performing RNA-seq. Analysis of the RNA-seq 
data revealed that three of the four characterised Nfix transcripts (NM_001081981, NM_001081982 
and NM_010906, respectively) were expressed by CGNPs at this stage of development (Figure 
2-14 A). Although RNA-seq produces robust results, lowly expressed transcript variants can often 
fail to be detected during analysis. Thus, to further validate the expression of all four known 
transcripts, we performed qPCR on mRNA isolated from the original RNA samples used for RNA-
seq (Figure 2-14 B).  The data were normalised to the housekeeping gene Gapdh, and confirmed 
that the Nfix variant 1 (NM_001081982) was the most abundantly expressed transcript found in P7 
CGNPs. Variant 2 (NM_010906) and 3 (NM_001081981) were less abundant at 2.6-fold and 28-
fold lower expression levels compared to variant 1. In contrast to the data generated by the RNA-
seq analysis, Nfix variant 4 (NM_001297601) transcript was detected, albeit at low levels, (65-fold 
less expression compared to variant 1). These data indicate that all of the four known Nfix variants 
are expressed within postnatal CGNPs. Similarly, we identified that multiple isoforms of other Nfi 
family members were expressed within these cells (data not shown). Collectively, these data reveal 
a dynamic pattern of Nfi isoform expression within the postnatal germinal zone of the EGL, 
indicative of NFIs potentially regulating different transcriptional targets via the production of 




Figure 2-9 Cerebellar Purkinje neurons do not express NFIX. 
Expression of DAPI (A, E, I), NFIX (B, F, J) and calbindin (C, G, K) in the cerebellum of P5 
(A-D), P15 (E-H) and adult (I-L) mice.  Merged panels are shown in D, H and L. Calbindin 
labels Purkinje neuronal cell bodies and their projections (arrows). The expression of NFIX was 
not detected within Purkinje neurons at either postnatal (A-H) or adult (I-L) ages. Scale bar (in 







Figure 2-10 Stellate and basket neurons express NFIX within the adult cerebellum. 
Expression of DAPI (A), NFIX (B) and parvalbumin (C) in the cerebellum of adult mouse.  The 
merged panel is shown in D. Parvalbumin-expressing Purkinjie neurons were not 
immunopositive for NFIX (arrows).  Within the molecular layer there were a population of 
parvalbumin-expressing cells that co-expressed NFIX (arrowheads in B-D); these are likely 
basket and stellate interneurons. There was also a population of NFIX-expressing cells within 
the molecular layer that did not express parvalbumin (double headed arrows).  Scale bar (in D) 






Transcriptional regulation of gene expression plays a crucial role in many facets of development. 
Recent work has highlighted that the NFI family of transcription factors play a pivotal role in 
regulating the development of many diverse physiological systems, including the lungs [108, 109], 
kidneys [158], skeletal system [159], musculature [160] and the central nervous system (for a 
review of NFIs in nervous system development, see [90]).  NFIs are intimately involved in the 
development of the nervous system, as evidenced by malformations in development of key 
structures such as the hippocampus, spinal cord and pons [108] in the absence of individual Nfi 
family members (Mason et al 2009).  Interestingly, whereas the role of NFIs in promoting neuronal 
progenitor cell differentiation has been well studied, the role of NFIs in other cell types is less well 
understood.  For instance, NFIA and B are widely expressed within the mature forebrain and 
cerebellum, but our understanding of which cells actually express NFIs, let alone what role NFIs are 
playing in these cells, is very limited.  Here we use the developing and mature cerebellum as a 
model to probe the cell-type expression of NFIX. We reveal that NFIX is expressed by progenitor 
cells within the embryonic rhombic lip and ventricular zone, as well as by CGNPs in the postnatal 
cerebellum. Moreover, we demonstrate that NFIX is expressed by multiple cell types within the 
mature cerebellum, including granule cells, astrocytes and basket and stellate cells. These findings 
reveal an unexpected breadth of cellular expression that implicates NFIX in many different roles 
within the developing and adult cerebellum. 
 
A key finding from this current study is that NFIX expression is evident in multiple different cell 
populations throughout development and in the adult cerebellum.  This broad pattern of expression 
makes the phenotypic interpretation of full Nfi knockout mice difficult. Indeed, most of the studies 
on the role of NFIs in cerebellar development have been performed in full knockout models. Mice 
lacking Nfix, for instance, display delays in differentiation of CGNPs and subsequent granule 
neuron migration, but whether this arises from deficits within NFIX-expressing EGL progenitor 
cells themselves, or because of delays in the production of CGNPs from the rhombic lip, is 
unknown.  How can the differing roles of Nfi genes be parsed in different cellular populations? This 
is now feasible as conditional alleles for Nfi genes, including Nfix, have been generated.  This has 
enabled the role of Nfix in muscular development, for example, to be analysed in a cell-type-
specific manner [161].  Looking forward, a similar approach would be a very powerful way to 
address the role NFIX plays in discrete cellular populations within the cerebellum.  For instance, 
crossing the Nfixfl/fl line to a Math1-Cre line [50] would enable the role of Nfix within progenitor 
cells within the rhombic lip to be assessed. Similarly, a tamoxifen-inducible Math1 line (Math1 
Cre-ER) would   
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Figure 2-11 Expression of NFIX by a subpopulation of unipolar brush cells within the 
cerebellum.  
Expression of DAPI (blue), NFIX (red) and calretinin (green) in mid-sagittal sections of P5 (a–
d), P15 (e–h), and adult (i–l) cerebellar tissue. At each of these ages, expression of calretinin 
was coincident with NFIX in some unipolar brush cells (arrows), but not in all of these cells 




enable ablation of Nfix from MATH1-expressing CGNPs in the EGL at different times during 
cerebellar development. This approach could also be valuable in the mature cerebellum to study the 
role of Nfix in astrocytes using the recently characterised GFAP-CreER line; the Cre-recombinase 
under control of a GFAP promoter [162]. Recent studies have also described inducible Cre-ER 
knocking lines that target GABAergic interneurons, which may allow the investigation of Nfix 
deletion in interneurons of the cerebellum, although a specific driver to target stellate and basket 
interneurons has not been clearly defined [163]. These experiments are critical if we are to pursue a 
comprehensive understanding of the role this transcription factor plays during formation and 
functioning of the cerebellum.  
 
Similar to the other NFI family members, Nfix undergoes alternative splicing during transcription to 
generate distinct variants with unique gene activation and repression profiles [157]. Here we have 
identified and quantified the expression of four known Nfix variants in CGNPs isolated from the 
early postnatal mouse cerebellum. Previous studies have identified alternatively spliced variants of 
Nfix in many different tissues in multiple species. For example, novel Nfix isoforms have been 
identified in both dairy goats [164] and cattle [165], with varied expression levels in different 
tissues, suggesting Nfix isoform function may be relative to tissue type. Multiple Nfix isoforms have 
also been reported in human neural tissue. For instance, the human NFI-X3 isoform is upregulated 
during the differentiation of astrocytic progenitors, and drives the expression of the astrocytic genes 
GFAP and SPARCL1 in glioma cells [166]. Interestingly, the NFI-X3 variant is also highly 
conserved across mammalian species [166]. We reveal here that the four known Nfix variants are 
present in cerebellar CGNPs at detectable levels via qPCR, with variants 1 and 3 showing 
significantly higher levels of expression. To ascertain the role of each transcript in cerebellar 
development, overexpression of individual variants in vitro, followed by RNA-seq analysis, would 
help to identify the relative transcriptomic changes observed when each transcript is overexpressed. 
In addition to this, lentiviral overexpression of individual variants could be used to determine the 
spatial and temporal roles of individual variants in vivo.  
 
Since NFIs play a key role in regulating the differentiation of neuronal and glial progenitors [90], 
they may also play a role in the failure of cells to differentiate - a hallmark trait of many cancer 
stem cells. Indeed, NFIs have been implicated in a variety of different cancers; Nfib has been 
identified as an oncogene in small cell lung cancer, [167] and Nfib variants have also been linked to 
metastasis in osteosarcoma [168]. Nfic has been shown to be involved in regulation of breast cancer 
[117] and downregulation of Nfia represses tumour cell growth in oesophageal carcinoma 
carcinoma [169] and medulloblastoma [136, 170]. Medulloblastoma is the most common paediatric  
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Figure 2-12 Expression of IBA1 and NFIX within the developing and adult cerebellum.  
Expression of DAPI (blue), NFIX (red), and IBA1 (green) in mid-sagittal sections of P5 (a–d), 
P15 (e–h), and adult (i–l) cerebellar tissue. Although we observed some co-expression of IBA1 
and NFIX within the cerebellum (arrows), the majority ofIBA1-expressing microglia were not 
immunopositive for NFIX (double arrowheads). Scale bar (in l) 50 µm 
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malignant brain cancer in humans, with four distinct subtypes based on variable gene expression 
and morphological profiles [171]. In the mouse cerebellum, conditional deletion of one Nfia allele 
has been demonstrated to result in decreased tumour latency and poorer prognosis in a SHH model 
of medulloblastoma [136]. The overlapping expression patterns of Nfia and Nfix in the cerebellum, 
coupled with the delay in differentiation of CGNPs lacking Nfix [91] suggests that aberrant NFIX 
expression may also be a feature in some medulloblastoma patients. Future work aimed at 
investigating the role of NFIX in medulloblastoma biology is needed to address whether or not this 
factor plays a role in the formation of this malignant cancer. Both conditional deletion and 
overexpression of the gene in vivo and in vitro will allow us to determine the role of Nfix in driving 
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Figure 2-13 Expression of NFIX by oligodendroglial cells within the cerebellum. 
 Expression of DAPI (blue), NFIX (red), and OLIG2 (green) in mid-sagittal sections of P5 (a–
d), P15 (e–h), and adult (i–l) cerebellar tissue. At each age, we observed OLIG2-expressing 
oligodendroglial cells that were immunopositive for NFIX (arrows), as well as oligodendroglial 
cells that were not (double arrowheads). Scale bar (in l) 50 µm. 
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Figure 2-14 Four Nfix isoform variants are expressed by granule neuron 
progenitor cells in the postnatal cerebellum. 
(A) Structure of the four characterized Nfix isoforms. Isoforms 1-3 were identified in 
the RNA-seq analysis. Variant four (shown in grey) was not sufficiently abundant to be 
identified in this analysis. (B) qPCR analysis performed on cDNA generated from 
isolated P7 CGNPs revealed that all four Nfix isoforms were expressed as this age, albeit 
with variants 2 and 4 at very low levels. Fold enrichment of mRNA expression was 
measured against the internal control, Gapdh. Error bars indicate SEM. Fold increase 
for each variant: Variant 1= 0.912 (± 0.251), Variant 2= 0.033 (±0.005), Variant 3= 
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2.8 Conclusions and Chapter Summary 
In conclusion, the research in this chapter shows that NFIX expression is extensive throughout the 
development of the postnatal cerebellum. Expression is present in cell-types of unique 
developmental origins and persists in both progenitor and post-mitotic populations. Additionally, 
we show that presence of four novel isoforms of NFIX are expressed in granule neuron progenitors. 
Taken together, this shows that NFIX plays a diverse role in cerebellar development and raises the 
question; what molecular mechanisms are being manipulated by the action of this transcription 
factor? 
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3.1 Chapter overview and aims 
 
Chapter 3, is the second data chapter of this thesis. Whilst Chapter 2 explored NFIX expression 
patterns in wild-type mice, chapter 3 utilises the Nfix-/- mouse line, and aims to determine a) what 
phenotypic changes occur upon global loss of NFIX and b) how loss of NFIX affects the 
transcriptomic network of the developing cerebellum. This work expanded on data in Chapter 2 that 
showed broad NFIX expression in postnatal CGNPs. Using RNA-sequencing and Chromatin 
Immunoprecipitation -sequencing (RNA-seq and ChIP-seq respectively), our data show that NFIX 
regulates the expression of an extensive network of developmentally significant genes, a number of 
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3.2 Chapter abstract  
Cerebellar granule neurons are the most numerous neuronal subtypes in the central nervous system. 
Within the developing cerebellum, these neurons are derived from a population of progenitor cells 
found within the external granule layer of the cerebellar anlage, namely the cerebellar granule neuron 
precursors. The timely proliferation and differentiation of these precursor cells, which, in rodents 
occurs predominantly in the postnatal period, is tightly controlled to ensure the normal morphogenesis 
of the cerebellum. Despite this, our understanding of the factors mediating how CGNP differentiation 
is controlled remains limited. Here, we reveal that the transcription factor nuclear factor I X (NFIX) 
plays an important role in this process. Mice lacking Nfix exhibit reduced numbers of CGNPs during 
early postnatal development, but elevated numbers of these cells at postnatal day 15. Moreover, Nfix-
/- CGNPs exhibit increased proliferation when cultured in vitro, suggestive of a role for NFIX in 
promoting CGNP differentiation. At a mechanistic level, profiling analyses using both ChIP-seq and 
RNA-seq identified the actin-associated factor intersectin 1 as a downstream target of NFIX during 
cerebellar development. In support of this, mice lacking intersectin 1 also displayed delayed CGNP 
differentiation. Collectively, these findings highlight a key role for NFIX and intersectin 1 in the 
regulation of cerebellar development. 
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3.3 Introduction 
During nervous system development, transcription factors play a variety of key roles, including the 
regulation of the genes that control proliferation and self-renewal, differentiation, migration and 
maturation. The cerebellum provides a salient example of how different transcription factors mediate 
the development of neural stem cells and their progeny [91, 103, 107]. The cerebellum coordinates 
the timing and execution of motor commands in response to sensory feedback from the peripheral 
nervous system [7, 44]. In the developing rodent brain, the cerebellum is ultimately derived at 
approximately embryonic day (E) 12 from precursor cells in the rhombic lip, a rapidly dividing group 
of neuroepithelial cells located within the emerging hindbrain [143]. The specification and 
proliferation of these cells is driven in large part by transcription factors including OTX2, PAX6 and 
MATH1 [50, 172, 173]. These progenitor cells then migrate to populate the outer surface of the 
cerebellar anlage [174], forming a secondary, transient proliferative zone known as the external 
granule cell layer (EGL) [143]. The proliferation of these cells continues well into the postnatal 
period, a process regulated by transcription factors including PAX6, ZIC1 and ZIC3 [73, 74]. During 
the first 2 weeks postnatally, progenitor cells within the EGL differentiate into immature granule 
neurons, which subsequently migrate radially into the emerging cerebellum to the inner granule layer 
(IGL), where they fully mature. Again, transcription factors such as NEUROD1, MBH1, MBH2, 
ZIC1 and ZIC2 contribute to these processes [175-177].  
 
Another suite of transcription factors that have been shown to regulate development of the hindbrain 
and cerebellum are the nuclear factor I (NFI) family [103, 107]. These transcription factors are 
expressed in a variety of progenitor cell populations within the developing [93, 130, 178] and adult 
nervous system [86, 179], as well as by progenitor cells in other regions of the body [97, 180, 181]. 
NFIs have been implicated in a variety of facets of brainstem development [103]. NFIB, for example, 
has been shown to mediate basilar pontine development, as precerebellar neurons and pontine neurons 
exhibit delayed differentiation in the absence of this gene [182]. NFIA and NFIB are also expressed 
by CGNPs within the postnatal EGL, and by the progeny of these cells as they migrate to, and 
differentiate within, the postnatal IGL [100]. Importantly, many aspects of granule neuron migration 
and maturation are abnormal in Nfia-/- mice, including migration, axonal formation and arborisation 
of dendritic processes [100, 101]. NFIs have further been shown to control these processes via the 
regulation of genes that mediate granule neuron maturation, including Tag1, Wnt7a and Gabra6 [99-
101]. These findings highlight the critical role played by NFI transcription factors in cerebellar 
development. 
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We have recently shown that another NFI family member, NFIX, is highly expressed by CGNPs 
within the postnatal EGL [Chapter 2]. Moreover, Nfix-deficient mice exhibit delayed cerebellar 
development [91]. These findings are suggestive of NFIX mediating progenitor cell differentiation 
within the postnatal cerebellum. Our previous work within the forebrain supports this concept, as we 
have shown NFIX to be a pivotal factor in promoting neural stem cell differentiation within the 
neocortex [86, 96] and hippocampus [84, 183], via the transcriptional regulation of genes such as 
Sox9, Gfap, Insc and Bbx [84, 183, 184]. Here we sought to define the mechanism by which NFIX 
regulates CGNP biology. We reveal that Nfix-/- mice exhibit delayed CGNP differentiation in vivo, 
and that Nfix-deficient CGNPs proliferate more extensively than control CGNPs in vitro. Moreover, 
we used both chromatin immunoprecipitation and sequencing (ChIP-seq) and RNA sequencing 
(RNA-seq) to identify potential NFI targets within postnatal CGNPs, and identified intersectin 1 as a 
target for NFIX-mediated transcriptional activation. Crucially, analysis of intersectin 1 mutant mice 
revealed phenotypically similar cerebellar defects. These findings thus provide novel insights into the 
transcriptional regulation of CGNP differentiation, revealing that NFIX-mediated regulation of 
intersectin 1 plays a central role in ensuring the timely differentiation of this postnatal neural 
progenitor cell pool.  
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3.4 Methods 
3.4.1 Animals and ethics approvals 
This research involved the use of animals. Nfix+/+ and Nfix-/-  mice were used in this study with 
approval from the University of Queensland Animal Ethics Committee (AEC approval numbers: 
QBI/143/16/NHMRC/ARC and QBI/149/16/ARC). Itsn1-deficient animals were also used in 
accordance with the recommendations of the Canadian Council on Animal Care and animal care 
regulations and policies of the Hospital for Sick Children, Toronto. Animals were genotyped as 
previously described [96, 185]. Primer sequences are available on request. All experiments were 
performed according to the Australian Code of Practice for the Care and Use of Animals for Scientific 
Purposes. Pregnant females were produced by placing male and female mice together overnight. The 
next day, females were inspected for the presence of a vaginal plug and, if present, this day was 
designated as E0. The day of birth was designated as postnatal day (P) 0. Mice were housed in 
Optimice IVC caging, with double HEPA filters and built in ventilation.  Food and water were 
available ad libitum.  
 
3.4.2 Immunohistochemistry 
Chromogenic immunohistochemistry and immunofluorescence labelling were performed as 
described in Chapter 2. Briefly, mice were anesthetised and perfused transcardially with phosphate-
buffered saline (PBS), followed by 4% paraformaldehyde (PFA), then post-fixed for 48-72 hours 
before long term storage in PBS at 4°C. Cerebella were isolated and embedded in 3% Noble agar and 
sectioned in a sagittal plane at 50 µm intervals using a vibratome. Sections were placed sequentially 
across the wells of a 6-well plate to ensure appropriate sampling from different medio-lateral regions 
of the cerebellum. There were between 6-8 cerebellar sections per well.  Thus, for all analyses we 
had >6 sections per animal to image and analyse. Sections were mounted on slides before heat-
mediated antigen retrieval was performed in 10 mM sodium-citrate solution at 95°C for 15 min. For 
chromogenic immunohistochemistry, sections were incubated overnight in primary antibodies at 
room temperature. A list of antibodies used in this study is given in Table 1. The following day, 
sections were rinsed in PBS, then incubated in a solution containing a biotinylated secondary antibody 
(Vector Laboratories) for 1 hour at room temperature, followed by processing with a VECTASTAIN 
ABC kit for 1 hour at room temperature (A used at 1/500, B used at 1/500, Vector Laboratories). 
Sections were rinsed again in PBS, then were processed for colour reaction using a nickel- 3,3'-
diaminobenzidine (DAB, Sigma) solution (2.5% nickel sulfate and 0.02% DAB in 0.175 M sodium 
acetate) activated with 0.01% (v/ v) hydrogen peroxide. The colour reaction was stopped by rinsing 
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multiple times with PBS, and sections were then coverslipped with DPX mounting medium (Thermo 
Fisher Scientific). For IF labeling, sections were incubated at 4°C overnight with primary antibodies 
against the target proteins (see Table 1). The following day sections were rinsed in PBS, then 
incubated with the relevant secondary antibodies (Table 1) for 1 hour in the dark at room temperature. 
Sections were rinsed in PBS, then were counterstained with 4’,6-diamidino-2-phenylindole (DAPI), 
and mounted in fluorescent mounting media (DAKO). For all experiments, at least three animals at 
each age were analysed. 
Table 3 Antibodies used in this chapter 
 
3.4.3 Cerebellar imaging 
All brightfield images were captured using an Aperio XT Slide scanner and visualized using Aperio 
ImageScope (Leica Biosystems). For fluorescence images a Diskovery inverted spinning disk 
confocal microscope using a 20 X objective and a 70 µm pinhole (Nikon TiE; Nikon) was used. We 
took 10 consecutive 1 µm-thick optical sections to generate a 10 µm-thick z-stack. In all cases the 10 
µm z-stack was taken from the middle of the section to minimize potential artefacts arising from the 
sectioning process such as damage to the tissue. Image acquisition was performed using NIS-elements 
Advanced Research software (Nikon). For comparative analysis of Nfix-/- and Nfix+/+ mice, high 
magnification images were taken of the same lobe of the cerebellum, using at least five biological 
replicates at each of the ages assessed. For Itsn1-/- and Itsn1+/+ mice, at least three biological replicates 
were used. For quantification of granule neuron and proliferative markers (PAX6 and Ki67, 
respectively), three 200 µm regions of the EGL were quantified for each section. This ensured more 
representative count of the EGL thickness. 1 µm-thick optical sections were viewed in Fiji, and the 
‘cell counter’ plugin used to mark and quantify cells expressing respective markers in each 
fluorescent channel. Cells co-expressing markers (for example PAX6 and Ki67) were also quantified 
this way, and DAPI was used to visualize the cell nucleus, to ensure accuracy, especially in areas of 





Dilution used Purpose 
NFIX Mouse SIGMA SAB1401263 1/200;1/1000 IF/IHC 
PAX6 Rabbit Millipore AB2237 1/400 IF 
NEUN Rabbit Millipore MAB377 1/200 IF 
GFAP Rabbit DAKO Z0334 1/1000 IF 
PHH3 Rabbit Millipore 06-570 1/400 IF 
Ki67 Mouse BD Pharmigen 550609 1/400 IF 
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3.4.4 Granule cell isolation 
CGNPs from P7 Nfix+/+ and Nfix-/- mice were isolated using the method outlined by Lee and 
colleagues [141] and a papain dissociation kit (Worthington Biochemical Corporation). Briefly, the 
cerebellum was dissected from three wild-type and three knockout mice and the tissue was dissociated 
using a 20 units/mL papain solution at 37°C for 15 mins.  A single cell suspension was obtained by 
trituration with a serum-coated P1000 pipette tip and nuclear membranes were removed using an 
albumin-ovomucoid inhibitor gradient.  CGNPs were separated from other cells using a 30%-60% 
percoll gradient.  Purified CGNPs were then lysed in Trizol (Ambion) and RNA isolated using an 
RNeasy miniprep kit (Qiagen).  RNA-sequencing was then performed on the samples using the 
Illumina NextSeq High Output system (Illumina; 150 base pair read length, paired-end reads).  
 
3.4.5 RNA-seq analysis 
Three RNA-seq replicates each from P7 wild type CGNPs and Nfix-/- mice were aligned by TopHat2 
(v2.0.9) [152] to the Mus musculus, UCSC, mm10 reference transcriptome and FASTA annotation 
downloaded from the TopHat index and annotations page 
(https://ccb.jhu.edu/software/tophat/igenomes.shtml). Cufflinks (v2.1.1) [152] was used to assemble 
each replicate’s transcripts from the alignment file generated by TopHat. Cuffmerge was used to 
create a single assembly containing transcripts across all samples and replicates. Cuffdiff was run 
using the merged set of transcripts and the three replicate TopHat2 bam files from each sample. Math1 
differential expression data was obtained from Klisch and colleagues [186], comparing RNA-seq 
expression of E18.5 wild-type and Math1-/- cerebellar tissue. 
 
3.4.6 NFIX ChIP-seq 
For chromatin immunoprecipitation, litters of P7 pups were pooled for CGNP isolation. Isolated 
CGNPs were crosslinked with 1% formaldehyde for 10 minutes, then were quenched with glycine. 
Cells were lysed in RIPA buffer supplemented with protease and phosphatase inhibitors (Roche) and 
sonicated with a Bioruptor (Diagenonde) for six 15 minute intervals of 30 seconds on, 30 seconds 
rest. Chromatin immunoprecipitation was performed as described previously [187], using a mouse 
anti-NFIX antibody (Sigma Aldrich). We have previously shown the specificity of this antibody using 
tissue from Nfix-/- mice [179]. Briefly, immunocomplexes were isolated with protein G-agarose beads 
(Roche), washed once for 5 minutes with buffers 1 through 4. Crosslinking was reversed by 
incubation with proteinase K (Roche) at 60 degrees overnight. DNA was isolated by phenol-
chloroform extraction then incubated with RNAse A (Roche) for 30 minutes before final cleanup 
with PCR columns (Qiagen). Sequencing libraries were constructed using the standard protocol for 
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the NEBNext Ultra II DNA Library Prep Kit for Illumina (New England BioLabs). Pooled libraries 
were sequenced on an Illumina HiSeq2000 (Illumina; 30 base pair single end read). 
3.4.7 ChIP-seq analysis 
Alignment was performed on both the NFIX ChIP-seq data and MATH1 ChIP-seq data set 
(GSE22111) by bowtie2 [188] to mm10. Unaligned reads and reads which aligned to multiple 
locations were removed leaving only uniquely mapped reads. MACS2 [189] was used to call narrow 
peaks with default parameters for both datasets. Both experiments contained two biological replicates 
and if both biological replicates shared a peak, it was recorded using the maximum boundaries of the 
supporting peaks to generate a merged set of peaks for each experiment. Uniform 500 base pair peaks 
from the NFIX ChIP-seq data were created using a ± 250 base pair window around peak centres. This 
uniform set of peaks was input to MEME Suite to perform de novo motif discovery using MEME-
ChIP version 5.0.1 [190, 191]. 
 
3.4.8 Annotation of ChIP-seq peaks 
A set of target genes was identified for both NFIX and MATH1 by the following method. A promoter 
region was defined as ± 2000 base pairs around a transcription start site. ChIP-seq binding sites 
located in a promoter region were annotated as proximal, while sites outside the promoter region but 
overlapping gene boundaries (transcription start to stop) were labelled as genic. All remaining binding 
sites were labelled as distal. A binding site annotated as proximal was assigned the nearest gene as a 
target while genic binding sites were assigned the overlapping gene as a target. Distal binding sites 
are difficult to assign target genes to, as they are not necessarily regulating the nearest gene (by 
genomic distance). CisMapper was used to annotate distal binding sites and provide a secondary 
annotation to proximal and genic sites, with resulting links filtered to a threshold of 0.05 [192]. 
 
After identifying a gene target for each NFIX binding site; the associated p-value from both the Nfix 
and Math1 RNA-seq differential expression analyses was recorded. Genes targeted by both Nfix and 
Math1 with a significant (p < 0.05) change in expression in both experiments were extracted. Genes 
showing coordinated positive or negative log fold change values across both experiments were 
selected to generate a putative set of genes under the control of Nfix and Math1. Functional annotation 
was performed using DAVID (6.8) on target genes identified for Nfix [193, 194]. 
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3.4.9 DNase I hypersensitivity analysis 
DNase I hypersensitivity (DHS) called peaks from whole cerebellum at P7 across three replicates 
were retrieved from Frank et al. 2015 (GEO: GSE60731). UCSC liftover was used to convert the 
mm9 files to mm10. If at least two replicates shared a peak, it was recorded using the maximum 
boundaries of the supporting peaks to generate a merged DHS peak file. Transcription factors are 
known to bind preferentially in regions of accessible chromatin [195, 196] and DHS was therefore 
used to extract NFIX ChIP-seq peaks occurring in accessible regions.  
 
3.4.10 Neurosphere assays 
CGNPs were isolated from P7 wild-type and Nfix-/- mice and were seeded into a T25 flask in 
neurobasal stem cell medium containing 20 ng/mL of epidermal growth factor (EGF), 10 ng/mL of 
basic fibroblast growth factor (bFGF) and 3.5 µg/mL of heparin. After 7 days, neurospheres were 
dissociated using trypsin to form a single cell suspension.  Cells were counted and seeded at a density 
of 2.5 x 105 cells per T25 flask.  Cells were passaged until passage three.  Neurospheres were counted 
and sphere diameter was measured at each passage.   
 
3.4.11 Medulloblastoma cell lines 
The medulloblastoma cell lines DAOY, D283, and UW228 were maintained in RPMI medium 
containing 10% foetal bovine serum. The MB4 primary cell line was maintained in StemPro NSC 
SFM media (Thermo Fisher). 2.5 x 105 cells were seeded into a 6 well plate and cells were lysed in 
Trizol (Ambion) after 48 hours. RNA was extracted using the RNAeasy miniprep kit (Qiagen). cDNA 
was prepared from RNA isolated from the medulloblastoma cell lines using a Superscript III Reverse 
Transcription kit (Invitrogen). cDNA was transcribed from human cerebellum RNA (Clontech) and 
used as a control for comparison of gene expression levels. qPCR was performed with the Quantifast 
SYBR kit (Qiagen). Gene expression was calculated using 2−ΔΔCt method relative to the housekeeping 
gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). 
 
3.4.12 qPCR analysis of target genes 
RNA isolated from CGNPs of wild-type and Nfix-/- mice at P7 was used to prepare cDNA as described 
previously [178]. qPCR was performed with Quantifast SYBR Green (Qiagen) to detect gene 
expression levels of the genes identified in the RNA-seq analysis. Gene expression was calculated 
using 2−ΔΔCt method relative to the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase 
(Gapdh). All the samples were tested in triplicate within each experiment, and each experiment was 
repeated three times. 
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Table 4 qPCR primers used in this chapter 
Gene Forward Rev 
Itsn1 TCAGTTTCCCACACCTTTCG TCAGGCTAAGGAACTGCTGG 
Kit CACATACACGTGCAGCAACA GAAGGCCAACCAGGAAAAGT 
Serpine2 ACGGCAAGACAAAGAAGCAG AGCCTTGTTGATCTTCTTCAGC 
Dab1 AACCAGCGCCAAGAAAGAC ATCAGCTTGGCTTTGTACCG 
Hes1 TCTGAGCACAGAAAGTCATCA AGCTATCTTTCTTAAGTGCATC 
Dll1 TTCTCTGGCTTCAACTGTGAG CATTGTCCTCGCAGTACCTC 
Notch3 AGTGCCGATCTGGTACAACTT CACTACGGGGTTCTCACACA 
Neurod1 ATGACCAAATCATACAGCGAGAG TCTGCCTCGTGTTCCTCGT 
Rbfox3 GGCAAATGTTCGGGCAATTCG TCAATTTTCCGTCCCTCTACGAT 
Gapdh GCACAGTCAAGGCCGAGAAT GCCTTCTCCATGGTGGTGAA 
Nfix AGGACTGTTTTGTGACTTCCG GGTTGATGTTGTAGTAGCTGGG 
Gapdh CCCTTCATTGACCTCAACTACAT TCCTGGAAGATGGTGATGG 
Itsn1 GGGCCATAACTGTAGAGGAAAGA ACAGGTTGAGGTAACCCAGAT 
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3.5 Results  
3.5.1 Delayed EGL differentiation in the cerebellum of postnatal Nfix-/- mice. 
In our preliminary description of the cerebellar phenotype of Nfix-/- mice, we demonstrated that these 
mice have reduced numbers of PAX6-positive CGNPs in the EGL at P5 in comparison to wild-type 
controls [91]. Within the embryonic forebrain of these mutant mice, radial glial progenitor cells 
exhibit delayed differentiation [183, 184]. We hypothesised that CGNPs within the EGL would 
exhibit a similar delay in differentiation within Nfix-/- mice. To test this hypothesis, we used PAX6-
immunocytochemistry to visualise CGNPs within the EGL of P5, P10 and P15 wild-type and Nfix-/- 
mice. At P5, there were fewer CGNPs in the EGL of mutant mice in comparison to controls, whereas 
at P10, the number of these cells in both genotypes was comparable (Figure 3-1 A-D). Interestingly, 
at P15 there were more PAX6-positive cells in the EGL of the mutant in comparison to the control 
(Figure 3-1 E, F), indicative of delayed CGNP differentiation.  
 
To quantify this phenotype, we performed co-immunofluorescence labelling against PAX6 and the 
proliferation marker, Ki67, followed by confocal microscopy. We performed cell counts within the 
EGL on confocal optical sections of the emerging cerebellum. At P5, there were significantly more 
cells expressing PAX6 and Ki67 in the wild-type EGL compared to the mutant (Figure 3-2 A-J). At 
P10, however, the numbers of PAX6-positive cells and proliferating cells within the EGL was not 
significantly different between genotypes (Figure 3-2 K-T). In contrast, there were significantly more 
CGNPs within the EGL of P15 Nfix-/- mice compared to the control, as the majority of these cells had 
differentiated in wild-type mice by this age (Figure 3-2 U-DD). A similar trajectory of CGNP 
differentiation was observed when we used a second marker for proliferation, the mitotic marker 
phosphohistone H3 (PHH3; Figure 3-3). 
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3.5.2 Nfix-/- CGNPs exhibit increased proliferation in vitro. 
These findings led us to posit that NFIX mediates CGNP differentiation, and that the absence of this 
gene could lead to elevated CGNP proliferation, as has been previously reported in the embryonic 
hippocampus of Nfix-/- mice [183]. To test this hypothesis, we isolated CGNPs from the EGL of P7 
wild-type and Nfix-/- mice using papain dissociation and a percoll gradient [141], [Chapter 2]. We 
performed qPCR on cDNA generated from this tissue, and revealed that the expression of the stem 
cell markers Hes1 and Notch 3 was significantly elevated in CGNPs isolated from P7 Nfix-/- mice in 
comparison to controls (Hes1: control 0.0051 ± 0.0001, Nfix-/- 0.0079 ± 0.0003; Notch 3: control 
0.0023 ± 0.0001, Nfix-/- 0.0038 ± 0.0002; p < 0.01, t-test). Moreover, the analysis of two markers for 
neuronal differentiation, Neurod1 and NeuN (Rbfox3) revealed significantly reduced expression of 
these factors in CGNPs isolated from P7 Nfix-/- mice in comparison to controls (Neurod1: control 0.53 
± 0.01, Nfix-/- 0.37 ± 0.002; Rbfox3: control 0.13 ± 0.003, Nfix-/- 0.005 ± 0.004; p < 0.01, t-test). 
 
Next, we used the percoll gradient protocol to again isolate CGNPs from the EGL of P7 wild-type 
and Nfix-/- mice and cultured these cells in a neurosphere assay. We cultured cells for three 
passages, and quantified both the number of spheres, as well as sphere diameter. At each passage, 
there were significantly more spheres in cultures derived from Nfix-/- EGL progenitors in 
comparison to controls (Figure 3-4 A-C). Furthermore, whereas the majority of wild-type spheres 
were less than 50 µm in diameter, in the mutant, the majority of spheres were over 70 µm in 
diameter (Figure 3-4 D). Interestingly, the expression of GFAP by developing Bergmann glia was 
also delayed in the absence of Nfix [Figure 3-5; [91]], suggesting that a delay in glial differentiation 
could also potentially underlie the accumulation of PAX6-positive cells within the EGL of Nfix-/- 
mice. However, our neurosphere data clearly indicate elevated levels of proliferation in CGNPs 
isolated from Nfix-/- cerebella, indicating that NFIX plays a central role in mediating the 
differentiation of cerebellar CGNPs. 
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Figure 3-1 Delayed differentiation of CGNPs in the cerebellum of Nfix deficient mice.  
Mid-sagittal sections of P5 (a–b’), P10 (c–d’) and P15 (e–f’) wild-type (a, c, e) and Nfix−/− (b, d, f) 
mice stained with antibodies against PAX6. The boxed regions in A-F are shown at higher 
magnification in a’–f’ respectively. The morphology of the cerebellum appeared grossly normal 
in mice lacking Nfix. However, higher magnification views of the external granule layer (EGL) 
revealed that this germinal zone was thinner at P5 in mutant mice. At P10 the EGL of the mutant 
was comparable to the control. At P15, whereas the EGL was almost completely depleted in the 
wild-type, there were still numerous PAX6-positive cells in this cellular layer of Nfix−/− mice. 
Scale bar (in a) a–f = 250 µm, a’–f’ = 25 µm 
 
  
  63 
Mutations in another NFI family member, Nfia, have previously been implicated in medulloblastoma, 
a paediatric cancer of the cerebellum [136]. Using a Sleeping Beauty transposon screen, Genovesi 
and colleagues [136] revealed that mutations to Nfia led to reduced latency of medulloblastoma 
formation in a Ptch1+/- background. Transposon insertions were also identified within the Nfix locus 
in this screen, but the role of NFIX in medulloblastoma is poorly defined. In light of our data in the 
developing cerebellum, we analysed NFIX expression in three medulloblastoma cell lines (DAOY, 
UW228 and D238), and a primary medulloblastoma cell line (MB4). NFIX mRNA was significantly 
reduced in comparison to control mRNA isolated from the adult cerebellum (Figure 3-4 E). A similar 
reduction in expression was also obtained when we analysed the expression of the other NFI family 
members, NFIA, NFIB and NFIC (data not shown). Collectively, these data are consistent with the in 
vivo cerebellar phenotype of Nfix-/- mice, and suggest that NFIX acts to drive the differentiation of 
cerebellar CGNPs.  
3.5.3 Transcriptomic profiling reveals a broad suite of potential targets of NFIX within GNPs. 
To define transcriptional targets for NFIX during CGNP differentiation, we undertook a range of 
bioinformatic approaches using both published, and newly generated, transcriptomic data, aimed at 
defining a small list of high-confidence targets that we could experimentally validate. To determine 
the transcriptomic landscape in CGNPs lacking Nfix, we first isolated CGNPs from both wild-type 
and Nfix-/- cerebella at P7, and performed transcriptomic profiling (RNA-seq) on the RNA isolated 
from these cells. Analysis revealed 1,402 genes as being significantly misregulated in Nfix-/- CGNPs 
in comparison to controls (Figure 3-6 A) Gene Ontology and Pathway analyses of these genes using 
DAVID [193, 194] identified a diverse range of processes potentially controlled by NFIX within 
CGNPs, including cell adhesion, extracellular matrix organisation and axon guidance (Figure 3-6 
B). 
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Figure 3-2 Retention of CGNPs in late postnatal Nfix−/− mice.  
Expression of the nuclear marker DAPI (blue), the proliferative marker Ki67 (green), and PAX6 
(red), a marker of CGNPs and their progeny, in P5 (a–h), P10 (k–r) and P15 (u–bb) mice. The 
EGL in delineated by brackets in panels c, g, m, q, w and aa. At P5 there were significantly more 
PAX6-positive cells (i) and PAX6/Ki67 double-positive cells (j) in the wild-type EGL in 
comparison to the mutant. At P10, there were no significant differences in either PAX6- (s) or 
PAX6/Ki67-expressing (t) cells between groups. At P15, however, there were significantly more 
PAX6-positive cells (cc) and PAX6/Ki67 double-positive cells (dd) in the EGL of Nfix−/− mice 
in comparison to the control. *p < 0.05, t test. Scale bar (in a) = 25 µm 
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To determine direct targets of NFIX in CGNP differentiation, we next performed ChIP-seq on DNA 
derived from isolated P7 CGNP preparations using an anti-NFIX antibody whose specificity has been 
previously demonstrated [179, 197]. This experiment identified 6,910 specific NFIX binding peaks 
(Figure 3-6 C). Interestingly, a recent publication used DNase 1 hypersensitivity analysis on whole 
cerebellar tissue to investigate chromatin accessibility within these cells at different stages in 
development [198]. We posited that NFIX ChIP-seq peaks identified within regions of open 
chromatin would be more likely to regulate gene transcription directly. As such, we filtered our NFIX 
ChIP-seq data using the DNase 1 hypersensitivity data from P7 [198], an analysis that revealed that 
5,843 of the NFIX ChIP-seq peaks were found in regions of accessible chromatin at this age (Figure 
3-6 C). Finally, the intersection of the differentially expressed genes identified via RNA-seq (Figure 
3-6 A) with those genes identified as having an NFIX ChIP-seq peak in an accessible region of 
chromatin (Figure 3-6 C) identified 578 genes as being potential targets for direct NFIX-mediated 
regulation within P7 CGNPs (Figure 3-6 D, Table A10). This analysis revealed a number of genes 
previously implicated in cerebellar development, such as Otx2 and Dab1, as well as a range of genes 
whose role in cerebellar development has not been previously studied (e.g. Heg1, Tiam2). 
Interestingly, Nfix was also identified via this filtering analysis, suggesting that NFIX autoregulates 
its own expression within the context of CGNP development.  
 
To search for further ways in which we could refine our list of potential NFIX target genes, we 
performed motif discovery and enrichment analyses (Bailey et al. 2009, Machanick et al. 2011) on 
the NFIX binding peaks isolated in our ChIP-seq experiment. As expected, the conserved motif bound 
by NFI transcription factors [107] was identified as being enriched in our ChIP-seq peaks. 
Interestingly, we also observed enrichment of the MATH1 binding motif within NFIX ChIP-seq 
peaks (Figure 3-7 A). MATH1 is strongly and specifically expressed by CGNPs, and has previously 
been shown to regulate the proliferation of these cells, as well as concomitantly priming them for 
differentiation [186]. This finding indicates that NFIX and MATH1 could potentially regulate a 
common suite of genes developmentally. Given this, we postulated that we could use the analysis of 
MATH1 target genes to further refine our list of potential NFIX targets. To do this, we used a recent 
analysis of the MATH1 targetome in cerebellar tissue [186]. This study mapped differential gene 
expression in E18.5 cerebellar tissue isolated from Math1-deficient mice, as well as identifying 
potential direct targets of  
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Figure 3-3 Delayed proliferation profile of CGNPs in the absence of Nfix.  
Transverse sections of P5 (a–d), P10 (f–i) and P15 (k–n) wild-type and mutant cerebella labelled 
with DAPI (blue) and antibodies against the proliferative marker phosphohistone H3 (PHH3). 
At P5, there were significantly more proliferating cells in the EGL of the wild-type (arrows in 
a, b) in comparison the control (arrowheads in c, d; quantified in e). At P10, however, the rate 
of proliferation within the EGL was comparable between sample wild-types and mutants 
(arrows in f–i; quantified in j). At P15, the situation was reversed, with there being significantly 
fewer proliferating cells within the EGL of wildtype mice (double arrowheads in k, l) in 
comparison to mutant mice (arrows in m, n; quantified in o). *p < 0.05, ***p < 0.001 t test. 
Scale bar (in a) = 25 µm 
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Figure 3-4 Fig. 4 Nfix−/− CGNPs exhibit elevated proliferation in vitro.  
CGNPs were isolated from P7 wild-type and Nfix−/− cerebella and were cultured in a neurosphere 
assay for multiple passages. At passage 3, wild-type spheres (a) were smaller and fewer in 
number than those derived from Nfix−/− CGNPs (b). Indeed, there were significantly more 
spheres derived from Nfix−/− GNPs at each passage in comparison to the control (c). Moreover, 
at passage 3, spheres derived from Nfix−/− CGNPs were on average larger than controls (d). e 
qPCR revealed that different medulloblastoma cell lines had significantly lower NFIX 
expression in comparison to normal cerebellar tissue. *p < 0.05, ***p < 0.001 ANOVA. Scale 
bar (in a) = 30 µm 
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MATH1 by performing ChIP-seq on P5 cerebellar tissue [186]. Analysis of these two sequencing 
datasets identified 1551 genes as potential MATH1 targets (i.e. the target gene contained at least one 
MATH1 ChIP-seq peak, and was significantly differentially expressed in E18.5 Math1-/- cerebellar 
tissue; Figure 3-7 B) [186]. The comparison of these potential MATH1 target genes with those 578 
NFIX target genes identified in our RNA-seq and ChIP-seq analyses (Figure 3-7 D) revealed 177 
genes as potential targets of both MATH1 and NFIX in cerebellar development. Critically, 90 of these 
genes were co-ordinately misregulated in both Nfix-/- CGNPs and Math1-/- cerebellar tissue (Figure 
3-7 B, C). This list of putative NFIX targets included Nfix itself, as well as other factors previously 
implicated in cerebellar development, including Otx2, Robo1 and Dab1 [173, 199, 200]. Interestingly, 
this analysis also revealed a range of genes that have not previously been implicated in cerebellar 
development, including Coro2b, and intersectin 1 (Itsn1; Figure 3-7D).  
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Figure 3-5 GFAP expression is reduced in early postnatal Nfix-/- mice. 
Expression of the nuclear marker DAPI (blue) and the glial marker, GFAP (green), in P5 (A-D) 
and P10 (E-H) wild-type (A, B, E, F) and Nfix-/- (C, D, G, H) mice. The EGL in delineated by 
brackets in panels B, D, F and H. At both P5 and P10 the expression of GFAP was reduced in the 
absence of Nfix. Scale bar (in A) = 25 µm 
  
  70 
3.5.4 Intersectin 1 is a target for transcriptional activation by NFIX during CGNP 
differentiation. 
Of those novel factors identified in our transcriptomic screens, Itsn1 was of particular interest to us. 
This gene encodes a multi-domain scaffold protein that has been implicated in regulating numerous 
cellular signalling pathways [201]. With relation to neuronal development, Itsn1 has been implicated 
in connectivity at the cortical midline of the dorsal telencephalon, with deficiencies to this gene 
correlated with aberrant higher order cognition [185]. Mechanistically, Itsn1 has recently been 
implicated in neuronal migration within the hippocampus as part of the reelin signalling pathway, via 
its interaction with the reelin receptor VLDLR, and with Dab1, a signalling molecule downstream of 
VLDLR [202]. Given the importance of reelin signalling for cerebellar development [203], and the 
identification of Dab1 in our transcriptomic screen, we focussed on Itsn1 as a target for NFIX in 
CGNP differentiation. We first validated our RNA-seq dataset by performing qPCR on CGNPs 
isolated from independent P7 Nfix-/- and control cerebella (Figure 3-8 A). In line with our sequencing 
results, Itsn1 mRNA was significantly reduced in Nfix-/- samples in comparison to controls, whereas 
the mRNA levels of Kit, serpine 2 and Dab1 were significantly increased in the mutant. These data 
suggest that NFIX acts to promote the expression of Itsn1 during CGNP differentiation. If this were 
the case, we would hypothesise that mice lacking Itsn1 would potentially phenocopy those lacking 
Nfix with regards to cerebellar development. To test this hypothesis, we analysed the cerebellum of 
Itsn1-/- mice at P15. Hematoxylin staining revealed that foliation of the cerebellum was grossly 
normal in these mice in comparison to controls (Figure 3-8 B, C). However, closer analysis of the 
EGL of mutant mice revealed that the EGL of Itsn1-/- mice at P15 was markedly thicker when 
compared to control mice (Figure 3-8 B’, C’). Indeed, immunofluorescence labelling with PAX6, 
followed by confocal microscopy, revealed significantly more CGNPs within the EGL of Itsn1-/- mice 
at this age than controls (Figure 3-8 D - J). Similarly, there were significantly more Ki67-expressing 
cells in the EGL of mutant mice at this age in comparison to wild-type controls (Figure 3-8 K). The 
expression of GFAP by Bergmann glia was comparable between wild-type and Itsn1-/- mice at this 
age (Figure 3-9), although it is possible that GFAP expression was reduced at earlier time points akin 
to what we observed with the Nfix mutant, and that this may also have contributed to the enlarged 
EGL at P15 in the absence of Itsn1. Finally, like NFIX, the expression of ITSN1 was also significantly 
reduced in medulloblastoma cell lines (Figure 3-8 L). Collectively, these data, in association with our 
RNA-seq and ChIP-seq analyses, suggest that NFIX-mediated regulation of Itsn1 plays an important 
role in CGNP differentiation during cerebellar development.  
 
 
  71 
 
Figure 3-6 Transcriptomic profiling of Nfix-/- CGNPs. 
(A) Volcano plot representing the transcriptional profile of P7 Nfix-/- CGNPs in comparison to 
controls. Red dots represent the 1,402 significantly misregulated genes in P7 Nfix-/- CGNPs as 
identified by RNA-seq. (B) Gene Ontology (DAVID 6.8) analysis, showing those biological 
processes, cellular components and molecular functions misregulated in P7 Nfix-/- CGNPs, as 
well as KEGG pathways identified as being abnormal in these cells. (C) To narrow the list of 
potential NFIX target genes, we performed ChIP-seq on wild-type P7 CGNPs with an anti-NFIX 
antibody. This revealed 6,910 NFIX binding peaks. We compared this with a published DNase 
I hypersensitivity analysis of P7 cerebellar tissue (Frank et al. 2015). Of the 6,910 ChIP peaks, 
5,843 were in regions of accessible chromatin. We then compared the 4,621 genes associated 
with these 5,843 NFIX peaks with our RNA-seq data (A). This analysis identified 578 potential 
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Figure 3-7 Combined analysis of Nfix-/- CGNPs and Math1-/- cerebellar tissue 
(A) MEME-suite de novo motif discovery run on NFIX ChIP-seq peaks revealed both the NFI 
motif, and the MATH1 motif, suggesting the two transcription factors potentially regulate a 
common suite of target genes. (B) Comparison of 1,551 genes bound by MATH1 and 
misregulated in Math1-/- cerebellar tissue [186] and 578 genes bound by NFIX and misregulated 
in Nfix-/- CGNPs identified 177 shared target genes. Of the 177 shared target genes, 90 were 
coordinately misregulated (i.e. up in both datasets, or down in both datasets) in both Math1-/- 
cerebellar tissue [186] and Nfix-/- CGNPs. These 90 genes are listed in panel C, with those genes 
in red being downregulated in Nfix-/- CGNPs, and those genes in green being upregulated in 
Nfix-/- CGNPs. The remaining 87 genes were not coordinately misregulated in the two datasets 
(i.e. expression was up in one dataset and down in the other, or vice versa). (D) Panel D shows 
genome browser tracks for the regions around the Itsn1 and Dab1 genes. The tracks reveal NFIX 
binding sites from our ChIP-seq dataset (NFIX_full, dark green), NFIX binding sites that appear 
in regions of accessible chromatin (NFIX_filtered, light green) and regions of open chromatin 
from published DNase 1 hypersensitivity analysis (DHS, red). Itsn1 has binding events 




  73 
3.6 Discussion 
Studies into the role of the NFI family in cerebellar development have highlighted a key role for these 
transcription factors in mediating neuronal migration and synaptic maturation [103]. Here, we extend 
these findings, revealing that NFIX regulates CGNP biology within the postnatal cerebellum. Indeed, 
the delayed differentiation of CGNPs in vivo in Nfix-deficient mice, coupled with the elevated 
proliferation of Nfix-/- CGNPs in vitro, are supportive of a role for NFIX in promoting timely CGNP 
differentiation within the postnatal cerebellum. This is in accordance with studies into the role of the 
NFI family during nervous system development [97, 204], with impairments in neural stem cell 
differentiation observed in the absence of NFIs from diverse regions of the brain, including the 
neocortex [205], hippocampus [84, 178] and spinal cord [206]. Collectively, these data implicate the 
NFI family, including NFIX, as key drivers of neural development via the promotion of neural stem 
cell differentiation. 
 
How do NFIs drive this process at a mechanistic level? A number of studies have investigated the 
roles these factors play during nervous system development. Early studies using Nfi-deficient mice 
revealed severe delays in astrocyte differentiation, suggesting a central role for this family in 
gliogenesis within the cerebral cortex and spinal cord [105, 207]. More recently, transcriptional 
profiling experiments such as microarrays, coupled with molecular analyses and bioinformatics, have 
identified a range of target genes in the developing and adult nervous system that act to either repress 
stem cell identity or to promote cellular differentiation [87, 183]. These include Apcdd1, Mmd2 and 
Zcchc24 (spinal cord) [208], Insc, Sox9 and Ezh2 and (hippocampus) [84, 178, 183], as well as Bbx 
and Hes1 (cerebral cortex) [130, 184]. The advent of genome-wide profiling using techniques such 
as RNA-seq and ChIP-seq now means that the direct targets of transcription factors like NFIX can be 
investigated globally in a more rigorous manner. To the best of our knowledge, this is the first study 
that has investigated downstream targets of a specific NFI family member within the nervous system 
by using these techniques co-operatively. Moreover, when coupled with available data relating to 
chromatin accessibility [198] and the MATH1 targetome [186], this study provides a significant 
conceptual advance in our understanding of the transcriptional landscape regulated by NFIX within 
the postnatal cerebellum. 
 
One of the novel targets identified as a potential regulator of CGNP biology downstream of NFIX 
using these techniques was the scaffold protein Intersectin 1. The gene coding for this factor contained 
NFIX ChIP-seq peaks near its 3’ UTR, and was significantly downregulated in the absence of Nfix. 
Moreover, mice lacking Itsn1 phenocopied Nfix-/- mice with regards to delayed differentiation of  
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Figure 3-8 Intersectin 1 is a downstream target for NFIX in CGNP development.  
(A) qPCR performed on P7 CGNPs from wild-type and Nfix-/- mice revealed significantly 
reduced levels of Itsn1. Levels of Kit, serpine 2 and Dab1 were, conversely, significantly 
elevated in the mutant in comparison to the controls.  (B, C) Mid-sagittal sections of P15 wild-
type (B) and Itsn1-/- (C) mice stained with hematoxylin. Gross morphology of the cerebellum 
was not altered in the absence of Itsn1. The boxed regions in B and C are shown in B’ and C’ 
respectively. These reveal that the EGL is markedly larger in Itsn1-/- mice on comparison to the 
controls. (D-I) Immunofluorescence staining with PAX6 revealed that, whereas few PAX6-
expressing cells remained in the EGL of wild-type mice (D-F) at this age, there were numerous 
PAX6-expressing CGNPs in in the EGL of Itsn1-/- mice (G-I). Quantitation of the EGL of P15 
mice revealed significantly more PAX6-expressing (J) and PAX6/Ki67-expressing (K) cells in 
the EGL of the mutant in comparison to the control at P15. (L) qPCR revealed that different 
medulloblastoma cell lines had significantly lower ITSN1 expression in comparison to normal 
cerebellar tissue. * p < 0.05, ** p < 0.01, *** p < 0.001 t-test 
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CGNPs within the postnatal EGL. These data suggest that Itsn1 contributes to the differentiation of 
CGNPs. At this stage, it is unclear precisely how Itsn1 regulates the differentiation of CGNPs. 
However, given the nature of this protein as a scaffold capable of binding and influencing many 
signalling pathways [201], there are many potential means by which Itsn1 could mediate CGNP 
differentiation. For example, Itsn1 has been shown to regulate Ras family GTPases, and is thought to 
promote Ras activation [209]. As Ras signalling has previously been shown to be required for the 
proliferation of CGNPs postnatally [210], abnormal activation of this factor, and the downstream 
ERK-MAPK pathway, may potentially contribute to the phenotype evident in these mice. Itsn1 has 
also been shown to mediate caveolin-mediated endocytosis [211]. This may be particularly pertinent 
for CGNP biology, as the continued proliferation of these cells is controlled, at least in part, by SHH 
released by Purkinje cells [212]. Endocytosis of the Shh receptor, Ptch1, to the lysosome plays a key 
role in continued CGNP proliferation [213]. It is feasible that Itsn1 may contribute to this process. 
Looking forward, proteomic studies performed on postnatal CGNPs will provide a framework in 
which to understand the molecular partners of ITSN1, and so the processes this scaffold protein may 
regulate in vivo.  
 
Our findings also suggest a potential role for Nfix in medulloblastoma, a malignant childhood cancer 
of the cerebellum. Another NFI family member, Nfia, was recently linked to the formation of 
medulloblastoma using a Sleeping Beauty transposon screen to identify genetic modifiers of tumour 
formation in Ptch1 heterozygous mice [136]. This study also identified Nfix as being significantly 
enriched as a tumour-suppressor. In humans, recent gene expression analyses of patient 
medulloblastoma samples revealed that NFIX expression is significantly lower in type 3α and type 
3γ medulloblastomas, subtypes with poor prognosis and increased frequency of metastasis [214]. 
Although both of these studies identified NFIX, Shh and Type 3 medulloblastoma subgroups are 
characterised by different oncogenic drivers. However, preliminary data suggest that Hedgehog-
dependent tumours, including medulloblastomas and basal cell carcinomas, are capable of switching 
oncogenic pathways, and hence becoming more metastatic [215, 216]. It remains to be tested whether 
NFI family members play a role in this transition, or appear as tumour suppressors solely due to their 
pro-differentiation roles. Furthermore, haploinsufficiency to NFIX in human patients culminates in 
Malan Syndrome, a disorder characterised by overgrowth of many organ systems, including the brain 
[121, 123]. This implies a pro-differentiation role for NFIX during development, and is consistent 
with our work on NFIX in the cerebellum.  
 
A key advance we have made in this work is to use RNA-seq, ChIP-seq (this study) and chromatin 
accessibility [198] to define the potential targets of NFIX during development. This approach enabled  
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Figure 3-9 GFAP expression is comparable in late postnatal Itsn1-/- mice. 
Expression of the glial marker, GFAP, in P15 wild-type (A, A’) and Istn1-/- (B, B’) mice. The 
boxed regions in A and B are shown at higher magnification in A’ and B’ respectively. The 
arrows in A’ illustrate GFAP-expressing Bergmann glia. These cells were also present in the 
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us to identify 5,843 high-confidence NFIX ChIP-seq peaks. Through the combination of our RNA-
seq analysis, these high-confidence peaks were subsequently linked to 578 target genes. Motif 
discovery further led us to identify MATH1 as a factor that may bind to similar genes as NFIX during 
CGNP development. Published data pertaining to the loss of Math1 expression [186] revealed that 
Nfix is downregulated in Math1-/- cerebellar tissue, suggesting that MATH1 potentially regulates Nfix 
expression. Indeed, a number of genes were commonly misregulated in both RNA-seq perturbation 
data sets (Figure 3-7 B). Therefore, genes bound by NFIX and showing expression changes in both 
data sets where NFIX was perturbed, albeit using different approaches, were considered to be high-
confidence target genes of NFIX.  
 
Ultimately, this focussed, multifaceted approach led us to identify 90 potential NFIX target genes. 
While we focussed here on Itsn1, the role of NFIX in mediating other genes identified via this screen 
offers a number of interesting avenues of future research. For example, the factors mediating the 
transcriptional activation of the NFIs themselves is very poorly defined. Our findings suggest that 
NFIX may autoregulate itself, a finding consistent with a recent report identifying NFIB as a regulator 
of Nfix expression in the developing spinal cord [206]. Moreover, investigating the expression and 
role of other novel factors highlighted in this screen will enhance our understanding of CGNP 
biology. Another point to consider is the fact that we filtered our target gene list (RNA-seq and ChIP-
seq; Figure 3-6 D) following our use of motif enrichment, which identified the MATH1 consensus 
binding site within our NFIX ChIP-seq peaks (Figure 3-7 A, B). We filtered our gene list based on 
those genes that were also potential targets of MATH1 [i.e. contained an MATH1 ChIP-seq peak, 
and were differentially regulated in Math1-deficient cerebellar tissue [186]] Many potential NFIX 
target genes (401 in total) were not identified in the MATH1 datasets, and as such, many more 
avenues remain to study novel targets of NFIX in CGNP differentiation (e.g. Tiam2, Lingo3, 
Adamts1). Finally, we also filtered our NFIX ChIP-seq peaks by only considering those peaks located 
within open chromatin [198]. An interesting finding of our ChIP-seq data was that many of the peaks 
were located in regions of closed chromatin. This suggests that NFIX may play roles in addition to 
regulating direct gene transcription. Indeed, NFIs have previously been shown to bind to histone H3, 
and to regulate nucleosomal architecture [204, 217, 218]. NFIB was also shown recently to regulate 
chromatin accessibility in small cell lung cancer in a manner that promoted tumour metastasis [219]. 
Looking forward, defining the functional significance of NFIX binding to closed regions of chromatin 
may provide new insights into how these factors regulate neural stem cell biology.   
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3.7 Conclusion 
In conclusion, the research in this chapter shows that loss of NFIX disrupts the developmental 
program of CGNPs, resulting in a delay in progenitor cell differentiation. NFIX directly regulates a 
large network of developmentally significant genes, of which a subset are co-ordinately regulated 
by the bHLH transcription factor MATH1. This suggests that NFI and bHLH transcription factors 
may work in tandem to drive CNS development, through regulation of downstream signalling 
pathways such as Reelin. The novel gene targets identified from this analysis warrant further 
investigation, not just from a developmental biology perspective, but also in the context of CNS 
cancer biology. Lastly, to get a wholistic picture of the role of NFIs in cerebellar development, we 
need to expand this analysis to include the other members of this transcription factor family.  
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Research included in chapter 4 was published in the journal The Cerebellum, in December 2019: A 
typeset version of this publication is included in the appendix.  
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 Common regulatory targets of NFIA, NFIX 
and NFIB during postnatal cerebellar development 
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4.1 Aims and chapter overview 
Chapter 4, is the last data chapter of this thesis. Chapter 4 expands on the work of the previous 
chapter utilising a similar methodology of combining RNA-seq and ChIP-seq, but this time 
incorporating data generated in Nfiafl/fl;Math1-cre conditional knockout mice with that from Nfix-/- 
mice. Our data show that NFI transcription factors regulate a discrete subset of genes in a co-
ordinate manner, including a number of other transcription factors of which a large portion have not 
previously been investigated in the cerebellum.  
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4.2 Abstract:  
In germinal niches, transcription factors play an overarching role in regulating the proliferation and 
differentiation of progenitor cells. Nuclear Factor One transcription factors regulate the 
differentiation of both neuronal and glial progenitors in the central nervous system and have an 
emerging role in neoplasms arising from these cells including medulloblastoma and glioma. 
Previous research has shown that loss of function or deletion mutations in NFI family members 
result in severe neural phenotypes in both humans and mice. These similar and often overlapping 
phenotypes suggest that this transcription factor family may co-ordinately regulate downstream 
gene targets. In the mouse cerebellum, we have shown that Nfix regulates the differentiation of 
cerebellar granule neuron progenitors by controlling the transcription of a large cohort of 
downstream gene targets. As of yet, a comprehensive functional profile of other NFI family 
members is lacking in these cells. Using co-immunofluorescence microscopy, we first found out 
that NFIA is expressed in CGNPs, CGNs and Glia in the postnatal cerebellum, in an expression 
pattern that closely overlaps that of NFIX in these cells. Next, we integrated transcriptomic 
sequencing and epigenetic profiling to reveal a specific subset of gene targets, co-ordinately 
regulated by Nfia and Nfix in postnatal CGNPs. Our results show that NFIs work both individually 
and co-ordinately, regulating a large number of developmentally significant genes and other 
transcription factors in these progenitors. Additionally, these data identify a large suite of novel 
target genes that may have roles in regulating neurogenesis in the cerebellum.  Collectively, these 
results highlight convergent roles of NFI family members in regulating CGNP development and 
position these transcription factor family members as key promoters of neurogenesis.  
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4.3 Introduction 
The development of the cerebellum is a complex process that relies on both directional and 
reciprocal interactions between transcription factors and gene targets, often in prominent signalling 
pathways. In germinal zones of the cerebellum, these interactions help demarcate progenitor 
populations and regulation their development and differentiation, often in a temporally dependent 
manner [28, 50, 149, 220, 221]. Many transcription factors in the cerebellum belong to families 
with multiple members similar binding motifs. Often these can work in tandem manner to drive 
developmental programs forward. Whilst expression analysis can be used to infer co-ordinated roles 
of TF family members in mediating development, a combination of both chromatin profiling and 
transcriptomic analysis is needed to provide functional insight into the role of individual family 
members in progenitor populations. For example, a combination of DNase-seq and RNA-seq 
recently identified a co-ordinated role of Zic1 and Zic2 in mediating CGNP maturation [198]. 
Indeed, if we are to fully understand the roles of other transcription factor families in the 
cerebellum, similar analysis is needed. 
 
NFI transcription factors are highly expressed in the central nervous system [90]. Despite this, little 
functional analysis has been undertaken to determine the individual or combined roles of this family 
in cerebellar development. Previously, we have shown that NFIX is highly expressed in CGNPs 
during postnatal cerebellar development, and that loss of expression results in a delay in progenitor 
cell differentiation [Chapter 3], [91]. Interestingly, Nfix and Math1 co-ordinately regulate a small 
subset of gene targets in CGNPs, suggesting transcription factors from these different families may 
have overlapping functions [Chapter 3]. Analysis of Nfia in the cerebellum has mainly focused on 
the Nfia-/- mouse strain, which alike with Nfix-/- mice display a delay in CGNP maturation, hinting at 
a shared role of with Nfix in governing progenitor development. Limited mechanistic or functional 
investigation of Nfia has been conducted in granule neurons. Nfia has been shown to promote 
GABRA6 expression [101], and loss of Nfia decreases expression of SYNAPSIN1 and WNT7A, 
both required for mossy-fibre-CGN synapse formation and axonal remodelling [99, 222, 223]. 
Interestingly, we have previously shown that loss of Nfix also leads to a reduction in both Wnt7a 
and Gabra6 expression [Chapter 3]. This similarity in both downstream gene targets and progenitor 
development delay in the respective null-mutants suggest that Nfia and Nfix may work in a co-
ordinate manner to regulate development of CGNPs. Additionally, both Nfix and Nfia have been 
both been implicated in the formation of medulloblastoma, of which CGNPs are the cell of origin in 
some subtypes.  For example, in a mouse model of SHH-type medulloblastoma, which arises 
exclusively from CGNPs, loss of Nfia results in a poorer prognosis and accelerated tumorigenesis 
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[136, 170]. These findings suggest that Nfia, alike with Nfix, likely play a significant role in the 
CGN developmental program and progenitor differentiation in the cerebellum.  
 
NFI transcription factors have been shown to interact with and regulate a number of other 
transcription factor families during neurogenesis. Interactions between NFI and bHLH transcription 
factors have been established previously in progenitor lineages in the developing cerebellum[130], 
[Chapter 3]. Additionally, we have shown that NFIX and MATH1 co-ordinately regulate a subset of 
genes important in CGNP differentiation in the previous chapter [Chapter 3]. Therefore, it is likely 
that if Nfix and Nfia are co-expressed in CGNPs, they could also work in tandem to co-ordinately 
regulate a number of key developmental genes, driving cerebellar development. Logically, it is also 
likely that several of these will be other transcription factors from different TF families. To answer 
this, in this chapter we set out to investigate 1) whether or not NFIA and NFIX expression overlaps 
in developing CGNPs, 2) whether co-ordinate regulation of gene targets by NFIA and NFIX exists 
in CGNPs and 3) and of these how many of these are transcription factors. We first looked at 
expression patterns of NFIA and NFIX in the postnatal mouse cerebellum using co-
immunofluorescence microscopy. Next, we used RNA-seq in wild-type, Nfia and Nfix-deficient 
CGNPs to identify differentially expressed genes in these mutants. To find directly regulated targets 
from this list, we used ChIP-seq with a-NFIA and a-NFIX antibodies and used DNase I 
hypersensitive regions to find which of these directly regulated gene targets are in regions of 
accessible chromatin. Finally, we compared these genes to online transcription factor and 
expression databases. Our analysis revealed that NFIA and NFIX co-ordinately regulate a 
substantial number of developmental genes and transcription factors in postnatal granule neuron 
progenitors. Of these genes and transcription factors, a large proportion have no previously 
identified role in CGNPs, but several are known regulators of neurogenesis. Additionally, several of 
these gene targets have identified roles as oncogenes in CNS tumours such as medulloblastoma. 
Taken collectively, these analyses provide a detailed expansion on the previously known role of 
NFIs in the cerebellum, and provide new evidence that these transcription factors work together to 
drive forward cerebellar development.  
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4.4 Methods 
4.4.1 Animal ethics details 
Nfia null mice on this genetic background are embryonically lethal. As such, we used a conditional 
Nfia allele (Nfiafl/fl) crossed to an Math1 cre line [224]. This line enabled the ablation of Nfia from 
MATH1-expressing cells from embryonic day 9 [50, 61] including the cells of the rhombic lip that 
will ultimately give rise to CGNPs within the EGL of the postnatal cerebellum. Knockout animals 
were Nfiafl/fl; Math1-cre+; controls were Nfiafl/fl; Math-cre−. Animals were used with approval from 
the University of Queensland Animal Ethics Committee (AEC approval numbers: QBI/143/16/ 
NHMRC/ARC and QBI/149/16/ARC). All experiments were performed according to the Australian 
Code of Practice for the Care and Use of Animals for Scientific Purposes. For all animals, 
genotyping was done by PCR using genomic DNA, which was extracted using alkaline lysis, from 
mouse-tail and toe tissue. Pregnant females were acquired by placing male and female mice 
together overnight. The next day, females were inspected for the presence of a vaginal plug and, if 
present, this day was designated as E0. The day of birth was designated as P0. Mice were housed in 
Optimice IVC caging, with double HEPA filters and built-in ventilation. Food and water was 
available ad libitum, and materials were provided for nesting and enrichment. 
4.4.2 Immunohistochemistry 
Chromogenic immunohistochemistry and immunofluorescence labelling was performed as 
described previously [Chapter 2]. Briefly, mice were anesthetised and perfused transcardially with 
phosphate-buffered saline (PBS), followed by 4% paraformaldehyde (PFA), then post-fixed for 48-
72 hours before long term storage in PBS at 4°C. Cerebella were isolated and embedded in 3% 
Noble agar and sectioned in a sagittal plane at 50 µm intervals using a vibratome. Sections were 
placed sequentially across the wells of a 6-well plate to ensure appropriate sampling from different 
medio-lateral regions of the cerebellum. For all analyses we had >6 sections per animal to image 
and analyze. Sections were mounted on slides before heat-mediated antigen retrieval was performed 
in 10 mM sodium-citrate solution at 95°C for 15 min. For chromogenic immunohistochemistry, 
sections were incubated overnight in primary antibodies at 4°C. A list of antibodies used in this 
study is given in Table 1. The following day, sections were rinsed in PBS, then incubated in a 
solution containing a biotinylated secondary antibody (Vector Laboratories) for 1 hour at room 
temperature, followed by processing with a VECTASTAIN ABC kit for 1 hour at room temperature 
(A used at 1/500, B used at 1/500, Vector Laboratories). Sections were rinsed again in PBS, then 
were processed for colour reaction using a nickel- 3,3'-diaminobenzidine (DAB, Sigma) solution 
(2.5% nickel sulfate and 0.02% DAB in 0.175 M sodium acetate) activated with 0.01% (v/ v) 
hydrogen peroxide. The colour reaction was stopped by rinsing multiple times with PBS, and 
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sections were then coverslipped with DPX mounting medium (Thermo Fisher Scientific). For IF 
labeling, sections were incubated at 4°C overnight with primary antibodies against the target 
proteins (see Table 1). The following day sections were rinsed in PBS, then incubated with the 
relevant secondary antibodies (Table 1) for 1 hour in the dark at room temperature. Sections were 
rinsed in PBS, then were counterstained with Hoechst 33342 (Thermo-Fisher Scientific) and 
mounted in fluorescent mounting media (DAKO). For all experiments, at least three animals at each 
age were analysed. 
Table 5 Antibodies used in this chapter 
4.4.3 Cerebellar imaging 
Fluorescent immunolabelling was visualized using a Nikon 20x Air objective on a spinning disk 
confocal microscope (Diskovery; Andor Technology, UK) on a Nikon Ti-E body (Nikon 
Corporation, Japan), equipped with a Zyla 4.2 10-tap sCMOS camera (Andor Technologies). For 
comparative sections, identical imaging parameters were used including pinhole size (70 µm), laser 
power and exposure time. We took 10 consecutive 1-µm-thick optical sections to generate a 10-
µmthick z-stack. In all cases, the 10-µm z-stack was taken from the middle of the section to 
minimize potential artefacts arising from the sectioning process such as damage to the tissue. Image 
acquisition, tiling and stitching were performed using NIS-Elements Advanced Research Imaging 
software (Nikon Corporation, Japan). All brightfield images were captured using an Aperio 
ScanScope XT Slide scanner (Leica Biosystems, Germany) with a doubled x20 objective (×40 
magnification overall; Nikon Corporation, Japan) and visualized using Aperio ImageScope 
software. For analysis of wild-type, Nfiafl/fl; Math1 Cre+ and Nfiafl/fl; Math1 Cre− mice, high-
magnification images were taken of the same lobule of the cerebellum, using at least three 
biological replicates at each of the ages assessed. For quantification of granule neuron and 
proliferative markers (PAX6 and Ki67, respectively), three 200-µm regions of the EGL were 
quantified for each section. This ensured a more representative count of the EGL thickness across 
the whole lobule. One micrometer- thick optical sections were viewed in ImageJ/Fiji, and the ‘cell 
counter’ plugin was used to mark and quantify cells expressing respective markers in each 
Antibody Source species Company Catalogue 
number 
Dilution used Purpose 
NFIX Mouse SIGMA SAB1401263 1/200;1/1000 IF/IHC 
NFIA Rabbit ABCAM HPA008884 1/200/1/1000 IF/IHC 
S100b - Alexa 647 Rabbit ABCAM AB196175 1/400 IF 
PAX6 Rabbit DAKO Z0334 1/400 IF 
NFIB Rabbit SIGMA HPA003956 1/400 IF 
Ki67 Mouse BD Pharmigen 550608 1/400 IF 
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fluorescent channel. Cells co-expressing markers (for example, PAX6 and Ki67) were also 
quantified this way, and DAPI was used to visualize the cell nucleus, to ensure accuracy, especially 
in areas of high cell density. 
4.4.4 Granule neuron progenitor isolation 
CGNPs from P7 Nfiafl/fl; Math1 Cre+ and Nfiafl/fl; Math1 Cre−  mice were isolated using the method 
outlined by Lee and colleagues [141] and a papain dissociation kit (Worthington Biochemical 
Corporation). Briefly, the cerebellum was dissected from three wild-type and three knockout mice 
and carefully separated from choroid plexus and meningeal tissue.  Remaining cerebellar tissue was 
dissociated using a 20 units/mL papain solution at 37°C for 15 mins.  A single cell suspension was 
obtained by trituration with a serum-coated P1000 pipette tip and nuclear membranes were removed 
using an albumin-ovomucoid inhibitor gradient.  CGNPs were separated from other cells using a 
30%-60% percoll gradient.  Purified CGNPs cells were then lysed in Trizol (Ambion) and RNA 
isolated using an RNeasy miniprep kit (Qiagen).  
4.4.5 RNA-seq analysis 
RNA sequencing was performed on the samples using the Illumina NextSeq High-Output system 
(Illumina; 150-bpread length, paired-end reads). We isolated cells from three P7 Nfiafl/fl; Math1-cre− 
mice and three P7 Nfiafl/fl; Math1-cre+ mice. RNA-seq analysis was performed on RNA isolated 
from P7 cerebella as described in previous chapters. Sequences were aligned using TopHat2 
(v2.0.9) [152] to the Mus musculus, UCSC, mm10 reference transcriptome and FASTA annotation 
downloaded from the TopHat index and annotations page 
(https://ccb.jhu.edu/software/tophat/igenomes.shtml). Cufflinks (v2.1.1) [152] was used to assemble 
each replicate’s transcripts from the alignment file generated by TopHat. Cuffmerge was used to 
create a single assembly containing transcripts across all samples and replicates. Cuffdiff was run 
using the merged set of transcripts and the three replicate TopHat2 .bam files from each sample. 
4.4.6 DNase I hypersensitivity analysis 
DNase I hypersensitivity (DHS) called peaks from whole cerebellum at P7 across three replicates 
were retrieved from Frank et al. 2015 (GEO: GSE60731). UCSC liftover was used to convert the 
mm9 files to mm10. If at least two replicates shared a peak, it was recorded using the maximum 
boundaries of the supporting peaks to generate a merged DHS peak file. Transcription factors are 
known to bind preferentially in regions of accessible chromatin [195, 196] and DHS was therefore 
used to extract NFIX and NFIA ChIP-seq peaks occurring in accessible regions.  
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4.4.7 ChIP-seq 
ChIP-seq was performed on chromatin isolated from P7 wildtype C57Bl/6 CGNPs as described in 
Chapter 3. We used antibodies against NFIA, NFIB or NFIX, for which specificity has previously 
been demonstrated [179]. For chromatin immunoprecipitation, litters of P7 pups were pooled for 
CGNP isolation. Isolated CGNPs were crosslinked with 1% formaldehyde for 10 min then were 
quenched with glycine. Cells were lysed in RIPA buffer supplemented with protease and 
phosphatase inhibitors (Roche) and sonicated with a Bioruptor (Diagenode) for six x 15-min 
intervals of 30s on, 30s rest. Chromatin immunocomplexes were isolated with protein G agarose 
beads (Roche) and washed once for 5 min with buffers 1 through 4. Crosslinking was reversed by 
incubation with proteinase K (Roche) at 60° overnight. DNA was isolated by phenol-chloroform 
extraction then incubated with RNase A (Roche) for 30min before final clean-up with PCR columns 
(Qiagen). Sequencing libraries were constructed using the standard protocol for the NEB Next Ultra 
II DNA Library Prep Kit (New England BioLabs). Pooled libraries were sequenced on an Illumina 
HiSeq 2000 (Illumina; 30-bp single end read). 
 
Previously we have published an NFIX ChIP-seq dataset in P7 CGNPs [Chapter 3]. Alignment was 
performed on an both NFIA and NFIX ChIP-seq data by bowtie2 [188] to mm10. Unaligned reads 
and reads which aligned to multiple locations were removed leaving only uniquely mapped reads. 
MACS2 [189] was used to call narrow peaks with default parameters for both datasets. Both 
experiments contained two biological replicates and if both biological replicates shared a peak, it 
was recorded using the maximum boundaries of the supporting peaks to generate a merged set of 
peaks for each experiment.  
4.4.8 Annotation of ChIP-seq peaks 
A set of target genes was identified for NFIA and NFIX by the following method; A promoter region 
was defined as ± 2000 base pairs around a transcription start site. ChIP-seq binding sites located in a 
promoter region were annotated as proximal, while sites outside the promoter region but overlapping 
gene boundaries (transcription start to stop) were labelled as genic. All remaining binding sites were 
labelled as distal. A binding site annotated as proximal was assigned the nearest gene as a target while 
genic binding sites were assigned the overlapping gene as a target. Distal binding sites are difficult 
to assign target genes to, as they are not necessarily regulating the nearest gene (by genomic distance). 
CisMapper was used to annotate distal binding sites and provide a secondary annotation to proximal 
and genic sites, with resulting links filtered to a threshold of 0.05 [192]. 
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4.4.9 qPCR analysis.  
cDNA was prepared from RNA isolated from P7 CGNPs using a Superscript III Reverse 
Transcription Kit (Invitrogen). qPCR was performed with the Quantifast SYBR kit (Qiagen). Gene 
expression was calculated using the 2-DDCT method, relative to the housekeeping gene glyceraldegyde 
3-phosphate dehydrogenase (Gapdh). All samples were tested in triplicate with each experiment and 
each was repeated three times. Mean values + SEM were entered into Graphpad Prism 7 and multiple 
t-tests conducted, with a Hold-Sidak method to correct for multiple comparisons. qPCR was 
performed on the QuantStudio7 Flex Real-Time PCR System (Applied Biosystems, USA). 
 
Table 6 qPCR primers used in this chapter 
Gene Forward Reverse 
Id3 CTGTCGGAACGTAGCCTGG GTGGTTCATGTCGTCCAAGAG 
Wnt5a CAACTGGCAGGACTTTCTCAA CCTTCTCCAATGTACTGCATGTG 
Gas6 GACCCCGAGACGGAGTATTTC TGCACTGGTCAGGCAAGTTC 
Kalrn AAGACCTACGGAAACTTGTGACG CCCCGCATGTCGATGATGAC 
Etv5 TCAGTCTGATAACTTGGTGCTTC CTACAGGACGACAACTCGGAG 
FoxO6 TCATGGACAGTGACGAAATGG ACCCAGCTCTGGTTAGGGG 
Gapdh GCACAGTCAAGGCCGAGAAT GCCTTCTCCATGGTGGTGAA 
4.4.10 Gene annotation and ontology  
After identifying a gene target for each NFIX binding site; the associated p-value from both the Nfix 
and Nfia RNA-seq differential expression analyses was recorded. Genes ‘targeted’ by Nfix and Nfia 
with a significant (p < 0.05) change in expression in both experiments were extracted. Genes showing 
coordinated positive or negative log fold change values across both experiments were selected to 
generate a putative set of genes under the control of both TFs. Functional annotation was performed 
using the PANTHER Gene Ontology system (Version 14.1, pantherdb.org)[225] through the Gene 
Ontology web portal (http://geneontology.org/), on target genes identified from our preceding 
transcriptomic and chromatin profiling analyses. Enriched GO-terms for Molecular function, 
Biological Process and KEGG Pathways were selected, based on corrected p-value and FDR of <0.05. 
To identify putative transcription factors from our gene lists, raw gene names were entered into 
TFCheckpoint, an online compendium of Human, mouse and rat transcription factors 
(www.tfcheckpoint.org)[226].  
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4.5 Results 
4.5.1 NFIA and NFIX show overlapping expression patterns in the postnatal cerebellum. 
To identify whether or not NFIA and NFIX co-regulate gene targets in the cerebellum, we first need 
to identify whether or not these transcription factors have overlapping expression patterns. NFIA 
and NFIX are both expressed in CGNPs (Chapter 2,3) [100, 101, 227] but co-expression is yet to be 
described. We used co-immunofluorescence staining (Co-IF) with anti-NFIX, anti-NFIA and anti-
s100b antibodies to look for co-expression, first in CGNPs and then in cerebellar glia across 
postnatal cerebellar development. Our data show that both NFIA expression and NFIX show strong 
expression in the cerebellar EGL at P3, P7 and P15 (Figure 4-1). Interestingly, expression of NFIX 
was strongest in the most posterior lobules at P3 and weaker in lobules anterior. However, NFIX 
expression was strong in the EGL of all lobules by P7 consistent with our previous data (Chapter 2]. 
Migratory cells in the ML (identified by their stretched polar morphology) express NFIA and NFIX 
at all ages investigated, and do not express s100b, suggesting they are newly post-mitotic CGNs 
(Figure 4-1 G, H, J, single arrowhead). The expression of both transcription factors is strong at all 
ages cells in the IGL, a majority of which are post-mitotic CGNs. Interestingly, both NFIA and 
NFIX are strongly expressed in the cell body of Bergmann Glia at all ages examined. This co-
expression also extends to astrocytes in the IGL at these ages (Figure 4-2). Indeed, both 
transcription factors are co-expressed in a majority of s100b+ cells, before the glial scaffold is fully 
in place (P3) and after, when glial projections extend to interact with CGNPs in the EGL (P15). 
These data suggest that NFIA and NFIX have strongly overlapping expression patterns in both 
cerebellar granule neurons and glia during development of the postnatal cerebellum, indicating 
potentially overlapping roles.  
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Figure 4-1 NFIX and NFIA are co-expressed in various cellular populations in the 
developing mouse cerebellum  
Sagittal cerebellar sections showing the nuclear marker DAPI (blue), NFIX (green), NFIA (red) 
and s100β expression (magenta) in P3 (a–e), P7 (f–j) and P15 (k– o) wild-type mice. NFIX and 
NFIA are co-expressed by CGNPs within the external granule layer (EGL; arrows in b–e, g–j, 
l–o). NFIX and NFIA are also expressed by s100β-positive glial cells (double-headed arrows in 
b– e, g–j, l–o). These transcription factors are also expressed by cells leaving the EGL 
(arrowheads in g–j, l–o); these are likely immature neurons migrating to the internal granule 
layer (IGL). ML molecular layer. Scale bar (in A) = 20 µm 
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Figure 4-2 NFIX and NFIA are co-expressed in astrocytes and glia in the postnatal 
cerebellum. 
High magnification sagittal cerebellar sections showing the nuclear marker DAPI (blue), NFIX 
(green), NFIA (red) and s100β expression (magenta) in P3 (A–J), P7 (K–T) and P15 (U–DD) 
wild-type mice. NFIX and NFIA are co-expressed in IGL white matter astrocytes at these ages 
(arrows in B–D, L–O, V–Y). NFIX and NFIA are also co-expressed in Bergmann glia at P3, P7 
and P15 (arrowheads in G–J, Q–T, AA–DD). The NFI factors are also co-expressed in mature 
granule neurons within the IGL (double-headed arrows in B– D, L–O, V–Y). IGL inner granule 
layer, ML molecular layer. Scale bar (in A) = 10 µm 
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Previously, we have shown that NFIX plays a role in the differentiation of CGNPs in the EGL, with 
Nfix-/- mice displaying delays in progenitor differentiation and increased proliferation in vitro 
[Chapter 3].  To determine the function of Nfia in these cells, we first examined co-expression of 
NFIA with the granule neuron marker PAX6 (Figure 4-3 A-D). Next, to determine expression 
patterns in the progenitor fraction of these neurons, we co-stained cerebellar with NFIA and Ki67, 
and examined the EGL of postnatal mice (Figure 4-3 E-H). At P7, a vast majority of fluorescently 
labelled cells are PAX6+/NFIA+ including cells in the EGL (single arrow), migratory CGNs in the 
ML (arrowhead) and adult granule neurons in the IGL (double arrow). Additionally, Ki67 staining 
revealed that a majority of PAX6+ progenitors in the EGL that are proliferative co-express NFIA. 
These expression patterns are almost identical to the previously identified expression patterns of 
NFIX in the cerebellum. This raises the hypothesis that these transcription factors have either 
complementary, inhibitory or fully independent roles in these cells stressing the need for further 
functional analysis. 
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4.5.2 Conditional deletion of Nfia in the mouse cerebellum causes  cerebellar abnormalities 
To investigate this hypothesis, we adopted a similar approach that was used in the previous chapter 
[Chapter 3], performing: RNA-seq and ChIP-seq on isolated CGNPs . Germline Nfia-null mutations 
are lethal on a C57/B6 background [105], so we utilised a conditional Nfia allele (Nfiafl/fl) crossed 
onto an Math1-cre mouse line [224]. As MATH1 is expressed by progenitors in the rhombic lip 
from ~E9 onwards [50, 61], an effective Math1-cre driver should selectively delete NFIA from all 
CGNPs which in turn arise from the RL from ~E12.5 onwards. Thus, we used this resultant Nfiafl/fl; 
Math1-cre mouse line to attempt to constitutively and selectively eliminate NFIA in CGNPs (Figure 
4-4 A-D). Immunolabelling using NFIA, and PAX6 as a marker for granule neurons revealed that 
NFIA is poorly expressed in CGNPs in the EGL of Nfiafl/fl; Math1-cre+ mice, with the most 
effective recombination in the more anterior lobules of the cerebellum (Figure 4-4 E-G). Of note, 
Nfia ablation was not completely penetrant in all lobes of the cerebellum, and deletion patterns 
seemed to mimic those previously seen in studies using this particular Cre driver [228, 229]. 
Interestingly, some NFIA expression is still found in the IGL. These cells are likely CGNs that 
arose from progenitors where Nfia was inefficiently deleted [single arrowhead Figure 4-4] or due to 
the presence of non-neuronal cells such as astrocytes, which we have shown express NFIA [Figure 
4-2]. As loss of Nfia and Nfix both result in similar phenotypic changes in other parts of the CNS, 
we examined the phenotype of our Nfiafl/fl; Math1-cre+  mouse. Haematoxylin staining at P15 
revealed that Nfiafl/fl; Math1-cre+ display increased lobulation compared to wild type controls 
[Figure 4-4 H, I] and an overall increase in PAX6+ cells in the EGL [Figure 4-4 L].  These data show 
that this mouse line is an effective way to study the phenotypes resulting from NFIA loss in 
CGNPs, without the lethality that occurs in Nfia-/- mice.  
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Figure 4-3 NFIA is ubiquitously expressed in granule neuron progenitors of the postnatal 
cerebellum. 
a-d Expression of the nuclear marker DAPI (blue, a), PAX6 (green, b) and NFIA (red, c) reveals 
NFIA expression in PAX6-positive EGL progenitor cells (arrows in b–d). NFIA is also 
expressed in IGL granule neurons (double headed arrows in b–d) and migrating cells exiting the 
EGL (arrowheads in b–d). e–h Expression of the nuclear marker DAPI (blue, e), Ki67 (green, 
f) and NFIA (red, g) also shows NFIA expression in proliferating EGL progenitor cells (arrows 
in f–h). EGL external granule layer, ML molecular layer, IGL inner granule layer. Scale bar (in 
a) = 20 µm 
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Figure 4-4 Conditional ablation of NFIA from EGL progenitors using Math1-cre.  
(A) Sagittal cerebellar section in a P7 Nfiafl/fl; Math1-cre+ mouse (Nfia cKO). (B-D) Co-
expression of PAX6 and NFIA was examined in different cerebellar lobes and is shown in the 
respective high magnification panels, with DAPI (blue), PAX6 (green) and NFIA (red). 
Expression revealed that cells at the margin of the molecular layer and IGL expressed NFIA 
(arrowheads in B–D). Importantly, the majority of cells in the EGL of lobes VI and IX were 
immunopositive for PAX6 but did not express NFIA (arrows in B, C). Within lobe X, there were 
more cells within the EGL that had not undergone Cre-mediated ablation and hence retained 
NFIA expression (double arrowheads in D). (E–G) Quantification of the percentage of cells 
within the EGL of lobes VI (E), IX (F) and X (G) that expressed NFIA. (H, I) Hematoxylin 
staining of Nfia control and Nfia cKO cerebella at P15. The cerebellum of mice lacking Nfia 
was dysmorphic, with elevated foliation of the cerebellar lobes evident. Expression of DAPI, 
PAX6 and Ki67 in Nfia control (J) and Nfiafl/fl; Math1-cre+ (K) cerebella at P15 revealed 
significantly more PAX6-positive cells within the EGL of the mutant (L), although the number 
of proliferating cells (M), and the width of the EGL(N), was not significantly different between 
sample groups. *p < 0.05, t test. Scale bar = 250 µm, in A; 400 µm, in H and I; 30 µm, in B–D; 
and 25 µm, in J and K. 
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4.5.3 Transcriptomic and chromatin profiling reveal a discrete set of co-ordinately regulated 
targets of NFIA and NFIX in postnatal CGNPs.  
Whilst we have determined overlapping expression patterns of NFIA and NFIX in the cerebellum, 
co-expression does not necessarily indicate a conserved functional role. Functional insight into the 
role of transcription factors can be determined by a combination of chromatin profiling (to 
determine putative TF binding sites) and transcriptomic analysis (to determine changes in gene 
regulation under different conditions. In Chapter 3, we used this analysis to investigate the role of 
NFIX in CGNPs. Here, we have used this approach to examine how Nfia functions in these cells in 
these cells, and combined our two datasets to look for shared gene targets between these two 
transcription factors.  
 
In Chapter 3, P7 CGNPs were isolated and purified from wild-type mice, before ChIP-seq was 
performed using an anti-NFIX antibody. This analysis revealed 6910 putative gene-associated 
NFIX binding sites. We then combined these data with a published dataset of global DNase I 
hypersensitivity at P7 [198]. DNase I hypersensitivity occurs in regions of accessible chromatin that 
are typically enriched for gene regulatory elements and transcription factor binding sites [230]. This 
analysis revealed 5843 accessible NFIX binding sites, associated with 4621 genes.  
 
With this method as a template, we repeated a similar analysis, this time using an anti-NFIA 
antibody to identify putative NFIA binding sites. In total, 14025 NFIA binding peaks were found, 
with 12539 found in DNase I-hypersensitive regions associated with 7870 known genes [Figure 4-5 
A, B]. A total of 1486 binding peaks were found in closed regions of chromatin. Next, we 
performed RNA-seq on CGNPs isolated from P7 control and Nfiafl/fl; Math1-cre+ mice. This 
analysis identified 2267 genes as being significantly mis-regulated in the absence of Nfia [Figure 
4-5 B].  We then took this gene list, and compared it with our cohort of 7870 known genes bound 
by NFIA in regions of accessible chromatin. This identified 1232 genes from the 2267 that were 
both significantly mis-regulated and contained an NFIA binding peak. We interpreted this as strong 
evidence that these genes were direct targets of NFIA in these cells during development.  
 
We then combined both of these datasets (NFIX and NFIA) to determine whether or not these two 
TFs directly regulated a common suite of gene targets [Figure 4-5 C]. Of the 1232 NFIA gene 
targets, and 578 NFIX gene targets, 304 were shared by both TFs. Additionally, of these 304 
common targets, 283 (~93%) were co-ordinately mis-regulated (i.e. the target gene was upregulated 
or downregulated in both the Nfix-/- and Nfiafl/fl; Math1-cre+ datasets), [Table A12]. Whilst we did 
not have access to Nfib-null mice for RNA-seq, we were able to use ChIP-seq dataset with an anti-
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NFIB antibody to look for potential binding sites in P7 CGNPs. This revealed 24950 NFIB-
associated ChIP peaks, of which 21712 were in regions of accessible chromatin. Interestingly, of 
the 283 co-ordinately mis-regulated genes from our Nfia/Nfix data, 282 also contained NFIB-
associated peaks.  
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Figure 4-5 Transcriptomic and epigenetic profiling of NFIA and NFIX in postnatal 
CGNPs identifies co-ordinately regulated gene targets 
(A, left-side) Combining ChIP-seq data using an anti-NFIA antibody with a dataset of DNase I 
hypersensitive sites [198], reveal putative binding sites for NFIA in regions of accessible 
chromatin. 14025 NFIA binding peaks were identified, with 12539 in accessible regions and 
1486 in inaccessible sites. This is compared to equivalent data for NFIX from Chapter 3, (A-
right-side) which identified 5843 accessible sites. B, left-side) of 12539 NFIA peaks in 
accessible regions, 7870 were associated with genes. RNA-seq in P7 Nfiafl/fl; Math1-cre and 
control CGNPs revealed a total of 2267 mis-regulated genes, of which 1232 contained binding 
peaks for NFIA. These data suggest these are directly regulated targets of NFIA. A similar 
analysis for NFIX (B, right-side) was conducted in Chapter 3, and found 578 direct targets. C) 
To determine if direct-targets from B) were co-regulated by NFIA and NFIX, gene lists were 
compared. 304 genes were directly regulated by both transcription factors, of which 283 were 
regulated in a coordinated manner (i.e. either upregulated or downregulated in both NFIA and 
NFIX datasets).  
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Whilst a number of these co-ordinately regulated gene targets have well established roles in 
cerebellar development, with a large list of genes it is possible to use GO-term analysis to look 
collectively and in an unbiased manner for broad changes in both biological processes and 
molecular function. Thus, we used the PANTHER protein classification system (v.14.1 [225]) for 
gene ontology analysis, to determine the biological context of these mis-regulated genes. 280 of the 
co-ordinately mis-regulated genes were successfully mapped to the Mus musculus reference 
genome, as having unique gene identifiers. There, the tool was used to determine statistically 
significant over-representation of both GO-terms related to biological process [Table 7] and 
molecular function [Table 8].  
 
As expected from the role that we and others have deduced for NFIs in the cerebellum, a number of 
key developmental GO-terms including ‘nervous system development’, ‘neurogenesis’ and ‘cell 
differentiation’ were ranked in the top 20, ranked based on p-value [Table 7]. Interestingly, a 
number of terms related to cell signalling (‘regulation of signalling’, ‘regulation of cell 
communication’, ‘modulation of chemical synaptic transmission’ and ‘regulation of trans-synaptic 
signalling’) were also highly ranked, suggesting that NFIs may play a broader role in establishing 
and regulating synaptic connections of developing granule neurons. This conclusion was further 
supported by examining the top 20 GO-terms related to molecular function. These almost 
exclusively related to ion/cation transmembrane transporter and channel activity [Table 8]. 
Combined, these data suggest that NFIs may drive the development of these cells by heavily 
regulating genes involved in synaptic connectivity and electrophysiological processes such as 
membrane potential.  
 
In addition to GO-term analysis, we then used PANTHER pathways to search for significantly 
over-represented biological pathways in our co-ordinately mis-regulated gene list. 278 of 282 genes 
were mapped to 177 reference pathways in the PANTHER database. Of these, 11 were significantly 
overrepresented, including axon guidance mediated by Robo/Slit and Cadherin, Notch and Wnt-
signalling, all of which have established roles in CGNP developmental programs [63, 77, 130, 222, 
231-235]. Whilst these data identify a number of genes, processes and pathways with established 
roles in mediating CGN development (for example: Otx2, NeuroD1, Robo1 and Rbfox3), a 
significant proportion of those identified have little to no information or data available in the 
cerebellum or cerebellar granule neurons. 
 
Lastly, we validated our dataset  by performing qPCR on a selection of gene targets of both known 
(Wnt5a) and novel (Foxo6, Kalrn, Etv5, ID3, Gas6) roles in cerebellar development potential role 
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based on family members/associated genes. In both Nfix-/- and Nfiafl/fl; Math1-cre+ CGNPs, 
expression was significantly higher than controls, replicating RNA-seq data [Figure 4-6].  
 
4.5.4 NFIs regulate the expression of other transcription factors magnifying downstream 
effects. 
Interestingly, a large number of genes identified in our RNA-seq analysis show differential 
expression despite no transcription factor binding site for either NFIA or NFIX. Since RNA-seq is a 
snapshot in time of RNA activity in a cell, it is hard to establish how directly regulated target genes 
may be influencing the expression of others downstream. However, this analysis does allow us to 
investigate our gene list and determine whether or not Nfia and Nfix are acting to co-ordinately 
regulate other transcription factors that may have functional roles in CGNP development, further 
broadening the role of NFIs in influencing the cerebellar transcriptome, albeit in an ‘indirect’ 
manner through effectors.  
 
To investigate this, we compared our directly and differently expressed genes targets with a 
published database of transcription factors (TFcheckpoint [226]). This comparison revealed that 
NFIA directly regulates at least 78 known murine TFs in CGNPs, with NFIX regulating at least 46. 
Additionally, 26 of these are shared targets of both NFIs [Table 9]. Out of these shared 26 
transcription factors targets, 25 of were co-ordinately regulated, with only one (NeuroD6) showing 
alternate regulation by NFIA and NFIX. This high proportionality of shared and co-ordinated 
targets further strengthens the hypothesis that NFIA and NFIX work synergistically to drive the 
developmental program of granule neurons in the cerebellum. This regulation of other transcription 
factors and their targets in turn are important to consider when determining the impact of gene 
deletions on the transcriptome.  
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Table 7 Gene ontology analysis showing the biological processes enriched in the co-ordinately regulated gene targets of NFIs. 
Raw gene targets names were used as input to search for GO-term over-representation, using the PANTHER Gene Ontology system (Version 14.1, 
pantherdb.org) through the Gene Ontology web portal (http://geneontology.org/). Of 282 coordinately upregulated gene targets identified in our 
analysis, 280 were uniquely mapped, against the PANTHER Mus Musculus reference gene list (22296 unique gene IDs). Biological process 
annotations were gained using the GO Biological Process tool. A Fisher’s exact test with FDR correction was used, and significance set at p <0.05. 
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Table 8 Gene ontology analysis showing the molecular function terms enriched in the co-ordinately regulated gene targets of NFIs 
Raw gene targets names were used as input to search for GO-term over-representation, using the PANTHER Gene Ontology system (Version 14.1, 
pantherdb.org) through the Gene Ontology web portal (http://geneontology.org/). Of 282 coordinately upregulated gene targets identified in our 
analysis, 280 were uniquely mapped, against the PANTHER Mus Musculus reference gene list (22296 unique gene IDs). Molecular function 
annotations were gained using the GO-molecular function tool. A Fisher’s exact test with FDR correction was used, and significance set at p <0.05. 
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Of the 26 transcription factors identified, there are a mixture of both transcription factors with an 
identified role in cerebellar development and neurogenesis, and a number with no defined role in 
either process. To identify overlooked roles in the cerebellum, we performed literature searches in 
the NCBI PubMed library for publications using relevant key word combinations including “<TF 
name>” + “Neurogenesis”, “<TF name>” + “Cerebellum”, “<TF name>” and “Cerebellar granule 
neuron”. Additionally, as novel genes with potential roles in development are often discovered 
through aberrant expression in diseased tissue compared to normal tissue, we included an addition 
al search for “<TF name>” + “medulloblastoma”. This preliminary search method revealed a 
number of transcription factors with no currently described role in neurogenesis or the cerebellum 
(Btbd11, Elk3, Hivep3, Mn1, Rfx4). A majority of transcription factors identified from our gene list 
returned hits for the search term “Neurogenesis” (19/26), and “Cerebellum” (15/26). Less returned 
hits for “Cerebellar granule neuron” (8/26), indicating that the role of these transcription factors in 
this particular cell type has not been investigated to the same level. Currently, there are a number of 
publicly available expression databases examining RNA and protein expression databases including 
the GENSAT expression project (www.gensat.org) [236] and GenePaint (www.genepaint.org) 
[237]. Searching for TF names in these databases provided expression data for 23/26 transcription 
factors at ages e14.5 and/or P7 in the form either RNA-in situ hybridisation, eGFP, tdtomato or Cre-
recombinase (Rosa26 reporter) expression. Interestingly, at e14.5 very few of the transcription 
factors showed expression isolated to the RL or EGL, mimicking and expression pattern we noted 
for NFIX at e15.5 (Chapter 2). Whilst a particular TF’s expression can vary dramatically at 
different embryonic and postnatal time-points, noting expression in RL progenitors does suggest 
that these transcription factors may co-ordinate with NFIs to regulate granule neuron progenitor 
development from the earliest stages. Furthermore, an additional eight of these TF’s (Ebf2, Elk3, 
Etv5, Irx1, NeuroD1, NeuroD4, NeuroD6 and Otx2) have data available at P7 showing expression 
in the EGL, with a select group of these shown in Figure 4-7. Taken together these data reveal that  
NFIs largely work in tandem to regulate a subset of genes with both novel and established roles in 
cerebellar granule neuron development. These include a number of transcription factors broadening 
the network of genes both directly and indirectly impacted by NFI expression in the developing 
cerebellum.  
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Figure 4-6 mRNA expression analysis of potential NFI targets by qPCR 
qPCR was performed on P7 CGNPs isolated from control, Nfiafl/fl; Math1Cre+ and Nfix-/- mice. 
Analysis revealed that loss of Nfia and Nfix resulted in significantly increased expression of Kalrn, 
Etv5, Gas6, Id3, FoxO6 and Wnt5a, recapitulating RNA-seq data. Expression levels are shown 
relative to the housekeeping gene Gapdh. *p < 0.05; **p < 0.01; ***p < 0.001, t-test. 
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  "Neurogenesis"  "Cerebellum" "Cerebellar granule neuron" "Medulloblastoma" GENSAT GENSAT localisation Genepaint exp 
Akna 1 0 0 1 n/a n/a e14.5 EGL 
Barhl2 2 2 1 0 n/a n/a e14.5 RL, VZ scattered 
Btbd11 0 0 0 0 n/a n/a e14.5 EGL 
Ebf2 12 9 0 0 Y P7 EGL, IGL, Lobule specific e14.5 widespread  
Elk3 0 0 0 0 n/a n/a e14.5 scattered in the EGL, P7 weak EGL/IGL 
Esrrg 0 2 0 2 n/a n/a n/a 
Ets1 4 2 0 0 n/a n/a e14.5 scattered throughout, P7 scattered 
Etv5 5 2 0 0 Y P7 Scattered expression e14.5 strong in VZ, weak EGL 
Foxo6 0 2 1 0 n/a n/a n/a 
Hivep3 0 0 0 1 n/a n/a e14.5 none 
Irx1 3 1 0 0 n/a n/a e14.5 strong VZ/RL/EGL, P7 PCL and EGL,  
Klf15 1 0 0 0 n/a n/a e14.5 weak VZ  
Klf9 8 7 0 0 n/a n/a e14.5 strong, widespread 
Mn1 0 0 0 0 n/a n/a e14.5 sparse VZ/RL 
Neurod1 138 19 6 6 Y P7 Strong EGL and IGL e14.5 RL/EGL/NTZ, P7 strong EGL, IGL,  
Neurod4 14 0 0 0 n/a P7 Strong IGL, moderate EGL e14.5 none 
Neurod6 21 4 1 0 n/a n/a  none at e14.5, P7 EGL, scattered IGL 
Nfix 10 8 3 0 n/a n/a e14.5 RL/VZ, proximal EGL 
Otx2 69 61 6 38 Y P7 Strong, lobule specific  e14.5 RL, P7 Strong EGL/IGL, lobule specific 
Pax3 51 8 1 5 n/a n/a e14.5 RL, proximal EGL, VZ strong 
Prdm13 4 1 0 1 n/a n/a n/a 
Rfx4 0 0 0 0 n/a n/a e14.5 weak RL/VZ 
Sall1 5 0 0 0 n/a n/a e14.5 none 
Scml4 1 0 0 0 n/a n/a e14.5 Prolific, widespread 
Scrt2 1 0 0 0 n/a n/a e14.5 VZ  
Smad3 24 8 1 2 n/a n/a e14.5 weak VZ/EGL 
Table 9 : Investigation of downstream target transcription factors using online expression databases and text-searching 
The respective gene name and the additional term (“Neurogenesis”, “Cerebellum”, “Cerebellar granule neuron” or “Medulloblastoma”) was used to 
search for relevant publications, and the total retrieved number of publications included. GenePaint expression data was primarily in the form of in 
situ RNA-hybridisation, whilst GENSAT data was in the form of either eGFP, tdtomato or Cre-recombinase expression. “None” denotes no 
appreciable cerebellar expression, whilst “n/a” denotes no expression data for the particular gene was available in this database. RL= rhombic lip, 
VZ = Cerebellar ventricular zone, NTZ – Nuclear Transitionary Zone
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4.6 Discussion 
4.6.1 Co-ordinate gene regulation by NFIs drives the developmental program of cerebellar 
granule neuron progenitors.  
NFI transcription factors are expressed in neural stem cells and progenitor populations of the 
developing CNS, where they play a multitude of roles such as mediating stem cell quiescence/self-
renewal and progenitor differentiation [83-85, 87, 130].  Following on from Chapter 3 where we 
found that NFIX regulates the differentiation of CGNPs partly by co-ordinate regulation of gene 
targets with the bHLH transcription factor Math1, we went back to examine whether other NFI 
transcription factors themselves had common regulatory targets in CGNPs. We followed a similar 
approach, investigating first with immunohistochemistry and immunofluorescence, followed by 
analysis at both a transcriptomic, DNA-binding and functional level. We have shown that both 
NFIA and NFIX are highly expressed in both pre- and post-mitotic cerebellar granule neurons, 
Bergmann glia and other astrocytes in an overlapping manner. We identified that NFIs likely work 
co-ordinately to directly regulate a large subset of genes, driving forward the differentiation of 
CGNPs. Interestingly, a number of these genes have no previously described role in cerebellar 
development or indeed the CNS as a whole. This is an exciting prospect as these may potentially be 
new regulators of progenitor cell differentiation.  
 
It is generally accepted that RNA-seq expression data show a high degree of concordance with 
qPCR expression data, despite generally being a noisier dataset [238]. To check that this was the 
case with the data from our RNA-seq analysis, we used qPCR to examine changes in expression 
levels of a number of gene targets (Gas6, Wnt5a, Kalrn, Foxo6, ID3 and Etv5), in both 
Nfiafl/fl;Math1 Cre+, Nfix-/- and control CGNPs. Of these genes, only Wnt5a has been investigated 
specifically in the cerebellum, where it has been shown to regulate progenitor proliferation [235]. 
This presented us with an exciting prospect; it is possible that these genes (and others identified 
from our analysis that we did not examine with qPCR) could a) play a key role in established 
CGNP development processes or b) themselves present as novel regulators of CGNP development, 
in the similar manner to Itsn1 in Chapter 3. Whilst examining these targets further was beyond the 
scope of this project, we can infer potential roles in the cerebellum from examining their roles in 
other parts of the CNS and progenitor populations where literature is available.  
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4.6.2 NFIs regulate Gas6 a potent activator of TAM RPTKs in proliferative cells.  
Growth arrest protein 6 (Gas6) binding activates the TAM (Tyro-3, Axl and Mer) group of receptor 
protein-tyrosine kinases (RPTKs). This binding axis has been shown to promote the proliferation of 
cancer cells and to regulate the self-renewal of cancer stem cells [239-242]. Gas6-TAM binding has 
been shown to prevent neuron death and encourage neurogenesis, depending on the particular 
receptor bound and the cellular context [243-247]. In the cerebellum, Tyro-3 is the predominate 
Gas6 binding partner, with expression noted in granule neurons and their parallel fibres, Bergmann 
glia and Purkinje neurons [248].  Normally, Gas6 is expressed in low levels in CGNPs. Our data 
suggests that NFIs may play an important part in repressing GAS6 expression in CGNPs, thus 
potentially modulating Tyro-3 activation in these cells. Interestingly, Tyro-3 has been found to be 
down-regulated in human childhood medulloblastoma samples compared to normal cerebellar 
tissue [249]. As Gas6 has been shown to exist in both receptor bound and secreted forms [241], it is 
possible that the changes in GAS6 expression we identified in our Nfi-null CGNPs could affect the 
activation of TAM receptors in Bergmann glia and Purkinje neurons. This in turn could affect the 
differentiation and development of CGNPs, in both cell autonomous and non-autonomous manners. 
Future investigations on the cell-type specific expression of GAS6, its functional role in CGNPs, 
and how manipulation of the GAS6-TAM axis impacts the developmental program of these cells, 
will help to form a complete picture of how altering NFI expression can impact the development of 
the postnatal cerebellum.  
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Figure 4-7 Selected transcription factor expression in the P7 mouse cerebellum.  
Whole brain images at P7 were obtained from both GENSAT (Rosa26 Cre and eGFP) and 
GenePaint (ISH) databases, and cropped to focus on the cerebellum. Both Cre and ISH images 
were available at 10x resolution, whereas eGFP images were available at 25x. Whole cerebellum 
images were selected from as close to the midline as available.   
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4.6.3 NFIs repress the Rho-GEF Kalirin, perturbing GTPase action in CGNPs 
Kalirin (Kalrn) is a multi-domain Rho-GEF essential for dendritic spine development and 
excitatory synapse formation [250-253]. Our data show enrichment for multiple NFI binding motifs 
in Kalrn genic, promoter and enhancer regions. This, combined with differential RNA expression of 
Kalrn in Nfi-null CGNPs, suggest that it is a directly regulated target of NFIs during cerebellar 
neurogenesis. Both alternate promoter usage and alternate splicing result in a number of Kalrn 
isoforms from a single gene with different functions, but largely overlapping expression in the CNS 
[254, 255]. Knockdown of Kalrn in vitro results in an arrest of BDNF-TrkB mediated neurite 
outgrowth in hippocampal neurons [256]. Additionally, Kalrn-/- mice have behavioural defects 
including deficiencies in cue and context-dependent fear conditioning [253, 257]. Kalrn has 
multiple GEF domains that activate GTPases including Rac1 and RhoA, both of which are 
expressed in the developing cerebellum [258, 259]. It is possible that NFI-repression of Kalrn in 
turn modulates the activation of these GTPases. Targeted deletion of RhoA from CGNPs using a 
Math1; CreERT2 driver results in delayed migration, abnormal morphogenesis and ectopic 
localisation of post-mitotic neurons [259]. Additionally, RhoA loss results in foliation defects and 
abnormal fissure formation in the postnatal cerebellum. Interestingly, loss of RhoA also resulted in 
non-cell autonomous defects in both Purkinje neurons and glia, demonstrating again the important 
role of CGNPs in maintaining normal development of the cerebellum.  
 
Our data shows that Nfia and Nfix act to upregulate another guanidine nucleotide exchange factor, 
Spata13 (Asef2). SPATA13 is strongly expressed in CGNs, where it is a target of thyroid hormone 
[260]. The function of this particular protein in CGNPs has not fully been determined; but alike 
with other GEFs it activates Rho GTPases Rac1 and Cdc42, this time regulating cell adhesion, 
migration and dendritic spine development [261-264]. We have previously shown [Chapter 3] that 
NFIX also directly regulates Itsn1, a scaffolding protein that has been shown to interact with other 
small GTPases in the CNS such as Ras [209, 265]. These data raise the possibility that NFIs may 
have a previously overlooked role in regulating several developmentally significant GTPase 
families. Interestingly, RhoA/Rock expression has been found to inhibit ERK kinase activation in 
embryonic myoblasts, which in turn, results in the downregulation of Nfix expression [266]. This 
relationship continues postnatally, albeit independent of RhoA/Rock, with ERK activation in turn 
increasing NFIX expression. The interaction between RhoA, ERK and Nfix is yet to be explored in 
the cerebellum, but if this relationship is conserved it could insinuate that a feedback loop important 
for temporal control of NFI expression and this developmental progression is in place.   
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4.6.4 New relationships between NFIs and Wnt-signalling in cerebellar development 
When it comes to signalling pathways involved in cerebellar development, few more are as prolific 
and extensive as the Wnt-signalling pathway. Our PANTHER pathway analysis revealed significant 
enrichment for the Wnt-signalling pathway in our co-ordinately regulated gene list, with 11 Wnt-
associated genes unearthed. We investigated one of these genes, Wnt5a, using qPCR to support our 
RNA-seq findings. Wnt5a has been shown to act as a ligand for Frizzled, Ror and Ryk receptors, 
activating either canonical (b-catenin) Wnt signalling, or non-canonical (b-catenin independent) 
Wnt signalling [267]. In the cerebellum WNT5A expression peaks at P1, with expression slowly 
declining as postnatal development progresses. Despite this decline, expression is still found, albeit 
at a reduced level towards the end of cerebellar development (P21)[235]. Interestingly, conditional 
deletion of Wnt5a under a Nestin promoter (Wnt5afl/fl; NestinCre) results in a reduction in the 
number of CGNPs migrating from the RL at E14.5. Additionally, P1 EGL progenitors show a 
marked decrease in proliferation, with reduction in the expression of Ki67, PHH3 and Cyclin 
D1[235]. 
 
Depending on the receptor bound and the pathway activated, Wnt signalling can have a number of 
roles and outcomes in the cerebellum. For example, defective canonical Wnt-signalling has been 
suggested to play a causative role in cerebellar vermal hypoplasia, seen in patients with Joubert 
syndrome [268]. Conversely, receptor binding of the ligand Wnt3 and subsequent activation of Non-
canonical Wnt signalling, antagonises the proliferative effects of SHH on CGNPs, through 
downregulation of SHH downstream targets such as Gli1, Gli2 and Ptch1 and activation of 
MAPK/ERK pathways[234]. Wnt5a has been shown to inhibit Canonical-Wnt signalling in 
haemopoietic stem cells maintaining their quiescence, adding to the complexity of interactions 
between both canonical and non-canonical Wnt-signalling pathways in stem and progenitor cells 
[269]. These data suggest that NFIs may act to regulate the interplay between Canonical and non-
canonical Wnt in the developing cerebellum, to help regulate the switch between proliferation and 
differentiation of progenitors. Moreover, our data suggest that NFIs regulate a number of other key 
Wnt-associated proteins, including two key pathway regulators Dkk3 and Sfrp1, the canonical Wnt 
ligand Wnt7b, and another Wnt-activator Amer3 (Fam123c) [270-273]. Interestingly, loss of Nfix 
and Nfia sees upregulation of Ebf2, which has been shown to act in synergy with b-catenin to 
regulate transcription, and downregulation of Tle2, a transcriptional co-repressor that inhibits this 
regulation [274-276]. The full effect of altered NFI expression on Wnt signalling in granule neurons 
is hard to determine without further experimentation, starting initially with examination of the role 
of each Wnt-related gene in the wild-type cerebellum. Examining the outputs and transcriptional 
activity of both canonical and non-canonical Wnt pathways in CGNPs would shed much needed 
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light on biases towards one pathway mediated by these transcription factors. Understanding 
transcriptional regulation of Wnt-signalling in the cerebellum is particularly important, as 
misregulation of Wnt-pathway is a hallmark of one of the four classical subtypes of 
medulloblastoma [277, 278].  
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4.6.5 NFI-regulation of other transcription factor families amplifies downstream effects 
Transcription factors can amplify their effects on a target cell population by directly regulating 
other transcription factors. Whilst loss of non-transcription factor gene targets may explain (at least 
partially) the observed phenotypes (as shown in Chapter 3 with Itsn1), transcription factor-
transcription factor regulation is important to investigate due to the amplified effect of 
developmental-gene regulation cascades. Our analysis revealed 26 transcription factors co-
ordinately regulated by Nfia and Nfix. Several have well established roles in neural development, 
but a number have not been investigated in the cerebellum or CNS as a whole.  
 
One of these transcription factors identified from our analysis and further investigated with qPCR is 
the forkhead box transcription factor FoxO6. FoxO proteins are transcription factors that function as 
part of a conserved PI3K-AKT-FoxO signalling pathway, and are required for NSC proliferation 
and renewal [279-281]. FOXO6 knockdown has been shown to inhibit the function of the 
PI3K/Akt/mTOR pathway and cell proliferation in colorectal cancer cells [282]. Similarly, 
overexpression of this TF is commonly found in breast cancer cells where it has been proposed 
activate proliferation [283]. High FOXO6 expression is correlated with poorer prognosis and 
increased aggressiveness of gastric cancer [284]. In the cerebellum FOXO6 is expressed in granule 
neurons, where it has been shown to be essential for the polarisation of developing progenitors 
[285]. Interestingly, knockdown of FoxO6 in the embryonic forebrain neurons leads to a reduction 
in the expression of a number of key developmental genes, including Nfia and Plxna4 [286]. Our 
data suggest that in postnatal CGNPs, Plxna4 is in turn directly and co-ordinately downregulated by 
Nfia and Nfix. This suggests that there may be a conserved interaction between NFIs, FoxO6 and 
plexins in both cerebellar neurons and neurons of the cortex. Plexins are crucial proteins in axon 
guidance processes, where they act as receptors for Semaphorins (for a thorough review, see [287], 
which are essential in regulating axon guidance in developing neurons.  Our data show that Nfia and 
Nfix also co-ordinately upregulate the semaphorin Sema3d in CGNPs. Knockdown of Sema3d has 
been shown to reduce both cell migration and proliferation in neural crest cells in zebrafish embryos 
[288]. Further investigation is needed to see whether this phenotype is conserved in the mouse 
hindbrain. Our data show that individually Nfix and Nfia directly regulate a number of other 
semaphorins in CGNPs, raising the possibility that a point of divergent function of NFIs in the 
cerebellum might be due to their interactions with this particular protein family. 
Our analysis unearthed direct regulation of members of the NeuroD family of bHLH transcription 
factors, which have established roles in neurogenesis and cerebellar development. NeuroD1 is 
essential for the differentiation of granule neurons; NeuroD1-null cerebella have a clear loss of 
CGNPs and thinning of the EGL early in postnatal development, particularly pronounced in the 
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posterior lobules of the cerebellum [289]. Additionally, NeuroD2 has been associated with survival 
of CNS neurons, including granule neurons in the postnatal cerebellum [290]. We have shown that 
the expression of two other NeuroD family members, NeuroD4 and NeuroD6 is up-regulated by 
Nfia and Nfix expression in postnatal CGNPs. Both NeuroD4 and NeuroD6 have no described role 
in cerebellar granule neurons, but GENSAT expression data suggests and overlap of expression 
localisation between these family members. Whether or not these bHLH family members display 
functional redundancy in these cells is currently unknown.  
 
Interestingly, NeuroD6 is regulated in a discordant manner by Nfia and Nfix, the only transcription 
factor from our dataset to be so. Depending on the magnitude of the role of NeuroD6, and whether 
functional redundancy with other NeuroD TFs exists, this discordance suggests a possible point of 
divergent function of Nfia and Nfix in CGNPs. This could in turn explain part of the varied 
cerebellar phenotype in Nfia-null and Nfix-null mice. Online expression databases show strong 
NEUROD6 expression in the forebrain of mice, where Nfia and Nfix regulate neurogenesis [96]. 
Further investigation into whether this discordant regulation pattern occurs in other regions of the 
brain where NFIs have been shown to regulate neurogenesis are warranted.  
 
Our data show that Nfia and Nfix directly co-ordinately upregulate the expression of the BarH-like 
homeobox transcription factor Barhl2. Additionally, Nfia also directly regulates expression of 
Barhl2 paralog Barhl1. The role of Barhl2 has not been extensively investigated in the cerebellum, 
although expression in the EGL and upper rhombic lip is evident at P1[291]. Both Barhl1 and 
Barhl2 can transactivate the Barhl1 promoter, indicating some redundancy between the two 
transcription factors [292].  Barhl1 has been shown to regulate the migration and survival of CGNs 
though regulation of Neurotrophin-3, and loss of this transcription factor results in lobulation 
defects of the cerebellum [293]. This is of interest as our Nfiafl/fl;Math1-Cre mutant also displayed 
altered lobule morphology. Investigation of Barhl2 loss of function mutations are yet to be 
conducted in the cerebellum or CGNPs. Interesting however, is the interplay between BarH and 
other bHLH transcription factors. Barhl2 has also been shown to regulate multiple neural bHLH 
genes [294].  Additionally, Barhl2 is itself activated by MATH1 in the spinal cord through MATH1 
binding to a downstream Barhl2 enhancer [295].  If this relationship extends to the cerebellum, it 
would thus confine Barhl2 expression to CGNPs. Adding to the this, loss of Barhl1 has been 
associated with poorer prognosis and survival rates in human medulloblastoma, with tumours 
expressing low levels of differentiation markers such as NEUN [296]. Barhl2 has been found to act 
upstream of the SHH-signalling pathway, playing a role in regulating patterning of progenitors in 
the diencephalon [297]. Our transcriptomic data combined with evidence from literature and 
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available expression databases suggest that NFI-regulation of BarH transcription factors in the EGL 
could indeed be another axis through which CGNP differentiation is mediated.    
 
The developmental program of CGNPs in the EGL starts early in embryonic development and 
persists until the third postnatal week, when this layer disintegrates. Whilst expression of some 
transcription factors appears temporally constrained, expression of others persists throughout this 
period of development (such as PAX6 for example). Examining where expression varies, and what 
key developmental events occur at that time, could provide functional insight into the role of certain 
transcription factors at that time. Likewise, consistent expression could dictate a role in 
housekeeping processes, or that a protein relies on significant post-translational modification to 
alter its function. Recently, an interesting study used laser micro-dissection (LCM) to isolate 
embryonic CGNPs and identify differential transcription factor expression patterns in these cells 
between E13 and E18 [298]. This study identified a significant number of novel transcription 
factors, of which a significant proportion displayed differential expression between these embryonic 
time points. Interestingly a number of targets identified as differentially expressed (Barhl2, Irx1, 
Neurod6, Pax3 and Ets1) in this dataset, are co-ordinately regulated targets of NFIs identified in our 
dataset at postnatal day seven. Additionally, a further six (Math1, Ebf1, Hes6, Insm1, Lhx1 and 
Zic1) transcription factors from this LCM analysis are directly regulated by Nfia at P7 and another 
four (Foxq1, Kcnip3, Klf4 and Sox7) are directly regulated by Nfix. For some transcription factors, 
these data suggest that their regulatory relationship with NFIs is initiated in the embryonic EGL and 
persists through postnatal development. However, for a substantial proportion of others, this 
suggests that the regulatory relationship may be forged during postnatal development. This is 
further evidence that the postnatal EGL is a dynamic regulatory environment.  
 
An interesting point of contrast with the co-ordinate action of NFI transcription factors is to 
investigate directly regulated targets of NFIA that are not regulated by NFIX, and vice versa. Our 
analysis showed 50 transcription factor targets unique to Nfia, and 20 unique to Nfix. NFIA 
regulates a number of genes with known roles in defining cell linages of embryonic cerebellar 
progenitors, such as Math1, Barhl1, NeuroD2, Insm1, Hes6 and Zic1, which are heavily involved in 
specialisation towards the granule neuron identity [61, 299]. NFIX on the other hand uniquely 
regulates few genes associated with this early granule neuron lineage specification. This raises the 
question as to whether Nfia plays a more dominant role than Nfix in regulating early CGNP 
development. Future work on lineage specification of progenitors in both our respective NFI-null 
mutants, potentially using laser microdissection and analysis of the rhombic lip, could provide key 
insights into these questions.  
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4.6.6 NFI’s may modulate CGNP response to neurotrophins, though the ETS transcription 
factors Etv5 
Another transcription factors, Etv5 was selected for further examination via qPCR. Etv5 is a 
member of the ETS-domain family of transcription factors, a number of which are expressed in the 
cerebellum and cerebellar granule neurons [300-302]. ETS-Family member Etv1 has been show to 
interact with NFIs in post-mitotic CGNs, acting as a positive regulator of NFI-binding to/activation 
of genes involved in neuron dendritogenesis [303]. Interestingly, our data show that Evt1 is a 
directly regulated target of Nfix in pre-mitotic progenitors (but not Nfia), with reduced expression of 
ETV1 upon Nfix loss. Very little is known about the role of Etv5 in the CGNPs (or indeed the 
cerebellum), but some function may be inferred from the actions of other ETV family members, 
who share a conserved binding sequence and often conserved biological functions [304]. For 
example, BDNF stimulated ERK1/2 expression has been shown to activate ETV4 and ETV5 
expression in Dorsal Root Ganglion neurons, initiating neurite outgrowth [305]. Additionally, 
ETV4 and ETV5 are required for proper dendrite development in hippocampal neurons [306]. 
BDNF is essential for proper cerebellar development, and preferentially activates the TrkB receptor 
in CGNPs and Purkinje neurons. Loss of BDNF results in extensive foliation defects in the 
developing cerebellum, as well as increased apoptosis and a reduction in the overall number of 
CGNPs in the postnatal IGL [307]. Additionally, the EGL persists for longer than normal, 
phenocopying the developmental delay we have previously identified in Nfix-/- mice [91], [Chapter 
3].  
Our data also show that that the low affinity neurotrophin receptor Ngfr (p75NTR) is also natively 
repressed by NFIs in CGNPs. This receptor is prolifically expressed in the EGL but not the IGL and 
binds neurotrophic factors such as BDNF and NGF [308, 309]. Activation of Ngfr has recently been 
shown to regulate timely cell-cycle withdrawal in the cerebellum, with loss of the receptor leading 
to extended proliferation of granule neuron progenitors [309]. Interestingly, this result seems to 
complement the phenotype we have witnessed in Nfix-/- mice; yet these mice should by extension 
have increased Ngfr expression, due to the lack of Nfix-mediated repression. It is possible that, since 
the receptor is co-ordinately regulated by both NFI transcription factors, Nfia may be acting to 
compensate for Nfix loss, through direct regulation or through other effectors.  Indeed, much further 
investigation is needed to determine the specifics of this transcription factor-growth factor 
relationship. Taken holistically however, these data show that NFI expression may play a crucial 
role in modulating the developmental response to neurotrophins in CGNPs, potentially at both a 
receptor and effector level.  
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4.7 Conclusion  
 
Cerebellar development is an incredibly complex process, requiring signalling from a multitude of 
pathways, influenced by a number of cell autonomous and non-autonomous factors. Here we have 
shown that two transcription factors, Nfia and Nfix, are expressed in broadly overlapping 
populations in the developing cerebellum, and co-ordinately regulate a subset of genes involved in 
cerebellar development. Additionally, we have shown that both NFIs exert further influence in 
regulating cerebellar development, by controlling the expression of other developmentally 
significant transcription factors, both individually and in a co-ordinated manner. Further 
investigation to the level of regulation and role of these gene targets may shed light on previously 
unknown developmental processes governing cerebellar development. Additionally, this may 
unearth new gene targets useful in the prognosis and treatment of malignant neoplasms of the 
cerebellum.
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 : General Discussion 
 
5.1 Aims of Chapter 5 
The research presented in this thesis comprehensively profiles the role of the Nuclear Factor One 
transcription factors in cerebellar development, focusing on progenitors in the EGL. First, we 
investigated the expression of NFIX in the embryonic and postnatal cerebellum, finding broad 
expression in a number of different cell lineages, including CGNS and their embryonic and 
postnatal progenitors. Next, focusing on CGNPs, we identified key downstream gene targets 
directly regulated by NFIX. From these, a number involved in regulating progenitor differentiation 
were identified including Itsn1, which encodes a scaffold protein in the Reelin signalling pathway. 
Lastly, we expanded on this analysis to determine which of these gene targets are also directly and 
co-ordinately regulated by NFIA. The evidence from these findings suggest that a NFIs co-
ordinately regulate an impressive number of developmentally significant genes, including other 
transcription factors. This chapter aims to contextualise the new findings from this research, and the 
broader implications that can be extrapolated from it, in understanding cerebellar development and 
the NFI family. It also aims to discuss the limitations of this thesis in terms of conclusions that can 
be drawn without further analysis. Lastly, it sets forward future avenues of investigation to help 
answer outstanding questions raised in this thesis to further understand the mechanics of cerebellar 
development.  
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5.1.1 Expanding on the roles of NFI transcription factors in the granule neurons 
The importance of studying the cell-type specific expression of proteins is especially pertinent in 
regions of the brain such as the cerebellum, as it consists of a largely heterogeneous population of 
cells. This thesis has shown that NFI TFs have overlapping roles in cerebellar progenitors within the 
EGL. NFI expression is also ubiquitous in the many cell types in the cerebellum. For instance, 
NFIA and NFIX are expressed in both neurons and glia, which have notably distinct developmental 
origins. We have shown that loss of Nfix affects the normal developmental program of CGNPs, 
complementing other research, showing NFIs have important roles in stem and progenitor cell 
populations in the CNS [84, 85, 130, 151, 183]. Additionally, we have shown that NFIA and NFIX 
are expressed in these progenitor cells, with transcriptomic analysis showing both co-ordinated and 
distinct targeting of downstream gene effectors. This work further highlights NFIs as key regulators 
of CGNP development from embryogenesis to adulthood. Despite our analysis, there are still a 
number of avenues to be explored in future work, notably a more extensive look at the role of Nfib 
in CGNP development.   
 
The work in this thesis predominately focused on NFIX and NFIA, but did not expand to examine 
the role of NFIB with the same depth. This is due partly to the lethality of Nfib-/- mutants and the 
absence of an available conditional deletion mutant line. Online expression data show that NFIA, B 
and X are all expressed in the embryonic rhombic lip, and expression is evident in postnatal CGNPs 
at P6 [100]. Previous studies have shown that Nfib-/- mice have similar, but more severe, neural 
defects in comparison to Nfia-/- mice, suggesting at least a partial overlap in function [100, 108]. At 
E18, Nfib-/- mice have a largely unfoliated cerebellum, a phenotype often found in cerebellar 
mutants with abnormal CGNPs, or where BG or Purkinje neurons development is disrupted [108]. 
No cell-type specific analysis of NFIB has been conducted in the normal cerebellum, despite strong 
evidence of expression postnatally [100]. Our data show a high overlap of NFIB binding peaks with 
that of NFIA and NFIX, supporting a conserved function in CGNPs. Following a similar protocol to 
that that was used in Chapter 3 and 4, a combination of cell-type specific analysis and 
transcriptomic data in Nfib-null CGNPs would help round out the picture as to what gene targets are 
shared amongst NFIs in these cells. Generating an Nfibfl/fl; Math1Cre mouse would allow 
investigation of the loss of Nfib specifically in embryonic and postnatal CGNPs and likely avoid the 
embryonic lethality seen in Nfib-/- mice. From there, co-ordinated regulation, misregulation or 
individual regulation of gene targets by each NFI could be ascertained.   
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The postnatal cerebellum is an incredibly dynamic environment, and different developmental 
programs have a distinctly temporal basis. We used P7 primarily as a starting point to examine 
CGNPs, as this correlates approximately with the peak number of progenitor cells in the EGL. It is 
highly likely that both the number of individually and co-ordinately regulated genes, by each NFI, 
may have a temporal basis in CGNPs. Further expanding our transcriptomic analysis to include 
other ages would provide a picture of how NFI-mediated gene regulation changes throughout 
postnatal cerebellar development. Another interesting finding from these studies is that a large 
proportion of NFI binding sites are found in regions of closed chromatin at P7. It is possible that 
NFIs may either rely on other factors to modulate chromatin accessibility, or indeed may promote 
accessibility themselves. Broadening ChIP-seq and DNase I hypersensitivity analysis to examine 
changes in NFI binding patterns in CGNPs at different time points may provide some answers here.    
 
The lack of double (Nfia/x, Nfia/b, Nfib/x) and triple (Nfia/b/x) knockout or knockdown mouse 
mutants limits our ability to make conclusions on how these family members natively interact in 
cerebellar granule neurons. With the single knockouts we used, it is possible that a compensatory 
function of other NFIs could obscure the roles of individual family members, considering our 
evidence of overlapping expression patterns and co-ordinated downstream gene targets. Phenotypic 
and transcriptomic profiling in a double or triple knockout line would further elucidate how these 
factors work together and provide insight into differences in function. Similar approaches using 
heterozygotes have been taken to investigate other transcription factors with prominent roles in 
CGNP development, such as the ZIC family[310]. However, as both Nfia-/- and Nfib-/- knockouts are 
perinatal lethal and Nfix-null mice die during postnatal development, it is possible that double and 
triple knockout mutants would not be viable for postnatal studies. Interestingly, Nfi-heterozygous 
mutants display intermediate neural phenotypes compared to full knockout counterparts and are 
viable postnatally [311]. Recently, Nfia+/- ; Nfib+/- double heterozygous mutants were shown to 
largely re-capitulate embryonic cortex defects seen in both Nfia-/- and Nfib-/- mice, but a cerebellar 
phenotype (if present) was not examined  [312]. Complete allelic loss of both Nfia and Nfib resulted 
in a more severe cortical phenotype at E16 [312]. Indeed, authors reported low embryonic viability 
of these mutants, in addition to perinatal lethality. Utilising double heterozygotes or crossing these 
double and triple mutants onto the aforementioned Math1;Cre or inducible Math1;CreERT2 [313] 
genetic background could be another way of investigating con-current loss of NFIs within the 
postnatal cerebellum. Additionally, a comparison to how heterozygosity of NFIs compares 
phenotypically and transcriptomically to the induced loss of these TFs in CGNPs would be of great 
interest.  
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NFI proteins form functional homo and heterodimers in vitro, yet how exactly these combinations 
work to drive different developmental programs is yet to be fully resolved in vivo [89, 312, 314]. 
Knocking out one (or multiple NFIs) would theoretically change the ratio of binding partners 
available to act as heterodimers versus homodimers. Indeed, natural fluctuations in expression of 
these and other TFs is likely a mechanism in which particular developmental programs are 
regulated. This may explain the more extreme cortical phenotypes witnessed in full homozygous-
null mutants, versus NFI-heterozygous mutants that can still function as heterodimers. Additionally, 
it is entirely possible that loss of one NFI family member can be partially compensated for in a 
functional manner by formation of heterodimers from remaining NFI TFs. This may explain the 
variations in severity of cerebellar and cortical phenotypes on NFI loss, especially if different NFIs 
have preferential binding partners. The similarity in cortical phenotype, strongly overlapping 
expression in the cerebellum at all timepoints and evidence of binding as cofactors for other 
transcription factors [312, 315], raises the possibility that NFIA and NFIB might form heterodimers 
together, in a preferential manner than forming them with NFIX. Further investigation here is 
needed if we are to fully understand how NFIs regulate gene expression in the developing 
cerebellum. Proximity based fluorescent assays such as FRET have previously been used to 
investigate dimerization of transcription factors in vitro [316, 317]. With the right constructs, this 
technique could be adapted to quantify both the levels of homo/heterodimerisation of NFIs, and 
changes in these ratios upon knockdown or loss of a family member. Additionally, this approach 
could be used to investigate the dimerization ability of the different NFI transcript variants found in 
CGNPs.  
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5.1.2 Targeting NFI expression outside of neurons would provide a more representative view 
of global NFI loss.  
From a cell extrinsic viewpoint, by isolating pure populations of cells for analysis, we struggle to 
fully recapitulate the native environment these cells reside in. This is especially pertinent for 
CGNPs as proper development relies on inputs and outputs of BG, interneurons, oligodendrocytes 
and Purkinje neurons. For example, loss of oligodendrocytes in the cerebellum alters the 
morphology of PNs and CGN, and reduces the expression of key signalling molecules SHH, BDNF 
and RELN [318]. Whether or not loss of NFIX or NFIA results in increased cell death of 
oligodendrocytes has not been investigated thoroughly throughout cerebellar development, however 
NFI expression is present in a proportion of these cells. 
 
Whilst this work predominately focused on CGNs, cell-type specific expression of NFIX and NFIA 
was shown in other cell types, including Bergmann glia. This is important to consider due to the 
dependent relationship between these cells and the migration of post-mitotic CGNPs [19]. Global 
loss of NFIX might therefore result in a double hit affecting CGNP migration- affecting cell-
intrinsic pro-differentiation mechanisms whilst simultaneously interfering with the essential 
scaffold required for migration of these differentiated cells. Loss of NFIX results in a reduction in 
GFAP expression at P7 [91] (Chapter 3), with significantly fewer GFAP+ glial fibres extending 
through the EGL to the pial surface. What role NFIX plays in the maturation of these particular glia 
is yet to be determined, however the work in chapter 3 has shown that loss of NFIX does delay glial 
maturation. Our data show strong NFIX expression in the embryonic cerebellar ventricular zone at 
e15.5, the site of genesis of cerebellar glial progenitors. Additionally, both NFIX and NFIA are 
expressed in s100b+ Bergmann glia as early as P3 in the postnatal cerebellum, and this expression 
persists until at least P15 (Chapter 4).  
 
In the cerebellum, conditional deletion mouse lines driven by either GFAP and GLAST promoters 
are used to selectively delete genes from glia and glial progenitors. Crossing both Nfixfl/fl, Nfiafl/fl 
and Nfibfl/fl mouse lines onto either (h)GFAP; Cre or GLAST; Cre genetic backgrounds, would be a 
logical next step to investigate how these NFI TFs directly affect Bergman glia development 
through cell intrinsic processes and could provide insight into how they indirectly (cell-
extrinsically) affect CGNP development. Additionally, generating a Nfixfl/fl, Nfiafl/fl, Nfibfl/fl double 
and triple mutants and crossing these strains onto hGFAP; Cre and GLAST;Cre genetic 
backgrounds could provide needed contrast to individual knockout mutants phenotypes. This would 
provide functional insight into independent or redundant roles of NFIs in these cells. One caveat of 
these experiments is that as of yet, no cerebellar-glia specific mouse line currently exists. Both 
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GFAP and GLAST, as well as newer glial specific promoters (such as Aldh1l1-CreERT2) all target 
astrocytes and glia prolifically throughout multiple regions the brain [319, 320]. One way to get 
around these off-target effects, would be to use glia-specific viral RNAi constructs injected 
proximally to the cerebellum, to knockdown NFIs in cerebellar BG and astrocytes with limited 
forebrain diffusion. 
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5.1.3 Manipulation of NFI expression; knockdown and rescue  
Germline and conditional knockout mouse models emulate complete and cell-type specific loss of 
NFI expression respectively. These models are useful in understanding global roles of NFI proteins, 
but do not always recapitulate the phenotype of spontaneous mutants, where a loss of function 
mutation can occur, often in clonally expanding progenitors such as CGNPs. These types of 
mutations are interesting as they can result in a mixed population of post-mitotic cells, both mutant 
and normal phenotypes in the same environment. Replicating these types of mutations can be 
achieved using virally delivered shRNA and RNAi constructs, and cell-type specificity can be 
achieved using specific promoters. Lentiviral knockdown of NFIs has previously been performed in 
CGNs in vitro [101]. These could likely be extended to target cerebellar neurons and glia, using 
precise, transcranial injection of viral constructs. In humans, allelic Nfix mutations result Malan-
Sotos syndrome, which has a variance severity of symptoms depending on the location and type of 
point mutation and/or deletion [118-122, 125, 321]. It is possible that viral delivery of CRISPR-
CAS9 constructs could be used to introduce patient specific point mutations into mice, to further 
examine how this disorder affects the development of the brain and potentially new avenues for 
treatment.  
 
Experiments using both adenoviral and lentiviral constructs in vivo have successfully transfected 
Purkinje neurons, Bergmann glia, granule neurons, cells in the molecular layer and in the white 
matter of the cerebellum with varying levels of specificity [322-324]. Virally-infected transgenic 
cells have been detected several weeks after injection in the cerebellum [324] suggesting that 
technique could be used to modulate NFI expression over the whole time-course of postnatal 
cerebellar development. As simultaneous co-injection of two adenoviruses and subsequent 
transgene expression has been successfully achieved in Purkinje Neurons [324], it is possible that 
this technique could be expanded to knockdown the expression of different combinations of NFIs at 
once. This might provide an alternate model to examine redundancy in NFI expression and function 
in these cells. Viral constructs could also be used in our germline and conditional mutants to 
knockdown the expression of additional NFIs, as well as other genes of interest. This approach may 
prove more time efficient than generating double and triple germline or conditional knockout 
mutants, with less potential side-effects such as perinatal lethality. It could also provide a useful 
intermediary between cell-type restricted NFI loss and global NFI-loss models.  
 
Viral overexpression/gene transfer on the other hand can act as useful control, to restore NFI 
expression in mutant cells and rescue the mutant phenotype. This approach is a way to show that the 
phenotypes witnessed are indeed a result of the loss of a particular protein (in this case NFIA or 
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NFIX). Future experiments could examine whether or not rescue of NFIA or NFIX expression is 
enough to reverse both cell-specific and morphological abnormalities in our mutant mice. 
Additionally, rescue of NFI expression at specific postnatal timepoints (for example P3, P7 or P15) 
and examination of the level of phenotype rescue would provide insight as to where each NFI is 
most active in exerting developmental control.  
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5.1.4 Does NFI loss alter neural circuitry in the cerebellum?  
The cerebellum is unique in the CNS in that it operates in a feed-forward manner, relying on a 
complex, interconnected signalling network of different cell types. Previous research left a gap as to 
what role NFIs played in the cerebellum, with some preliminary studies focusing predominately on 
CGNs and not expansively investigating these other cell types. The work in this thesis set out to 
investigate both the molecular mechanisms dictated by NFIs in CGNPs, and help fill in the gaps left 
by previous work. For example, we have shown for the first time that NFIX is expressed in basket 
and stellate interneurons in the molecular layer of the cerebellum [Chapter 2]. These inhibitory 
interneurons are crucial regulators of both feed-forward and feedback loops in this layer and form 
inhibitory synapses with Purkinje Neurons [325, 326]. It is possible that loss of NFIX expression in 
these interneurons causes cell intrinsic changes, as well as extrinsic effects that could exacerbate 
and contribute to the delay phenotypes we have identified in Nfix-/- mice. In CGNPs at least, we 
have shown that NFIs regulate the expression of a number of key axon growth and synaptic 
signalling proteins [Chapter 4]. Considering we have shown that NFIX is expressed in all cerebellar 
regions that contain interneuron progenitors during postnatal development including the embryonic 
VZ, and postal ML, IGL and WM (Chapter 2), it is possible that this TF regulates a similar suite of 
genes essential for interneuron synapse formation, like it does in CGNPs. Using Golgi-cox staining 
combined with high magnification stereomicroscopy would provide key details into any 
morphological deficits in axon, spine and synapse formation in these cells in vivo. Purification of 
interneuron subpopulations and downstream mRNA analysis has recently been achieved in the rat 
cortex using FACS [327]. FACS followed by qPCR or RNA-sequencing would allow investigation 
of changes in the expression of key axonal growth and signalling related genes, in pure populations 
of interneurons isolated from mutant cerebella.  
 
One unexplored avenue in this thesis is how changes in NFI expression alter the electrophysiology 
of neurons and interneurons in the cerebellum. A number of different methods have been used to 
effectively measure the electrical activity of ML interneurons, PNs, Golgi cells and CGNs [328-
334]. Examining induced and spontaneous firing activity in our mutants and comparing that with 
activity in our controls would provide novel insight into just how NFI loss alters the signalling 
pathways of the cerebellum. Combining this analysis with cell-type specific conditional deletion 
mutants with, would allow examination of cell intrinsic changes in mutant cells, as well as the 
subsequent extrinsic affects these mutations cause other cells in the cerebellar signalling network. A 
hallmark consequence of NFI loss or disruption is developmental delay and behavioural deficits, 
with associated ASD-like features [315, 335-339]. Unravelling how NFI loss impacts signalling 
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networks and synapse activity in the cerebellum would provide new information as to the biological 
changes that underpin these phenotypes.  
 
From our DAVID and PANTHER analysis, it was noted that a number of GO-terms related to both 
signalling, ion and electrical activity were strongly enriched from our co-ordinately regulated gene 
lists [Chapter 3, 4]. Membrane depolarisation is a crucial component of CGNP development, 
encourages Ca2+ entry and activates kinase CaMK and phosphatase CaN. This signalling cascade 
upregulates factors involved in proliferation, differentiation and neuron migration, such as BDNF 
[340-342]. Potassium channels and K+ levels control resting membrane potential and the duration of 
action potentials in neurons. K+ can also induce apoptosis in granule neurons [343, 344]. Our data 
showing NFI regulation of multiple voltage gated potassium channels subunit genes suggest that 
these transcription factors could influence membrane potential, affecting downstream 
developmental signalling cascades.  Determining how NFI-null CGNPs respond to manipulated K+ 
levels in vitro would be a logical first step to see if mis-regulation of these potassium channel genes 
affects both neuron survival and action potential excitability.  
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5.1.5 Targeting NFIs in tumour therapy 
Due to their prevalence in many tissues and in pools of proliferative progenitors, it is not 
unexpected that NFI mutations are associated with many different types of tumours. Indeed, the role 
of NFIs in developmental tumours was recently extensively reviewed, demonstrating a degree of 
convergence between family members [345].  In the cerebellum, NFIA, B and X expression have all 
been shown to have a potential role as a tumour suppressor in medulloblastoma [136, 170]. In 
human medulloblastoma cell lines, we have shown that NFIX is downregulated [Chapter 3]. Our 
analysis has shown that both NFIs directly regulate WNT and Notch signalling pathway members 
previously implicated in MB formation, as well as a number of pro-oncogenes and pro-
differentiation factors [234, 346-355]. Further investigation is needed as to through which particular 
target pathways and effectors NFI-regulation mediates anti-tumour effects. Poorer outcomes from 
NFI loss in the Ptch+/- SHH-MB mouse model suggest that manipulation of this pathway may also 
be a mechanism in which NFIs exert a purported tumour-suppressive effect [136].  
 
This exposes the inherent complexity in transcription factor mutations in cancer; the downstream 
affects are often incredibly varied and extensive. Drug therapies targeting transcription factors often 
focus on their degradation through proteolysis, functional inhibition or downregulation [356]. This 
strategy is less compatible with pro-differentiation transcription factors such as NFIA and NFIX, as 
their inhibition could potentially encourage tumour cell proliferation. Thus, analysis similar to what 
is presented in this thesis is essential in understanding normal TF-gene target relationships in native 
cells in the normal microenvironment. This provides essential understanding as to what genes and 
pathways are likely disrupted in neoplasms developing from these cells, offering a suite of targets 
potentially more druggable than TFs themselves. 
  
NFI expression in glia has an important disease context. Gliomas arise from glia and are the most 
common malignancies in the CNS. In glioblastoma, NFIB has can act as a tumour suppressor 
(depending on the particular tumour subtype) and can suppress tumour cell migration [357, 358]. 
This is in contrast to NFIA which has been shown to promote glioblastoma tumour cell migration 
and survival [359, 360]. This presents a number of difficulties from a therapeutic perspective; a) the 
risk of cross reactivity between NFIs in targeted immunotherapies b) resistance to therapy due to 
autoregulation or redundancy between NFIs. Focusing instead on the downstream cascades and key 
oncogenic targets of NFIs is likely a more fruitful endeavour, but the importance of genetic 
profiling of these tumours cannot be understated even if for purely prognostic rather than treatment 
purposes.   
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5.1.6 Moving beyond transcriptomic analysis  
Whilst this thesis has provided strong evidence and support for the conclusions within there are 
limitations in the methodology employed. A large proportion of our analysis focused on RNA-
expression changes in cells isolated from the developing cerebellum. These changes can provide a 
good indication of global activity when using grouped analysis methods, such as GO-terms to look 
at broad changes in pathway activity, biological activity and molecular function.  Correlation 
between mRNA and protein levels can be tenuous at best, and shows levels of tissue and context 
dependency[361-364]. RNA-analysis does not fully capture the myriad of post-translational 
modifications and factors that can affect both protein production, function and resultant expression 
in tissue. Indeed, the known cross and self-regulatory nature of the signalling pathways and 
transcription factors pulled out in our analysis beg the question; what protein:protein interactions 
are influencing the mutant phenotypes witnessed? Incorporating immunoassays such as ELISAs 
could be useful here to quantify protein expression of our identified co-ordinately regulated/mis-
regulated targets in NFI-deficient granule neurons. These assays can be adapted using a number of 
commercial multiplexing systems to investigate multiple targets at once, which is invaluable 
considering the sheer number of downstream targets identified using our ChIP-seq + RNA-seq 
combined approach. Like other immunoassays however, these assays rely on the availability of 
specific antibodies, minimising its application in investigating novel targets proteins from our 
datasets. This hurdle can be surpassed however, by using approaches such as Label-free HPLC-
tandem mass spectrometry, which was recently used to identify differentially expressed proteins in 
human cerebellar tissue [326, 365]. The high throughput nature of this technique provides an 
additional added advantage to immunoassay-based approaches. A recent study generated a 
workflow that combined RNA-seq, MS proteomics and a global post-translational modification 
database to help surpass the aforementioned shortcomings [366]. Adapting our analysis to 
incorporate similar workflows would provide greater confidence in our conclusions and 
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5.2 Conclusion: 
This thesis set out to examine the Nuclear Factor One family of transcription factors and how they 
drive the development of the cerebellum. It showed that NFIs are expressed in a number of different 
cell types in the cerebellum and are notably highly expressed in cerebellar granule neurons and their 
progenitors. It investigated the changes in gene expression that occur when NFIs are deleted from 
these cells and though this, generated a dataset of gene targets directly regulated by each NFI. Our 
findings place Nfia, Nfib and Nfix as key drivers of the differentiation of cerebellar granule neuron 
progenitors in the postnatal brain. These findings have broad implications in better understanding 
the neurobiology of development, but also in understanding how mis-regulation of transcription 
factor expression can lead to disorder and disease. This thesis acts as the foundation for future 
research; investigating the biological significance of the key gene targets we have identified, 
incorporating proteomics into the analysis pipeline to improve coverage to protein expression, and 
is the first step in identifying new therapeutic targets for cerebellar tumours such as 
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Appendix 
Chapter 3  
Downregulated NFIX genes Upregulated NFIX target genes 
1700048O20Rik Il16 Snap25 Arl4a Cyth4 Gsg1l Msrb3 Resp18 Tmem179 
A730043L09Rik Impg2 Soga1 Arl4c Dab1 Gstm6 Mxra7 Rfx4 Tmem196 
Abca2 Iqcj Sorbs1 Asap1 Dact2 Gusb Myrip Rgs3 Tmem200a 
Abcc8 Itsn1 Sostdc1 Ass1 Dennd3 Hdac11 Ncam2 Rgs4 Tnc 
Adam11 Jph4 Sowahb Atp13a4 Dhrs3 Hhip Nckap5 Rgs8 Tnf 
Adamts18 Kcna1 Spata13 Atp2b4 Dkk3 Hmga2 Ndufc2 Rhbdl3 Triqk 
Adcy1 Kcnip3 Sphkap B3gat1 Dlc1 Hpca Nek7 Rhoj Trpc7 
Ahdc1 Kcnj11 Sptbn4 Barx2 Dlgap2 Hspa12a Nell1 Rimbp2 Tsc22d4 
Amer3 Kcnj9 Srcin1 Bcan Dnm3 Htr7 Neurod6 Rnd3 Tspan11 
Ano5 Kcnk1 Srrm4 Bcas1 Dock2 Icmt Nfam1 Robo1 Tspan9 
Ap3b2 Kcnk3 Stxbp5l Begain Dpp6 Ier5 Nfkbiz Rtn4rl1 Txlnb 
Arid1a Kcnq5 Syne1 Blnk Dpysl4 Igf2bp2 Ngfr Rtp4 Txnrd3 
Arpp21 Kcns2 Syt9 Bmp5 Dtx4 Igfbp2 Nhlrc4 Rxra Vim 
Atp2b1 Kl Tenm1 Bmper Dusp2 Igfbp3 Ninj1 Ryr3 Vit 
Atp2b3 Klf9 Tgfb2 Btbd11 Dusp6 Igsf11 Nkain2 Sall1 Vstm2b 
Barhl2 Ksr2 Tle2 C1qtnf4 Dync1i1 Il17rd Notch3 Samsn1 Vwf 
Brinp2 Ky Tmem63c Cacna1h Ebf2 Ildr2 Nptx1 Scml4 Wnt5a 
Btbd17 Lipc Tmprss13 Cacna2d2 Ecscr Inpp5a Ntng2 Scn1a Wnt7b 
Cacna1c Lrrtm3 Trim67 Cacng4 Efnb1 Insc Nuak2 Scn3a Zfp618 
Cacna2d3 Lyst Trpc4ap Calb1 Egln3 Iqsec1 Nwd2 Scube2 Zfp804a 
Cadps Marchf3 Tspan4 Calcrl Elfn2 Iqsec3 Nxph1 Serinc5   
Camk4 Map3k5 Unc13a Camk1d Elk3 Irx1 Ogdhl Serpine2   
Car10 Megf10 Unc5b Camk1g Eln Islr Optc Sgcd   
Cdh15 Miat Vat1l Camk2n1 Emp1 Itgb5 Osbpl5 Sgcz   
Celf4 Mmp17 Wnt7a Car8 Enc1 Itpka Osm Sgk1   
Cemip Mpp3 Zbtb20 Cartpt Enpp1 Kalrn Otof Sh3pxd2a   
Cenpf Mrgprf Zdhhc22 Cbln4 Epha4 Kank4 P4ha2 Shh   
Cerkl Mtss1 Zfhx2 Ccbe1 Epha5 Kcna6 Pam Siglech   
Cipc Myocd Zfhx2os Ccdc184 Epha8 Kcnb1 Paqr8 Sik1   
Cmss1 Ncam1 Zfhx4 Cd109 Esrrg Kcne4 Pax3 Skor2   
Cntn2 Neurod1 Zfpm2 Cd44 Ets1 Kcnf1 Pcdh15 Slc14a2   
Col8a1 Neurod4 Zfyve28 Cd83 Etv5 Kcnip1 Pcdh19 Slc17a8   
Coro2b Nfix Zhx2 Cd93 Fam20c Kcnip4 Pcdh20 Slc2a4   
Crabp1 Nos1 
 
Cdh11 Fam43b Kcnma1 Pcp2 Slc35f1   
Crhr1 Ntf3 
 
Cdh20 Fam46a Kcnn3 Pcp4 Slc41a3   
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Csmd2 Ntrk3 1110015O18Rik Cdh4 Fat4 Kcnv1 Pcsk5 Slc5a7   
D430041D05Rik Nxpe3 1810011O10Rik Cdh7 Fbln1 Kctd14 Pcsk6 Slc6a1   
D630010B17Rik Olig3 2310015A10Rik Cdh9 Fbln2 Kctd16 Pde1c Slc6a11   
Dio2 Otx2 9630028H03Rik Cdkn1c Fbxo2 Kif26a Pde2a Slco2b1   
Dock4 Paqr6 A730017C20Rik Cebpb Fibcd1 Kit Pdgfa Slit1   
Efcab5 Pcdh7 Abcb6 Cend1 Fos Klf15 Pdgfc Smad3   
Ephb1 Pde3a Abcb9 Chd5 Foxq1 Klf4 Pdzd2 Smoc1   
Etv1 Pde9a Ackr3 Chl1 Frem1 Lamb1 Pdzrn4 Snph   
Exph5 Pik3c2b Acot7 Chrna4 Frmpd4 Lamc2 Pecam1 Sorcs1   
Fam107a Plxna2 Adamts1 Chrnb4 Fscn1 Lgr6 Pgf Sorcs2   
Fat2 Ppfia4 Adamts14 Chst1 Fxyd7 Lhfpl3 Phactr2 Sorcs3   
Fbn1 Prkce Adamts3 Chst8 Fzd9 Lhpp Pkdcc Sowaha   
Fgf14 Prox1 Adamtsl1 Cnr1 Gaa Lhx5 Pla2g5 Sox7   
Foxo6 Prune2 Adarb2 Cntn5 Galnt10 Lifr Plat Spats2l   
Ftx Rapgef3 Adcy2 Cntn6 Galnt14 Limch1 Plcxd3 Sstr2   
Gabbr2 Rbfox3 Adcyap1 Cntnap5a Galnt18 Lingo2 Plxdc1 St6galnac5   
Gabra2 Rimkla Agtrap Cntnap5b Gas6 Lingo3 Plxna4 Stac   
Gabra6 Rims1 AI593442 Col25a1 Gem Lix1l Ppp1r16b Stac2   
Gabrd Rnf112 Aif1 Col26a1 Gfod1 Lmx1a Ppp1r1b Stc1   
Galr1 Rnf165 Aif1l Col27a1 Ghr Loxl1 Prdm13 Sv2c   
Gfap Rnf182 Ajap1 Col4a1 Gldc Lpar1 Prkar1b Sybu   
Gjb6 Ryr2 Ak1 Col4a2 Glis3 Lrig3 Prkch Syt13   
Gm9899 Samd12 Akap2 Col5a1 Glyctk Lrtm2 Pros1 Syt16   
Gpr158 Schip1 Akna Col9a1 Gm14204 Lum Prr5 Tenm3   
Gpr3 Scrt2 Aldh1l1 Col9a3 Gm5083 Luzp2 Prss23 Tenm4   
Grb10 Sept3 Aldoc Cpxm2 Gm5089 Ly86 Ptpn3 Tex29   
Grin2a Sel1l3 Alk Crtac1 Gm5607 Lypd6 Ptprm Thbs1   
Grin2c Sema3d Angpt1 Cryba4 Gm8909 Masp1 Ptpru Thsd4   
Grm1 Sez6 Ankrd55 Csdc2 Gpr12 Mb21d2 Ptprz1 Thy1   
Grm4 Sfrp1 Ano1 Csgalnact1 Gpr153 Mcam Pvalb Tiam2   
Heg1 Sgsm1 Ano4 Csrnp1 Gpr26 Mcc Pvrl1 Tmem130   
Hivep2 Sh3rf3 Apod Csrp2 Gria1 Mdga2 Pxylp1 Tmem132b   
Hivep3 Slc25a22 Apold1 Cttnbp2 Grik3 Medag Qpct Tmem132c   
Hsd11b1 Slc4a4 Arap1 Cyp11a1 Grik4 Mgat5 Rab27b Tmem132d   
Igsf10 Slc7a11 Arhgap15 Cyp26b1 Grm7 Mn1 Rab3b Tmem176b   
Table A10: Directly regulated gene targets of NFIX from Chapter 3 (578)  
Data was obtained by comparing RNA-seq in Nfix+/+ and Nfix-/- in CGNPs, with ChIP-seq for NFIX 
binding sites, and filtering through DNaseI hypersensitive data to find genes in regions of accessible 
chromatin. Red = downregulated, Green = upregulated. 
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Table A11: Breakdown of NFIX ChIP-seq binding events for gene targets from 
Chapter 3 
Analysis of histone marks using ChIP-seq reveals that a majority of NFIX binding evens 
are found in distal and genic regions, with only a small portion (4.22%) in the region of 
the promoter. For annotating binding events, a combination of NearestGene and 
Cismapper was used, with 1090 NFIX binding events associated with 578 gene targets.  
This analysis was published as part of the thesis: “A computational analysis of 
transcription factor interactions and binding guided by epigenetics”. Essebier, A. 2020. 
PhD Thesis, School of Chemistry and Molecular Biosciences, The University of 




Epigenetic Label Count   % of binding events 
Accessible 533 48.90% 
Active Accessible 49 4.50% 
Active Enhancer 41 3.76% 
Active Promoter 14 1.28% 
Active Regulatory 2 0.18% 
Poised Enhancer 443 40.64% 
Poised Promoter 3 0.28% 
Poised Regulatory 5 0.46% 
   
   
Location Count   % of binding events 
Promoter 46 4.22% 
Genic 583 53.49% 
Distal 461 42.29% 
   
Annotation Approach   % of binding events 
NearestGene 792 72.66% 
Cismapper 298 27.34% 
   
Total Binding events 1090  
Total Genes Bound 578  




Figure A1: Venn diagrams comparing NFIA and NFIX ChIP-seq data with RNA-seq data, 
separated into up and downregulated genes (Chapter 3, 4).  
NFIA ChIP-seq (left) found peaks associated with 7870 genes in accessible chromatin (orange), of 
which 1232 were identified as mis-regulated by RNA-seq in Nfiafl/fl; Math1-Cre+ CGNPs compared 
to controls. Of these, 895 were upregulated (green) upon Nfia loss, and 337 were downregulated 
(blue). NFIX ChIP-seq (right) found peaks associated with 4619 genes in accessible chromatin 
(orange), of which 578 were identified as mis-regulated by RNA-seq in Nfix-/- CGNPs compared to 
controls. Of these, 405 were upregulated upon Nfix loss (green), and 173 were downregulated 
(blue). These data demonstrate that when NFIA or NFIX are lost, a larger proportion of genes are 
upregulated than are downregulated, that in normal tissue, both transcription factors function as 
repressors a majority of the time.  
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Downregulated targets Upregulated targets 
Sept3 Neurod4 Adcy2 Chrna4 Fbxo2 Kif26a Pcdh20 Slc35f1 
Abcc8 Nfix Adcyap1 Col26a1 Frem1 Kit Pcsk5 Slc5a7 
Adcy1 Nos1 Agtrap Col27a1 Frmpd4 Klf15 Pcsk6 Slc6a1 
Amer3 Otx2 Ak1 Col4a1 Fscn1 Lgr6 Pde1c Slc6a11 
Arpp21 Pde3a Akap2 Col4a2 Gaa Lhfpl3 Pde2a Slit1 
Atp2b3 Prkce Akna Col5a1 Galnt10 Lhpp Pdgfa Smad3 
Barhl2 Rbfox3 Aldh1l1 Col9a3 Gas6 Lhx5 Pdgfc Smoc1 
Car10 Rimkla Aldoc Cpxm2 Glyctk Lifr Pdzd2 Sorcs1 
Celf4 Rims1 Alk Crtac1 Gm5607 Limch1 Pdzrn4 Sorcs2 
Cerkl Samd12 Angpt1 Csdc2 Gpr153 Lix1l Pkdcc Sowaha 
Cntn2 Scrt2 Ano1 Cttnbp2 Gpr26 Loxl1 Pla2g5 Spats2l 
D430041D05Rik Sema3d Apod Cyp26b1 Gria1 Lpar1 Plat Sybu 
D630010B17Rik Sez6 Arap1 Dab1 Grik3 Lrtm2 Plxna4 Syt13 
Exph5 Sfrp1 Arl4a Dhrs3 Grik4 Lum Prdm13 Tenm4 
Fat2 Sh3rf3 Asap1 Dkk3 Grm7 Luzp2 Prss23 Thbs1 
Foxo6 Snap25 Ass1 Dlc1 Gsg1l Masp1 Ptpn3 Thsd4 
Gabra2 Sowahb Atp13a4 Dnm3 Hdac11 Mcc Ptprm Thy1 
Galr1 Spata13 Atp2b4 Dpp6 Hhip Mn1 Ptprz1 Tmem132b 
Grm1 Sphkap B3gat1 Dpysl4 Hpca Mxra7 Pvalb Tmem132c 
Grm4 Srcin1 Bcan Dtx4 Hspa12a Ncam2 Pxylp1 Tmem176b 
Heg1 Syt9 Bcas1 Dync1i1 Icmt Nckap5 Qpct Tmem200a 
Hivep3 Tenm1 Begain Ebf2 Ier5 Nell1 Rab27b Tnc 
Igsf10 Tgfb2 Bmper Egln3 Igfbp2 Ngfr Rfx4 Tsc22d4 
Il16 Tle2 Btbd11 Elk3 Il17rd Nhlrc4 Rgs3 Tspan11 
Jph4 Tmprss13 Cacna2d2 Emp1 Ildr2 Notch3 Rgs4 Tspan9 
Kcna1 Unc5b Cacng4 Enpp1 Iqsec1 Nptx1 Rhoj Txlnb 
Kcnj11 Vat1l Calcrl Epha4 Irx1 Ntng2 Robo1 Vim 
Kcnk1 Zfpm2 Camk2n1 Epha5 Islr Nuak2 Ryr3 Vit 
Kcnq5 A730017C20Rik Cartpt Epha8 Itgb5 Ogdhl Sall1 Wnt5a 
Kcns2 Abcb6 Cbln4 Esrrg Kalrn Optc Scml4 Wnt7b 
Klf9 Abcb9 Cd44 Ets1 Kank4 Osbpl5 Scn3a Zfp618 
Lrrtm3 Ackr3 Cd93 Etv5 Kcna6 P4ha2 Scube2  
Map3k5 Acot7 Cdh11 Fam20c Kcnb1 Pam Serinc5  
Mpp3 Adamts1 Cdh20 Fat4 Kcnn3 Paqr8 Serpine2  
Mtss1 Adamts14 Cdkn1c Fbln1 Kcnv1 Pax3 Sh3pxd2a  
Neurod1 Adarb2 Chl1 Fbln2 Kctd14 Pcdh15 Sik1  
Table A12: Co-ordinately regulated gene targets by NFIA and NFIX from Chapter 4 
Data was obtained by combining RNA-seq in Nfix-/- and Nfiafl/fl;Math1-Cre CGNPs, ChIP-seq for 
NFIA and NFIX, and filtering through DNaseI hypersensitive data to find genes in regions of 
accessible chromatin. Red = downregulated, Green = upregulated. 
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Abstract  
 
Transcriptional regulation plays a central role in controlling neural stem and progenitor cell 
proliferation and differentiation during neurogenesis. For instance, transcription factors from the 
nuclear factor I (NFI) family have been shown to co-ordinate neural stem and progenitor cell 
differentiation within multiple regions of the embryonic nervous system, including the neocortex, 
hippocampus, spinal cord and cerebellum. Knockout of individual Nfi genes culminates in similar 
phenotypes, suggestive of common target genes for these transcription factors. However, whether or 
not the NFI family regulate common suites of genes remains poorly defined. Here, we use granule 
neuron precursor cells (GNPs) of the postnatal murine cerebellum as a model system to analyse 
regulatory targets of three members of the NFI family; NFIA, NFIB and NFIX. By integrating 
transcriptomic profiling (RNA-seq) of Nfia- and Nfix-deficient GNPs with epigenomic profiling 
(ChIP-seq  against NFIA, NFIB and NFIX, and DNase I hypersensitivity assays), we reveal that these 
transcription factors share a large set of potential transcriptional targets, suggestive of complementary 
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Introduction 
 
Transcription factors are integral to nervous system development, orchestrating a broad range of 
processes including cell proliferation, migration, differentiation, and maturation. The nuclear factor I 
(NFI) family of transcription factors (NFIA, NFIB, NFIC and NFIX) mediate several of these 
processes in the developing rodent nervous system [1-3]. For example, during embryogenesis, NFIs 
regulate cellular proliferation and differentiation in the neocortex, hippocampus, spinal cord and 
cerebellum [4-12]. Given these key roles of NFIs in the developing nervous system, it is perhaps 
unsurprising that their expression is highly overlapping. Indeed, NFIs are expressed by a broad range 
of cell types in the developing central nervous system, including radial glia, intermediate progenitors 
and neurons [3,13-16]. In the developing cerebellum, NFIA, NFIB and NFIX are expressed by GNPs 
at postnatal day (P) 6 [3]. Thus, the expression of NFIs across key cellular populations, and within 
multiple brain regions, enables these transcription factors to coordinate nervous system development. 
 
The role of the NFIs in nervous system development is also evident through the analysis of knockout 
mouse models. The phenotypes of Nfi knockout mice are markedly similar. For example, 
neuroanatomical defects are evident in Nfia, Nfib and Nfix knockout mice, including aberrant 
development of the corpus callosum and hippocampus [8,10,13,17,18]. Midline glial populations also 
fail to develop correctly in Nfia, Nfib and Nfix knockout mice [13,17,18], reflecting altered astrocytic 
development. Indeed, with regards to the development of the neocortex and hippocampus, mice 
lacking Nfia, Nfib and Nfix show delayed differentiation of radial glial stem cells into mature neurons 
and glia [8-10,19], in part due to delayed generation of intermediate progenitor cells [7]. In the 
cerebellum, NFIX was recently shown to promote GNP differentiation [20], and, while the role of 
other NFI family members in GNP biology is unclear, the expression of NFIA and NFIB by GNPs at 
P6 [3] is indicative of a role in regulating GNP differentiation. Moreover, NFIs have been shown to 
bind to the same DNA recognition motif [21]. Collectively, these data suggest that these transcription 
factors regulate the expression of similar cohorts of genes. 
 
Despite much work outlining the expression and proposed function of NFIs in brain development, 
whether NFI family members actually regulate similar gene targets is poorly defined. To date, there 
has been one published report highlighting overlapping NFIA and NFIB gene targets in the 
developing forebrain [22]. This analysis, whilst insightful, did not include epigenomic data to refine 
potential gene targets and was performed on a heterogeneous population of cells. We therefore sought 
to overcome these limitations, and examined if NFIs regulate similar gene targets using the 
developing cerebellum as a model system. In the rodent brain, cerebellar development begins at 
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approximately embryonic day (E) 12, when ATOH1-expressing granule neuron precursors (GNPs) 
are generated in the rhombic lip [23]. These GNPs then proliferate and migrate tangentially, forming 
a transient germinal zone called the external granule layer (EGL) [23-25]. Cerebellar development 
continues postnatally, with GNPs proliferating and differentiating into immature neurons, which 
ultimately migrate radially through the molecular layer, becoming mature granule cells within the 
internal granule layer (IGL) of the cerebellum [26]. Whilst NFIA, NFIB and NFIX are expressed in 
GNPs [3] it remains an open question whether or not the NFIs are co-expressed in these cells. 
Moreover, it is unclear whether these transcription factors share any common gene targets during 
cerebellar development. Here, we reveal co-expression of the NFI transcription factor family within 
GNPs of the EGL. Moreover, using a combination of transcriptomic and epigenomic profiling, we 
reveal that a significant proportion of potential target genes are common between the NFI family 
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Materials and methods 
 
Animals  
All the mice used in this study were maintained on a C57Bl/6 background. Nfia null mice on this 
genetic background are embryonic lethal. As such, we used a conditional Nfia allele (Nfiafl/fl)  crossed 
to a Atoh1 cre line [27]. This line enabled the ablation of Nfia from ATOH1-expressing cells from 
embryonic day (9) [25] including the cells of the rhombic lip, that will ultimately give rise to GNPs 
within the EGL of the postnatal cerebellum.  Knockout animals were Nfiafl/fl; Atoh1-cre+; controls 
were Nfiafl/fl; Atoh1-cre-. Animals were used with approval from the University of Queensland 
Animal Ethics Committee (AEC approval numbers: QBI/143/16/NHMRC/ARC and 
QBI/149/16/ARC). Animals were genotyped by PCR; primer sequences are available on request. All 
experiments were performed according to the Australian Code of Practice for the Care and Use of 
Animals for Scientific Purposes. Pregnant females were acquired by placing male and female mice 
together overnight. The next day, females were inspected for the presence of a vaginal plug and, if 
present, this day was designated as E0. The day of birth was designated as postnatal day (P) 0. Mice 
were housed in Optimice IVC caging, with double HEPA filters and built in ventilation.  Food and 
water was available ad libitum, and materials were provided for nesting and enrichment.  
 
Immunohistochemistry 
To analyze the cell-type specific expression of NFIA, NFIB and NFIX, we performed co-
immunofluorescence labelling, as described previously [14]. Briefly, postnatal mice at P3, P7 or P15 
were anesthetized with pentobarbital and perfused transcardially with phosphate-buffered saline 
(PBS), followed by 4% paraformaldehyde, then post-fixed for 48-72 hours before long term storage 
in PBS at 4°C. Cerebella were isolated and embedded in Noble agar (3%) and sectioned (50 µm) in 
a sagittal plane using a vibratome. Sections were placed sequentially across the wells of a 6-well plate 
to ensure appropriate sampling from different medio-lateral regions of the cerebellum. Sections were 
mounted on SuperFrost Plus (Thermo Scientific) slides, before heat-mediated antigen retrieval was 
performed in 10 mM sodium-citrate solution (pH 6.0) at 95°C for 15 min. Sections were blocked for 
2 hours in a solution containing 2% serum and 0.2% Triton-X-100 in PBS. Sections were then 
incubated overnight at 4°C with primary antibodies against the target proteins (Table 1). 
Subsequently, sections were rinsed in PBS, then incubated with the relevant secondary antibodies 
(Table 1) for 2 hours in the dark at room temperature. Sections were rinsed in PBS, then were 
counterstained with 4’,6-diamidino-2-phenylindole (DAPI), and mounted in fluorescent mounting 
media (DAKO). For all experiments, at least three animals at each age were analyzed. 
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Cerebellar imaging 
Fluorescent immunolabelling was visualized using a Nikon 20x Air objective  on a spinning disk 
confocal microscope (Diskovery; Andor Technology, UK) on a Nikon Ti-E body (Nikon Corporation, 
Japan), equipped with a Zyla 4.2 10-tap sCMOS camera (Andor Technologies). For comparative 
sections identical imaging parameters were used including pinhole size (70 µm), laser power and 
exposure time. We took 10 consecutive 1 µm-thick optical sections to generate a 10 µm-thick z-stack. 
In all cases the 10 µm z-stack was taken from the middle of the section to minimize potential artefacts 
arising from the sectioning process such as damage to the tissue. Image acquisition, tiling and 
stitching was performed using NIS-elements Advanced Research Imaging Software (Nikon 
Corporation, Japan). All brightfield images were captured using a Aperio ScanScope XT Slide 
scanner (Leica Biosystems, Germany) with a doubled 20x objective (40x magnification overall, 
Nikon Corporation, Japan) and visualized using Aperio ImageScope software. 
 
For analysis of wildtype, Nfiafl/fl; Atoh1 Cre+ and Nfiafl/fl; Atoh1 Cre- mice, high magnification images 
were taken of the same lobule of the cerebellum, using at least three biological replicates at each of 
the ages assessed. For quantification of granule neuron and proliferative markers (PAX6 and Ki67, 
respectively), three 200 µm regions of the EGL were quantified for each section. This ensured more 
representative count of the EGL thickness across the whole lobule. 1 µm-thick optical sections were 
viewed in Fiji, and the ‘cell counter’ plugin used to mark and quantify cells expressing respective 
markers in each fluorescent channel. Cells co-expressing markers (for example PAX6 and Ki67) were 
also quantified this way, and DAPI was used to visualize the cell nucleus, to ensure accuracy, 
especially in areas of high cell density. 
 
Granule cell isolation 
To isolate GNPs from the cerebellum of P7 Nfix+/+ and Nfix-/- mice, and of P7 Nfiafl/fl; Atoh cre+ and 
Nfiafl/fl; Atoh cre- mice, we used a technique originally described by Lee and colleagues [28]. To do 
this, we isolated the cerebellum from wild-type and knockout mice, carefully removing the choroid 
plexus and meningeal tissue. Cerebellar tissue was dissociated using a 20 units/mL papain solution 
at 37°C for 15 mins. A single cell suspension was obtained by trituration with a serum-coated P1000 
pipette tip and nuclear membranes were removed using an albumin-ovomucoid inhibitor gradient.  
GNPs were separated from other cells using a 30%-60% percoll gradient. GNPs were lysed using 
Trizol (Ambion). We next used an RNeasy miniprep kit (Qiagen) to isolate RNA from lyzed GNPs. 
 
 
  159 
RNA-seq analysis 
RNA-sequencing was performed on the samples using the Illumina NextSeq High Output system 
(Illumina; 150 base pair read length, paired-end reads). We isolated cells from three P7 Nfiafl/fl; Atoh 
cre- mice and three P7 Nfiafl/fl; Atoh cre+ mice. RNA-seq analysis was performed on RNA isolated 
from P7 cerebella as described previously. Briefly, the three replicates for each cohort were aligned 
by TopHat2 (v2.0.9) [29] to the Mus musculus, UCSC, mm10 reference transcriptome and FASTA 
annotation downloaded from the TopHat index and annotations page 
(https://ccb.jhu.edu/software/tophat/igenomes.shtml). Cufflinks (v2.1.1) [29] was used to assemble 
each replicate’s transcripts from the alignment file generated by TopHat. Cuffmerge was used to 
create a single assembly containing transcripts across all samples and replicates. Cuffdiff was run 
using the merged set of transcripts and the three replicate TopHat2 bam files from each sample. 
 
ChIP-seq 
ChIP-seq was performed on chromatin isolated from P7 wild-type C57Bl/6 GNPs as described [20]. 
We used antibodies against NFIA, NFIB or NFIX, for which specificity has previously been 
demonstrated [30]. For chromatin immunoprecipitation, litters of P7 pups were pooled for GNP 
isolation. Isolated GNPs were crosslinked with 1% formaldehyde for 10 minutes, then were quenched 
with glycine. Cells were lyzed in RIPA buffer supplemented with protease and phosphatase inhibitors 
(Roche) and sonicated with a Bioruptor (Diagenode) for six 15 minute intervals of 30 seconds on, 30 
seconds rest. Chromatin immunocomplexes were isolated with protein G-agarose beads (Roche), 
washed once for 5 minutes with buffers 1 through 4. Crosslinking was reversed by incubation with 
proteinase K (Roche) at 60 degrees overnight. DNA was isolated by phenol-chloroform extraction 
then incubated with RNAse A (Roche) for 30 minutes before final cleanup with PCR columns 
(Qiagen). Sequencing libraries were constructed using the standard protocol for the NEB Next Ultra 
II DNA Library Prep Kit (New England BioLabs). Pooled libraries were sequenced on an Illumina 
HiSeq2000 (Illumina; 30 base pair single end read). 
 
ChIP-seq analysis 
Alignment was performed on the NFIA, NFIB and NFIX ChIP-seq data sets by bowtie2 [31] to 
mm10. Unaligned reads and reads which aligned to multiple locations were removed leaving only 
uniquely mapped reads. MACS2 [32] was used to call narrow peaks with default parameters for both 
datasets. Each experiment contained two biological replicates and if both biological replicates shared 
a peak, it was recorded using the maximum boundaries of the supporting peaks to generate a merged 
set of peaks for each experiment. 
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Annotation of ChIP-seq peaks 
A set of target genes was identified for NFIA, NFIB and NFIX by the following method. A promoter 
region was defined as 2,000 base pairs either side of a transcription start site. ChIP-seq binding sites 
located in a promoter region were annotated as proximal, while sites outside the promoter region but 
overlapping gene boundaries (transcription start to stop site) were labelled as genic. All remaining 
binding sites were labelled as distal. A binding site annotated as proximal was assigned to the nearest 
gene as a target while genic binding sites were assigned to the overlapping gene as a target. Distal 
binding sites are difficult to assign target genes to, as they are not necessarily regulating the nearest 
gene (by genomic distance) and proximal and genic sites are also capable of regulating a gene other 
than the nearest. While distal binding sites were also annotated to the nearest gene, where available, 
CisMapper was used to provide a secondary annotation to all sites, with resulting links filtered to a 
threshold of 0.05 [33]. Both the CisMapper annotation and nearest gene annotation were used where 
available. 
 
After identifying a gene target for each NFI binding site; the associated p-value from both the Nfix 
and Nfia RNA-seq differential expression analyses was recorded. Genes targeted by both NFIX and 
NFIA with a significant (p < 0.05) change in expression in both experiments were extracted. Genes 
showing coordinated positive or negative log fold change values across both experiments were 
selected to generate a putative set of genes under the control of NFIX and NFIA. Functional 
annotation was performed using DAVID (6.8) on target genes identified for NFIX, target genes 
identified for NFIA and target genes under the control of both NFIX and NFIA [34,35]. 
 
DNase I hypersensitivity analysis 
The DNase I hypersensitivity (DHS) data from Frank et al. 2015 (GEO: GSE60731) [36] was 
accessed for comparison to our transcriptomic and epigenomic profiling. These data contain called 
peaks from whole cerebellar tissue at P7 across three replicates. UCSC liftover was used to convert 
the mm9 files to mm10. Maximum boundaries of the supporting peaks were used to generate a merged 
DHS peak file, with the stipulation that peaks need to be shared by at least two replicates. Given that 
transcription factors preferentially bind to regions of accessible chromatin [37,38], DHS was used to 
extract NFI ChIP-seq peaks occurring in accessible regions. 
 
qPCR analysis of target genes 
RNA isolated from P7 GNPs from the cerebella of Nfix+/+, Nfix-/-, Nfiafl/fl; Atoh cre- or Nfiafl/fl; Atoh 
cre+  mice was used to prepare cDNA as described previously [9]. qPCR was performed with 
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Quantifast SYBR Green (Qiagen) to detect gene expression levels of the genes identified in the RNA-
seq analysis.  The primers for these genes are listed in Table 2. Gene expression was calculated using 
the 2−ΔΔCt method relative to the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase 
(Gapdh). All the samples were tested in triplicate within each experiment, and each experiment was 
repeated three times. qPCR was run using the QuantStudio 7 Flex Real-Time PCR system (Applied 
Biosystems, USA). 
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Results 
 
NFIA and NFIX are co-expressed in the developing cerebellum 
NFI transcription factors are expressed across the developing and adult central nervous system. This 
includes the cerebellum, where NFIX is broadly expressed in the embryonic, postnatal and adult 
cerebellum [11,14], and where it regulates postnatal GNP differentiation [20]. NFIA is also critical 
for cerebellar development, and is expressed by GNPs [3,39,40]. Given the broad roles of NFI 
transcription factors in progenitor cell differentiation and that their protein expression overlaps in 
other brain regions [22,41], we first examined whether NFIA and NFIX were co-expressed in GNPs. 
We used co-immunofluorescence to analyse NFIX and NFIA expression across postnatal cerebellar 
development (P3, P7 and P15). We found that not only do GNPs in the EGL express NFIX, in 
agreement with our previous data [14], but we also found that these cells co-express NFIA (Fig. 1). 
Indeed, analysis at P7 revealed that over 90% of cells within the EGL co-expressed NFIA and NFIX 
at this age. Expression of Nfi family members is also seen within the embryonic rhombic lip (Supp. 
Fig. 1). 
 
NFIX expression is also detected within astrocytes within the emerging cerebellum [14]. We also 
labelled sections with an antibody against the astrocytic marker s100b, and revealed that astrocytes 
within the IGL were immunoreactive for both NFIX and NFIA (Figs. 1 and 2). Moreover, we also 
found co-expression of NFIX and NFIA in Bergmann glia across these ages (Fig. 2); indeed, we 
observed that over 95% of s100b-expressing Bergmann glia at P15 were also immunopositive for 
both NFIA and NFIX. These analyses also revealed that granule neurons within the IGL also co-
express NFIA and NFIX (Fig. 2). Finally, to verify the expression of NFIA in GNPs in the EGL, we 
performed co-immunofluorescence labelling with the progenitor cell marker, PAX6, and the 
proliferation marker Ki67. We found co-expression of NFIA and PAX6 within the EGL (Fig. 3A-D). 
Consistent with this, those proliferating cells in the EGL were also immunopositive for NFIA (Fig. 
3E-H). These data suggest that NFIA, in addition to driving the development of mature cerebellar 
neurons [3] may also contribute to GNP proliferation and differentiation. Collectively, these data 
demonstrate that NFIX and NFIA expression is overlapping in the developing cerebellum, with both 
transcription factors expressed by GNPs within the postnatal EGL. This led us to hypothesize that 
these transcription factors drive GNP differentiation in the postnatal cerebellum through regulation 
of common target genes. We sought to address this hypothesis via co-ordinate analysis of 
transcriptomic and epigenomic profiling datasets.   
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Nfia cKO mice exhibit cerebellar abnormalities 
To determine the extent of overlap in function between NFI family members in cerebellar GNPs, we 
first sought to define the cohort of genes potentially under direct control of NFIA. To do this, we used 
a number of transcriptomic and epigenomic sequencing approaches, as well as utilising published 
DNase I hypersensitivity analyses detailing chromatin accessibility within the whole cerebellum at 
P7 [36]. As Nfia null mice on a C57Bl/6 are embryonic lethal [17], we employed a conditional Nfia 
allele (Nfiafl/fl) crossed to a Atoh1 cre line [27]. ATOH1 is expressed by progenitor cells within the 
nascent rhombic lip from E9 [25], and thus enables the removal of Nfia from these cells, as well as 
their progeny, including GNPs. We crossed the Nfiafl/fl line to the Atoh1 cre, and analyzed NFIA 
expression in GNPs within the postnatal cerebellum (P7) to validate ablation of Nfia. 
Immunolabelling with NFIA, and PAX6, revealed that NFIA expression was still present within cells 
at the border of the IGL (likely Bergmann glia that are not derived from Atoh1-expressing progenitor 
cells within the embryonic brain) and within the IGL (Fig. 4). However, expression of NFIA was 
dramatically reduced within the EGL of Nfiafl/fl; Atoh1 cre+ mice (hereafter referred to as Nfia cKO 
mice). Interestingly, the ablation of Nfia was not fully penetrant within all of the lobes of the 
cerebellum, with GNPs within lobe X retaining a higher percentage of NFIA expression in 
comparison to lobes IV-V and VIII (Fig. 4 E-G). Incomplete ablation of a conditional Nfib allele was 
recently reported [7], suggesting that some cells may escape Cre-mediated depletion when this 
strategy is used to ablate Nfi family members. Thus, the NFIA-expressing cells within the IGL of Nfia 
cKO mice likely comprise astrocytes (Fig. 2) and granule neurons derived from EGL progenitors in 
which Nfia was not deleted. Despite this caveat, these data suggest that this is a valid model in which 
to study the role of NFIA in GNP biology.  
 
The role of NFIA in cerebellar development has been studied almost exclusively through the prism 
of the migration and maturation of postmitotic granule neurons [39,40,42]. In other regions of the 
nervous system, such as the developing hippocampus, Nfia-/- mice exhibit very similar phenotypes to 
Nfix-/- mice [8,10]. Given that a delay in the differentiation of GNPs is evident in the cerebellum of 
P15 Nfix-/- mice, we posited that a similar delay would be evident in Nfia cKO mice. We firstly 
analysed the gross morphology of the cerebellum in Nfia control and Nfia cKO mice. In contrast to 
Nfix-/- mice [20], haematoxylin staining at the level of the vermis revealed increased foliation in Nfia 
cKO mice in comparison to the controls, with lobe VI showing the clearest phenotype (Fig. 4H, I). 
Critically, however, PAX6 and Ki67 labelling revealed there were more PAX6-positive cells within 
the EGL of the mutant at this age in comparison to controls (Fig. 4J-M), although the width of the 
EGL was comparable between mutant and control animals at this age (Fig. 4N). These data reveal 
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that the retention of PAX6-expressing GNPs within the EGL is a shared phenotype between mice 
lacking either Nfia or Nfix.  
 
Transcriptomic profiling in GNPs reveals common gene targets of the NFI transcription factor 
family 
The co-expression of NFIA and NFIX (Fig. 1), coupled with the retention of GNPs within the EGL 
at P15 in both strains (Fig. 4; [20]) led us to posit that these transcription factors may regulate a 
common set of genes during GNP development. We have recently detailed transcriptomic profiling 
(RNA-seq) of Nfix-/- P7 GNPs, coupled with genome-wide analysis of NFIX binding (ChIP-seq; [20]). 
To determine the extent of shared targets between NFIA and NFIX, we repeated these analyses with 
NFIA. Firstly, we isolated P7 control and Nfia cKO GNPs, and performed RNA-seq. Analysis of 
these datasets revealed 2,267 genes as being significantly misregulated in the absence of Nfia (Fig. 
5A; Supp. Table 1). Profiling of these data using the Gene Ontology and Pathway tool in DAVID 
[34,35] revealed a suite of different biological processes (e.g. cell adhesion; nervous system 
development), cellular components (e.g. membrane; proteinaceous extracelluar matrix) and 
molecular functions (e.g. calcium ion binding; integrin binding) (Fig. 5B; Supp. Table 2). 
 
To begin to refine this potential list of NFIA target genes, we performed ChIP-seq with an NFIA-
specific antibody [30], using GNPs isolated from wildtype P7 cerebella. This profiling identified 
14,025 NFIA binding peaks (Supp. Table 3). Cross correlation of these data with published chromatin 
accessibility data (DNase I hypersensitivity analysis) from P7 cerebellum [36] revealed that 12,539 
of these NFIA binding peaks were in accessible regions of chromatin, whereas 1,486 were in closed 
regions of chromatin (Fig. 5C). Interestingly, the 12,539 NFIA ChIP-seq peaks in regions of 
accessible chromatin correlated to 7,870 NFIA-bound genes. When we took this cohort of 7,870 genes 
and compared it to the list of differentially regulated genes within Nfia cKO GNPs (Fig. 5A), we 
determined that 1,232 of the 2,267 genes that were significantly misregulated also contained a NFIA 
ChIP binding peak (Fig. 5D, Supp. Table 4), highlighting them as strong candidates for direct 
regulation by NFIA. Critically, DAVID analysis on this NFIA targetome of 1,232 genes identified 
many processes and functions previously identified in our analysis of Nfix-deficient GNPs [20], 
including many associated with neural function (e.g. axon guidance; neuronal cell body; cell 
adhesion; Fig. 5D; Supp. Table 2), indicative of potential shared functions of these transcription 
factors.  
 
Finally, to define whether or not NFIA and NFIX regulate a common cohort of genes, we compared 
our refined NFIA targetome (1,232 targets; Fig. 5) with an analysis performed the same way but 
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targeting NFIX (578 targets; [20]). This analysis revealed that 304 genes were high-confidence targets 
for both NFIA and NFIX in P7 GNPs, and, moreover, that more than 93% of these (283 out of 304) 
were co-ordinately regulated by both NFIA and NFIX (i.e. gene was downregulated in both Nfia cKO 
and Nfix-/- datasets, or upregulated in both; Fig. 6, Supp. Table 5).  
 
NFIB is also expressed by NFIX-expressing GNPs within the postnatal cerebellum (Supp. Fig. 1; 
[3]). Although we did not have access to the conditional strain crossed to a cerebellum-specific driver, 
we were able to gain insight into potential NFIB targets by performing ChIP-seq on isolated P7 GNPs 
using a specific NFIB antibody [30]. This analysis identified 24,950 NFIB ChIP-seq peaks (Supp. 
Table 3), of which 21,712 were in regions of accessible chromatin. Comparison of the accessible 
binding sites in each of the three NFI ChIP-seq datasets revealed that, of the 22,129 sites where at 
least one of NFIA, NFIB of NFIX had a binding event associated with it, ~25% were bound by all 
three of these transcription factors (Supp. Fig. 3). Furthermore, over 55% of sites were bound by two 
of the NFI family (Supp. Fig. 3). Importantly, when we overlaid our NFIB ChIP-seq results onto our 
combined NFIA/NFIX targetome (Fig. 6A), the analysis that revealed that 282 of the 283 co-
ordinately regulated NFIA/NFIX targets genes also possessed an associated NFIB ChIP-seq peak. 
DAVID analysis revealed that categories enriched in this dataset included axon, neuron projection, 
neuronal cell body and nervous system development (Fig. 6B). This cohort of genes potentially 
targeted by NFIA, NFIB and NFIX included a number of genes known to mediate cerebellar 
development, including Otx2, Epha4 and Nfix itself, as well as a number of factors whose role in 
cerebellar genesis is novel (Fig. 6C). Analysis of the proportion of NFI ChIP-seq peaks in proximal, 
genic or distal locations revealed that the majority of binding sites were in distal or genic locations 
(Fig. 6D). Finally, we validated six of these misregulated genes using qPCR, focussing on a mix of 
genes with known (Wnt5a) and novel (Kalrn, FoxO6, Id3, Gas6 and Etv5) roles in cerebellar 
development. We confirmed that the levels of Kalrn, Wnt5a, FoxO6, Id3, Gas6 and Etv5 mRNAs 
were significantly higher in both Nfia-/- and Nfix-/- GNPs at P7 (Fig. 6E-J). 
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Discussion 
The NFI proteins are transcription factors that exhibit conserved N-terminal DNA-binding domains, 
as well as a common DNA recognition motif [43]. Within the nascent mouse nervous system, neural 
stem and progenitor populations have been shown to co-express individual NFI family members [1], 
and, moreover, individual Nfi knockout mice exhibit broadly similar cortical phenotypes [4,8,10,12]. 
However, the extent to which these factors share common regulatory targets has not been investigated 
thoroughly, apart from a recent study that used RNA-seq in developing cortical tissue from both Nfia-
/- and Nfib-/- mice to investigate potential overlap in gene regulation [30]. Here, we use a range of 
transcriptomic approaches to more clearly demarcate common targets of the broader NFI family, 
demonstrating that NFIA, NFIB and NFIX likely regulate a common suite of genes to promote the 
differentiation of GNPs within the postnatal cerebellum.  
 
A coherent theme emerging from many of the studies on NFI function is their role in promoting 
differentiation and maturation. Within the cerebellum, NFIX is required for the timely differentiation 
of GNPs within the postnatal EGL [20], and NFIA has been reported to regulate a program of gene 
expression required for the migration and maturation of granule neurons [3,39,42]. Within the broader 
central nervous system, NFIB has also been shown to regulate neural stem cell differentiation within 
the cerebral cortex [5], a function also reported for NFIA and NFIX [44]. Outside the nervous system, 
NFIs have also been shown to regulate differentiation; for instance, NFIX has been shown to 
contribute to skeletal myogenesis by promoting a switch from embryonic to fetal-specific gene 
programs [45,46]. In line with this, our transcriptomic analyses suggest that the NFI family are key 
mediators of GNP differentiation within the postnatal cerebellum. Indeed, our DAVID analysis of the 
282 genes we identified as potential NFI targets included a high proportion of terms associated with 
the nervous system (Supp. Table 2). For instance, of the 20 most enriched terms for Cellular 
Component in the DAVID analysis, 10 were directly associated with the nervous system (e.g. Neuron 
projection, Axon, Dendrite, Neuronal cell body), with a further seven associated with the plasma 
membrane and extracellular matrix, both of which are central to mature neural biology. These data 
reinforce the role for NFIs in promoting neural differentiation within the cerebellum. 
 
The targetome identified for the NFI family within postnatal GNPs includes a number of specific 
factors that highlights their role in promoting differentiation. For example, Wnt5a, a factor known to 
regulate neural progenitor proliferation within the cerebellum [47], is upregulated in the absence of 
either Nfia or Nfix, consistent with the phenotype for delayed GNP differentiation in these strains. 
Conversely, factors known to promote neural differentiation, such as Neurod1, Neurod4 and Nfix 
were reduced, as was the neuronal marker Rbfox3. In addition to these individual factors identified as 
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likely targets of co-regulation by the NFI family, a novel theme to arise from this multi-faceted 
analysis was that NFIs may regulate cohorts of genes related to similar processes. For example, within 
the NFI targetome we identified 6 collagen genes, 13 genes encoding potassium channel or glutamate 
receptor subunits, and a range of factors related to axon guidance (e.g. Slit1, Robo1, Epha4, Epha5, 
Epha8). These findings may point to previously unrecognised roles for the NFI family. For example, 
NFIs are widely expressed in neurons [30], but their role in these cells is unknown. The identification 
of potassium channel and glutamate receptor subunit genes in our target list suggests that NFIs may 
contribute to the process of neurotransmission. Looking forwards, more sophisticated approaches 
using multiple conditional Nfi alleles crossed to cell-type specific drivers (e.g. CamK2a CreERT2) 
may enable the role of the NFI family in specific functions such as neurotransmission to be 
investigated.  
 
Our approach to determine shared NFI target genes also highlighted a number of other interesting 
elements of NFI biology whose significance has not been previously appreciated. For example, 
partitioning of reported ChIP-seq peaks for each of NFIA, NFIB and NFIX into defined regions 
(proximal, genic or distal) revealed that only 3-6% of binding peaks were in proximal regions (defined 
as ± 2000 base pairs from a transcriptional start site), whereas approximately 44% were found in 
genic regions (sites outside the promoter regions but overlapping gene boundaries), with the 
remaining ~50% of ChIP-seq peaks within distal regions. This implicates a large portion of NFI 
binding may be related to interactions with distal enhancers. The role of NFIs in distal binding is at 
this stage unclear, but a recent report of NFIB mediating chromatin accessibility in small cell lung 
cancer [48] may point to this family playing a much broader role in transcriptional architecture than 
regulating promoter activity. In future, the role of NFIs in mediating enhancer activity could be 
investigated using techniques including luciferase assays, whereas chromatin interaction analysis by 
paired-end tag sequencing (ChIA-PET) could be used to interrogate the role of NFIs in mediating 
long-range chromatin interactions in vivo. Our findings also suggest that numerous NFI binding sites 
can be found in regions of closed chromatin. Exactly what this means is, at this stage, unclear, but the 
possibility of the NFIs acting to promote chromatin accessibility in a developmental context, in 
addition to that seen in small cell lung cancer [48], is a tantalising possibility. One way in which could 
be analysed would be to combine ChIP-seq on GNPs at different developmental stages with DNase I 
hypersensitivity analyses at the same age. From this, the capacity of NFIs to bind to, and potentially 
open, regions of previously compressed chromatin, could be ascertained.  
 
Our analyses also raise a number of questions. For instance, our analysis revealed a high proportion 
of ChIP-seq peaks that were common between NFIA, NFIB and NFIX. One interpretation of this 
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could be that the NFI proteins promiscuously form heterodimers to bind DNA. Although 
heterodimerization of the NFIs has long been known to occur in vitro [49], its prevalence in vivo is 
less clear. NFIA and NFIB were recently reported to co-immunoprecipitate in lysates from embryonic 
day 13 mouse cerebral cortical tissue [22]; our data suggest that heterodimerization between NFIA, 
NFIB and NFIX may be a common theme in the way this family regulates development, a theory 
supported by the similar neural phenotypes observed following knockout of individual Nfi genes 
[4,8,10]. Despite this, our analyses revealed that the role of Nfia and Nfix may not be entirely 
overlapping. Indeed, there were a number of genes identified as NFIA targets that were not identified 
as NFIX targets (Fig. 6A). Although care needs to be taken when interpreting the differences in our 
targetomes, as experimental conditions may underlie this (e.g. variations in antibody affinity for 
ChIP-seq), the fact that the Nfia cKO mutant cerebellum exhibited increased foliation (Fig. 4I), 
whereas the Nfix mutant does not [20], provides a morphological indication of some distinct functions 
between these transcription factors. Potential differences in the targets of NFIA and NFIX (and, 
potentially, NFIB) could relate to the capacity of different family members to bid to co-factors. The 
C-terminal region of each family member is less well conserved [43], indicative of potentially 
different affinity for protein-binding partners. There is surprisingly little known regarding other 
proteins that the NFIs interact with. One recent study performed in HEK298T cells used tandem 
affinity purification followed by mass spectrometry to reveal an interaction between NFIX and 
CREB1 [50] In future, the use of sophisticated approaches like this, in conjunction with specific 
cellular populations like GNPs, could be ways in which proteins that interact with NFIs could be 
identified. In conclusion, our study has enhanced our understanding of neural development 
specifically, and NFI biology more broadly, using molecular and transcriptomic assays to reveal that 
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Table 1: Antibodies used in this study. 
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Antibody Source species Company Catalogue 
number 
Dilution used 
NFIX Mouse Sigma-Aldrich SAB1401263 1/200 
NFIA Rabbit Sigma-Aldrich HPA008884 1/400 
NFIB Rabbit Sigma-Aldrich HPA003956 1/400 
S100b-Alexa647 Rabbit ABCAM AB196175 1/400 
PAX6 Rabbit DAKO Z0334 1/400 
Ki67 Mouse BD Pharmigen 550609 1/400 




Figure 1. NFIX and NFIA are co-expressed by various cellular populations in the developing 
mouse postnatal cerebellum. 
Sagittal cerebellar sections showing the nuclear marker DAPI (blue), NFIX (green), NFIA (red) and 
s100b expression (magenta) in P3 (A-E), P7 (F-J) and P15 (K-O) wild-type mice. NFIX and NFIA 
are co-expressed by GNPs within the external granule layer (EGL; arrows in B-E, G-J, L-O). NFIX 
and NFIA are also co-expressed by s100b-positive glial cells (double-headed arrows in B-E, G-J, L-
O). These transcription factors are also expressed by cells leaving the EGL (arrowheads in G-J, L-
O); these are likely immature neurons migrating to the internal granule layer (IGL). ML = molecular 
layer. Scale bar (in A): 20 µm. 
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Figure 2. NFIX and NFIA are co-expressed in Bergmann glia and astrocytes in the developing 
cerebellum. 
High magnification sagittal cerebellar sections showing the nuclear marker DAPI (blue), NFIX 
(green), NFIA (red) and s100b expression (magenta) in P3 (A-J), P7 (K-T) and P15 (U-DD) wild-
type mice. NFIX and NFIA are co-expressed in IGL white matter astrocytes at these ages (arrows in 
B-D, L-O, V-Y). NFIX and NFIA are also co-expressed in Bergmann glia at P3, P7 and P15 
(arrowheads in G-J, Q-T, AA-DD). The NFI factors are also co-expressed in mature granule neurons 
within the IGL (double-headed arrows in B-D, L-O, V-Y). IGL = inner granule layer, ML = molecular 
layer. Scale bar (in A): 10 µm. 
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Figure 3. PAX6-positive EGL progenitors express NFIA. 
(A-D) Expression of the nuclear marker DAPI (blue, A), PAX6 (green, B), and NFIA (red, C) reveals 
NFIA expression in PAX6-positive EGL progenitor cells (arrows in B-D). NFIA is also expressed in 
IGL granule neurons (double-headed arrows in B-D) and migrating cells exiting the EGL (arrowheads 
in B-D). (E-H) Expression of the nuclear marker DAPI (blue, E), Ki67 (green, F), and NFIA (red, G) 
also shows NFIA expression in proliferating EGL progenitor cells (arrows in F-H). EGL = external 
granule layer, ML = molecular layer, IGL = inner granule layer. Scale bar (in A): 20 µm. 
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Figure 4. Conditional ablation of NFIA from EGL progenitors using Atoh1-cre. 
(A) Sagittal cerebellar section in a P7 Nfiafl/fl; Atoh1-cre+ mouse (Nfia cKO). Co-expression of PAX6 
and NFIA was examined in different cerebellar lobes  and is shown in the respective high-
magnification panels (B-D).  (B-D) DAPI (blue), PAX6 (green) and NFIA (red) expression revealed 
that cells at the margin of the molecular layer and IGL expressed NFIA (arrowheads in B-D). 
Importantly, the majority of cells in the EGL of lobes VI and IX were immunopositive for PAX6, but 
did not express NFIA (arrows in B, C). Within lobe X, there were more cells within the EGL that had 
not undergone Cre-mediated ablation, and hence retained NFIA expression (double arrowheads in 
D). (E-G) Quantification of the percentage of cells within the EGL of lobes VI (E), IX (F) and X (G) 
that expressed NFIA. (H, I) Hematoxylin staining of Nfia control and Nfia cKO cerebella at P15. The 
cerebellum of mice lacking Nfia was dysmorphic, with elevated foliation of the cerebellar lobes 
evident. Expression of DAPI, PAX6 and Ki67 in Nfia control (J) and Nfia cKO (K) cerebella at P15 
revealed significantly more PAX6-positive cells within the EGL of the mutant (L), although the 
number of proliferating cells (M), and the width of the EGL (N), was not significantly different 
between sample groups . * p < 0.05, t-test. Scale bar (in A): 250 µm, A; 400 µm, H, I; 30 µm, B-D; 
25 µm, J, K. 
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Figure 5. Transcriptomic profiling of GNPs in Nfiafl/fl; Atoh1-cre+ mice.  
(A) Volcano plot of misregulated genes following RNA-seq in P7 Nfia cKO mice GNPs in 
comparison to Nfia controls. Red dots represent the 2,267 genes misregulated in Nfia mutant GNPs. 
(B) Gene Ontology (DAVID 6.8) analysis identifying Biological processes, Cellular components, 
KEGG pathways and Molecular functions as misregulated in P7 Nfia cKO mice GNPs in comparison 
to controls. Only the top five items for each category are shown; full details can be found in Supp. 
Table 2. The p value was corrected using the Benjamani-Hochberg method. (C) To narrow the list of 
potential NFIA target genes, we performed ChIP-seq on wild-type P7 GNPs with an anti-NFIA 
antibody. This revealed 14,025 NFIA binding peaks (green circle). We compared this with a 
published DNase I hypersensitivity analysis of P7 cerebellar tissue (red circle [36]). Of the 14,025 
NFIA ChIP peaks, 12,539 were in regions of accessible chromatin. (D) We then compared the 7,870 
genes (yellow circle) associated with these 12,539 NFIA peaks with our RNA-seq data (blue circle). 
This analysis identified 1,232 potential direct NFIA target genes. (E) DAVID Gene Ontology analysis 
was performed again following refinement of our target gene list. The top five categories for the 
NFIA targetome from each of Biological processes, Cellular components, KEGG pathways and 
Molecular functions identified are shown; full details can be found in Supp. Table 2. 
  176 
 
Figure 6. Identification of coregulated targets of NFI family members in GNP development.   
(A) Cross comparison of our NFIA targetome (red circle) with a similar analysis performed against 
NFIX (blue circle; [20]) revealed that there were 304 coregulated genes (i.e. identified in both 
datasets). Of these, 283 demonstrated coordinated regulation (i.e. either upregulated in RNA-seq 
experiments from P7 GNPs in both Nfia cKO GNPs and Nfix-deficient GNPs, or downregulated in 
both). Of these 283 coordinated targets, 282 also possessed an associated NFIB ChIP-seq peak (Supp. 
Table 3), indicative of shared regulatory roles for all three NFI family members in GNP biology. (B) 
DAVID Gene Ontology analysis was performed on these 282 genes. The top five categories from 
each of Biological processes, Cellular components, KEGG pathways and Molecular functions 
identified are shown; full details can be found in Supp. Table 2. The p value was corrected using the 
Benjamani-Hochberg method. (C) Curated list of genes from DAVID analysis (Biological Processes), 
highlighting downstream NFI targets (upwards pointing arrow denotes mRNA upregulation in mutant 
GNPs, downwards pointing arrow denotes mRNA downregulation in mutant GNPs). (D) Analysis of 
ChIP-seq binding events for NFIA, NFIB and NFIX, showing the proportion of distal, promoter and 
genic binding. (E-J) Validation of potential NFI targets using qPCR. * p < 0.05; ** p < 0.01; *** p < 
0.001, t-test. 
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Supplementary Figure 1. Expression of Nfia, Nfib and Nfix within the embryonic rhombic 
lip. 
Sagittal sections of E14.5 mouse brains, showing the expression of Nfia (A), Nfib (B) and Nfix 
(C) within the rhombic lip (arrows in A-C). These data are derived from the online repository, 
GenePaint - https://gp3.mpg.de/. 
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Mice - genetically 
modified
tdTomato +/-; 
Math1 Cre ER+/- 
(breed)
Adults Mix Institutional 
Breeding Colony
36 36
Mice - genetically 
modified
NfiX +/- (Cull) Adults Mix Institutional 
Breeding Colony
516 357
Mice - genetically 
modified
Nfix delta neo 
Flox/Flox (cull)
Adults Mix Institutional 
Breeding Colony
468 468




Adults Mix Institutional 
Breeding Colony
522 522
Mice - genetically 
modified
Nfix delta neo 
Flox/+ ; Math1 
Cre ERT2+/- 
(cull)
Adults Mix Institutional 
Breeding Colony
558 487
Mice - genetically 
modified




Adults Mix Institutional 
Breeding Colony
846 846




Adults Mix Institutional 
Breeding Colony
540 540
Mice - genetically 
modified
Nfix delta neo 
Flox/+; tdTomato
+/- (cull)
Adults Mix Institutional 
Breeding Colony
540 540
Mice - genetically 
modified




Adults Mix Institutional 
Breeding Colony
558 558
Mice - genetically 
modified
NfiX delta neo 
flox/+; tdTomato 
+/-; Math1 Cre 
ERT2+/- (cull)
Adults Mix Institutional 
Breeding Colony
558 529
Mice - genetically 
modified





Adults Mix Institutional 
Breeding Colony
846 846





Adults Mix Institutional 
Breeding Colony
288 288




Adults Mix Institutional 
Breeding Colony
36 32




Adults Mix Institutional 
Breeding Colony
540 512
Mice - genetically 
modified
Math1 Cre +/- 
(breed)
Adults Mix Institutional 
Breeding Colony
36 36
Mice - genetically 
modified
Math1 Cre +/- 
(cull)
Adults Mix Institutional 
Breeding Colony
558 558




Adults Mix Institutional 
Breeding Colony
36 36




Adults Mix Institutional 
Breeding Colony
558 558
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Mice - genetically modified (Math1 Cre ERT2+/- (cull), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 522 522
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 522
Mice - genetically modified (Math1 Cre ER+/- (breed), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 36
Mice - genetically modified (Nfia flox/+:Math1 Cre +/- (breed), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Mod #1 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 36
Mice - genetically modified (Nfia flox/flox (breed), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Mod #1 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) -4 32
Mice - genetically modified (Nfia flox/+:Math1 Cre +/- (cull), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Mod #1 558 558
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 558
Mice - genetically modified (Nfia flox/flox (cull), Mix, Adults, Institutional Breeding Colony)
Mice - genetically modified (Math1 Cre +/- (cull), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Mod #1 558 558
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 558
Mice - genetically modified (Math1 Cre +/- (breed), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Mod #1 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 36
Description Amount Balance
Approval Details





Adults Mix Institutional 
Breeding Colony
72 62





Adults Mix Institutional 
Breeding Colony
846 767
Mice - genetically 
modified
NSD1 +/- (breed) Adults Mix Institutional 
Breeding Colony
36 34
Mice - genetically 
modified
NSD1 +/- (cull) Adults Mix Institutional 
Breeding Colony
720 720
Mice - non 
genetically 
modified






1)  The amount of animals shown on this certificate only includes your Breeders(s) and projected culled (ie wrong 
genotype, incorrect gender etc) limit.
2)  Progeny used for Colony maintenance should be reported on this project.
3)  Whilst estimated progeny are required on the application however the final numbers of progeny transferred to Research 
Project(s) must be reported only on the Research Project.
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Mice - genetically modified (Nfix delta neo Flox/+; tdTomato+/- (breed), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 36
Mice - genetically modified (NfiX delta neo flox/+; tdTomato +/-; Math1 Cre ERT2+/- (cull), Mix, Adults, Institutional 
Breeding Colony)
11 May 2016 Initial Approval 558 558
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) -29 529
Mice - genetically modified (NfiX delta neo flox/+; tdTomato +/-; Math1 Cre ER+/- (breed), Mix, Adults, Institutional 
Breeding Colony)
11 May 2016 Initial Approval 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) -3 33
Mice - genetically modified (Nfix delta neo Flox/+; tdTomato+/- (cull), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 540 540
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 540
Mice - genetically modified (Nfix delta neo flox/flox; Math1 Cre ER+/- (breed), Mix, Adults, Institutional Breeding 
Colony)
Mice - genetically modified (Nfix delta neo Flox/Flox (cull), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 468 468
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 468
Mice - genetically modified (Nfix delta neo Flox/Flox (breed), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 36
Mice - genetically modified (Nfia flox/flox:Math1 Cre +/- (cull), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Mod #1 846 846
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) -79 767
Mice - genetically modified (Nfia flox/flox:Math1 Cre +/- (breed), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Mod #1 72 72
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) -10 62
11 May 2016 Mod #1 540 540
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) -28 512
Mice - genetically modified (NfiX +/- (Breed), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) -10 26
Mice - genetically modified (Nfix delta neo Flox/+ ; Math1 Cre ERT2+/- (cull), Mix, Adults, Institutional Breeding 
Colony)
11 May 2016 Initial Approval 558 558
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) -71 487
Mice - genetically modified (Nfix delta neo Flox/+ ; Math1 Cre ER+/- (breed), Mix, Adults, Institutional Breeding 
Colony)
11 May 2016 Initial Approval 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) -5 31
Mice - genetically modified (NfiX +/- (Cull), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 516 516
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) -159 357
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Mice - genetically modified (tdTomato +/- (Cull), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 540 540
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 540
Mice - genetically modified (tdTomato +/- (Breed), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 36
Mice - genetically modified (NSD1 +/- (cull), Mix, Adults, Institutional Breeding Colony)
8 Jun 2016 Mod #2 480 480
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 480
10 May 2017 Mod #3 240 720
Mice - non genetically modified (C57BL/6 (breed), Mix, Adults, Institutional Breeding Colony)
10 May 2017 Mod #3 18 18
Mice - genetically modified (tdTomato +/-; Math1 Cre ERT2+/-  (cull), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 288 288
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 288
Mice - genetically modified (tdTomato +/-; Math1 Cre ER+/- (breed), Mix, Adults, Institutional Breeding Colony)
11 May 2016 Initial Approval 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 36
Mice - genetically modified (NSD1 +/- (breed), Mix, Adults, Institutional Breeding Colony)
8 Jun 2016 Mod #2 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) -2 34
Mice - genetically modified (NfiX delta neo flox/flox; tdTomato +/+ (Breed), Mix, Adults, Institutional Breeding 
Colony)
11 May 2016 Initial Approval 36 36
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 36
Mice - genetically modified (Nfix delta neo flox/flox; Math1 Cre ERT2+/- (cull), Mix, Adults, Institutional Breeding 
Colony)
11 May 2016 Initial Approval 846 846
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 846
11 May 2016 Initial Approval 72 72
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 72
Mice - genetically modified (Nfix delta neo flox/flox; tdTomato+/-; Math1 Cre ERT2+/- (cull), Mix, Adults, 
Institutional Breeding Colony)
11 May 2016 Initial Approval 846 846
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 846
Mice - genetically modified (Nfix delta neo flox/flox; tdTomato+/-; Math1 Cre ER+/- (breed), Mix, Adults, 
Institutional Breeding Colony)
11 May 2016 Initial Approval 72 72
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 72
Mice - genetically modified (NfiX delta neo flox/flox; tdTomato +/+ (Cull), Mix, Adults, Institutional Breeding 
Colony)
11 May 2016 Initial Approval 558 558
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22717) 0 558
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Please note the animal numbers supplied on this certificate are the total allocated for the approval duration
1. When ordering animals from Animal Breeding Houses
2. For labelling of all animal cages or holding areas.  In addition please include on the label, Chief Investigator's name and 
contact phone number.
3. When you need to communicate with this office about the project.
It is a condition of this approval that all project animal details be made available to Animal House OIC.
(UAEC Ruling 14/12/2001)
The Chief Investigator takes responsibility for ensuring all legislative, regulatory and compliance objectives are satisfied 
for this project.
This certificate supercedes all preceeding certificates for this project (i.e. those certificates dated before 16-May-2017)
Please use this Approval Number:
Cumbrae-Stewart Building
Research Road
Brisbane Qld 4072 Australia
Animal Welfare Unit
UQ Research and Innovation
The University of Queensland
+61 7 336 52925 (Enquiries)
+61 7 334 68710 (Enquiries)
+61 7 336 52713 (Coordinator)
animalwelfare@research.uq.edu.au
uq.edu.au/research
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Office of Research Ethics
Director
Nicole Shively
Animal Ethics Approval Certificate 23-Feb-2018
Please check all details below and inform the Animal Ethics Unit within 10 working days if anything is incorrect.
Activity Details
Chief Investigator: Associate Professor Michael Piper, Biomedical Sciences
Title: Assessing the role of NFIX in cerebellar development
AEC Approval Number: QBI/143/16/NHMRC/ARC
Previous AEC Number:
Approval Duration: 17-May-2016 to 17-May-2019
Funding Body:
Group: Anatomical Biosciences
Other Staff/Students: Tracey Harvey, Kim Woolley, Oressia Zalucki, Michelle Sanchez Vega, James Fraser, 
Kevin Mutemi, Raul  Ayala Davila, Danyon  Harkins, David Hollingsworth, Suzy 
Alexander, Raquelle Ludwig, Thomas Burne, Maria Kashermann, Jack Wood, Sazia 
Sharmin
Summary
Subspecies Strain Class Gender Source Approved Remaining
Mice - genetically 
modified
Nfix delta neo 
flox/flox; Math1 
Cre ER+/-
Adults Mix 168 168
Mice - genetically 
modified
Nfix delta neo 
flox/flox; Math1 
Cre ER+/-
Juvenile / Weaners 
/ Pouch animal
Mix 920 920
Mice - genetically 
modified
Nfix ko Juvenile / Weaners 
/ Pouch animal
Mix 920 920
Mice - genetically 
modified
Nfix ko Prenatal / Embryo Mix 336 336
Mice - genetically 
modified




Juvenile / Weaners 
/ Pouch animal
Mix 1050 1050
Mice - genetically 
modified
Nfix ko Adults Female 56 56





Adults Mix Institutional 
Breeding Colony
84 84










Mice - genetically 
modified
NSD1 +/- Adults Mix Institutional 
Breeding Colony
20 20
Mice - genetically 
modified





Location(s): St Lucia Bldg 79 - Queensland Brain Institute
Cumbrae-Stewart Building
Research Road
St Lucia Qld 4072 Australia
Animal Ethics Unit
Office of Research Ethics
The University of Queensland
+61 7 336 52925 (Enquiries)
+61 7 334 68710 (Enquiries)
+61 7 336 52713 (Coordinator)
animal.ethics@research.uq.edu.au
uq.edu.au/research
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Mice - genetically modified (Nfix delta neo flox/flox; tdTomato+/-; Math1 Cre ER+/-, Mix, Juvenile / Weaners / Pouch 
animal, )
11 May 2016 Initial approval 1050 1050
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) 0 1050
Mice - genetically modified (Nfix delta neo flox/flox; Math1 Cre ER+/-, Mix, Juvenile / Weaners / Pouch animal, )
11 May 2016 Initial approval 920 920
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) 0 920
Mice - genetically modified (NSD1 +/- , Mix, Juvenile / Weaners / Pouch animal, Institutional Breeding Colony)
Mice - genetically modified (Nfix ko, Female, Adults, )
11 May 2016 Initial approval 56 56
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) 0 56
Mice - genetically modified (NSD1 +/- , Mix, Adults, Institutional Breeding Colony)
8 Jun 2016 Mod #3 20 20
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) 0 20
Mice - genetically modified (Nfix ko, Mix, Prenatal / Embryo, )
11 May 2016 Initial approval 336 336
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) 0 336
Mice - genetically modified (Nfix ko, Mix, Juvenile / Weaners / Pouch animal, )
11 May 2016 Initial approval 920 920
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) 0 920
Mice - genetically modified (Intersectin Knockout (Tissue Only), Mix, Adults, Institutional Breeding Colony)
18 Apr 2017 Mod #5 10 10
Mice - genetically modified (Nfix delta neo flox/flox; Math1 Cre ER+/-, Mix, Adults, )
11 May 2016 Initial approval 168 168
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) 0 168
Mice - genetically modified (Nfia flox/flox:Math1 Cre +/- , Mix, Juvenile / Weaners / Pouch animal, Institutional 
Breeding Colony)
8 Jun 2016 Mod #2 460 460
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) -70 390
Mice - genetically modified (Nfia flox/flox:Math1 Cre +/- , Mix, Adults, Institutional Breeding Colony)
11 May 2016 Mod #2 84 84
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) 0 84
Description Amount Balance
Approval Details
Mice - genetically 
modified
NSD1 +/- Prenatal / Embryo Mix Institutional 
Breeding Colony
40 40





Adults Mix Institutional 
Breeding Colony
10 10
Mice - non 
genetically 
modified
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Please note the animal numbers supplied on this certificate are the total allocated for the approval duration
1. When ordering animals from Animal Breeding Houses
2. For labelling of all animal cages or holding areas.  In addition please include on the label, Chief Investigator's name and 
contact phone number.
3. When you need to communicate with this office about the project.
It is a condition of this approval that all project animal details be made available to Animal House OIC.
(UAEC Ruling 14/12/2001)
The Chief Investigator takes responsibility for ensuring all legislative, regulatory and compliance objectives are satisfied 
for this project.
This certificate supercedes all preceeding certificates for this project (i.e. those certificates dated before 23-Feb-2018)
Please use this Approval Number:
Mice - non genetically modified (C57BL/6J , Mix, Juvenile / Weaners / Pouch animal, )
11 May 2016 Initial approval 1842 1842
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) -13 1829
Mice - genetically modified (NSD1 +/- , Mix, Prenatal / Embryo, Institutional Breeding Colony)
8 Jun 2016 Mod #3 40 40
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) 0 40
8 Jun 2016 Mod #3 110 110
31 Dec 2016 Use in 2016 (from 2017 MAR; AEMAR22705) 0 110
Cumbrae-Stewart Building
Research Road
St Lucia Qld 4072 Australia
Animal Ethics Unit
Office of Research Ethics
The University of Queensland
+61 7 336 52925 (Enquiries)
+61 7 334 68710 (Enquiries)
+61 7 336 52713 (Coordinator)
animal.ethics@research.uq.edu.au
uq.edu.au/research
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